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Introduction and Tasks of the Thesis 
 
Palladium catalyzed transformations have gained remarkable importance for C-C bond 
formation; these reactions are being used for the synthesis of a number of natural products, 
pharmaceutical drugs and advanced materials. The aim of this work is to enhance the scope of 
palladium catalyzed reactions. In recent years, site-selective palladium(0)-catalyzed cross-
coupling reactions of di- and trihalogenated molecules or the corresponding triflates have 
been studied. The Langer group has also greatly contributed to this. This paragraph outlines 
the tasks of this thesis. A more detailed introduction is given at the beginning of each 
individual chapter.  Heck cross coupling reactions using substituted acrylates and styrenes on 
1-bromopyrene was the primary task in the research work. 
R
O
O
R
 
I have also studied the site-selectivity of palladium catalyzed transformations of a number of 
mono- and difluoro-substituted dibromo benzenes. Site-selective reactions of the substrates 
discussed in the thesis have not been previously studied by other research groups. 
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Although a diverse set of substrates were studied, the general topic of this thesis was to 
develop new polyiodinated benzene derivatives and their application as substrates in 
Sonogashira reactions for the synthesis of polyethynylbenzenes. 
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In continuation of the task, the synthesis of polyarylbenzenes was also performed by the 
application of the Suzuki-Miyaura cross coupling protocol. 
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Based on this, an important goal was to study the absorption and fluorescence properties of all 
products. 
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Chapter 1.  Synthesis and Properties of 1-Alkenylpyrenes  
 
1  Synthesis and Properties of 1-Alkenylpyrenes  
1.1 Introduction  
1.1.1 Photochemical Properties of Pyrene 
 
A critical photoactive component in supramolecular complexes and organic light emitting 
diodes is pyrene which has been selected for the present work, since it is by far the most 
frequently used dye in fluorescence studies of labeled polymers. Also, polycyclic aromatic 
hydrocarbons (PAH) and π-conjugated systems are interesting as fluorescent dyes,1 optical 
sensors, molecular electronics,2 nonlinear optical materials, light emitting diodes, photovoltaic 
cells and field-effect transistors.3 
 
Pyrene has a reasonable excited state life time (650 ns) and shows a strong emission at 372 
nm. Pyrene fluorescence has led to its use in various sensor applications where fluorescence 
quenching is a useful reported characteristic. Pyrene readily forms excimers. Moreover, it acts 
as an energy acceptor via nonradiative energy transfer from several dyes and the vibronic 
band structure of its emission is sensitive to the environment.4 Our interest to make pyrene a 
part of our research interest is due to the high symmetry and interesting electronic structure of 
this polynuclear aromatic compound. The pyrene nucleus has three C2 axes which allow some 
symmetry to be retained in various mono- and disubstituted derivatives. Also the pyrene 
nucleus is electroactive, having an oxidation potential of +1.28 V and a reduction potential of 
-2.09 V.5 Pyrene has a strong chromophore that extends over the whole molecule. 
 
The pyrene absorption spectrum has three prominent monomer absorption peaks at 314 nm, 
328 nm and 344 nm. Absorption of a photon by the ground state of pyrene leads to the 
formation of excited states (1Py* and 3Py), which can either fluoresce with its natural lifetime 
(τM, usually in the 200-300 ns range) in the blue region of the visible light spectrum or 
encounter another ground-state pyrene.6 The emission spectrum of pyrene in the blue region 
has also three prominent monomer emission peaks at 370 nm, 380-381 nm, and 390-391 nm. 
When the local concentration of pyrene is high, the excited pyrene molecule may bind to a 
ground-state pyrene molecule to form an excimer. The broad excimer fluorescence emission 
peak is observed at 470 nm (Ie). The ratio of two monomer peaks I1/I3 is sensitive to the micro 
17 
 
environmental polarity around the pyrene molecule,7 and the excimer to monomer 
fluorescence intensity ratio. Ie/Imon, for solubilized pyrene has been used to evaluate its 
distribution among micelles. Because excimer fluorescence requires dimerization during an 
excited-state lifetime, a minimum of two pyrenes per micelle is required for solubilized 
pyrene to produce excimer emission.8 
 
A problem related to these systems is based on the fact that their emission in the solid state is 
suppressed by the formation of excimers by π-π-stacking.9 The fluorescence properties of 
parent pyrene are well known and characterized by long excited state life times and distinct 
solvatochromic shifts. Furthermore, pyrene exhibits a characteristic excimer formation in 
concentrated solutions and in the solid state, due to self association by π-π-stacking.10 These 
effects are disadvantageous because they lead to a dramatic decrease of the fluorescence and 
to less defined, broadened fluorescence spectra. Therefore, excimer formation of pyrene can 
be used to study the phenomenon of aggregation. In addition, the sensitive solvatochromic 
shifts of pyrene have been used to explore the inner structure and polarity of dendrimers by 
introducing pyrene in the outer and inner area of the dendritic structure.11 Intramolecular 
charge transfer (ICT) in organic systems has been widely investigated in order to understand 
the factors controlling the charge separation and charge recombination.12 Substituted pyrenes 
show interesting fluorescence properties and good quantum yields along with efficient 
excimer emission.13 In fact, pyrene derivatives, containing appropriate substituents, have been 
applied as fluorescent biological probes,14 as components of photoelectric devices, and as 
liquid crystalline materials.15 The synthesis and photophysical properties of substituted 
pyrenes have been previously studied. For example, 1-arylpyrenes have been prepared by 
Suzuki-Miyaura reactions of monohalogenated pyrenes.16 In my thesis, I have synthesized, 1-
alkenylpyrenes by what are, to the best of my knowledge, the first Heck cross-coupling 
reactions of 1-bromopyrenes. The products contain a pyrene moiety linked to donor and 
acceptor substituents through an alkenyl bridge. The absorption and fluorescence properties 
and the electrochemical characteristics of the products have been studied. The electrochemical 
band gaps are correlated with the HOMO-LUMO energy gaps derived from photophysical 
measurements and from theoretical calculations performed by density functional theory 
(DFT) calculations. 
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In the present studies, the Heck type reaction of 1-bromopyre with electron withdrawing and 
electron donating substituted styrenes and acrylates has been reported. This type of reaction 
gives rise to the products in an excellent yield. 
1.2 Results and Discussion 
1.2.1 Synthesis of styrene sunbtituted ethenylpyrenes 
 
The parent pyrene 1 was used as a starting point of our synthetic strategy for the synthesis of 
different styrenes. To realize the syntheses of 4a-i, pyrene 1 was treated first with NBS to 
afford 1-bromopyrene 2 (Scheme 1) according to a known procedure.17 The Heck reaction of 
2-bromopyrene 2 with styrenes 3a-i (1.2 equiv.) afforded the 2-alkenylpyrenes 4a-i and in 72-
94% yields (Scheme 2 Table 1). The best yields were obtained when the reactions were 
carried out using Pd(OAc)2 (5 mol%) and the biarylmonophosphine ligand XPhos (10 mol%). 
The use of Pd(PPh3)4 as the catalyst proved to be unsuccessful. The reaction was carried out in 
DMF at 60-70 °C for 5-6 hours. The yields significantly decreased when the temperature was 
increased. The use of potassium carbonate as the base proved to be very important. The 
employment of triethylamine resulted in the formation of an unseparable mixture of products, 
partly due to hydrogenation of the double bond. 
 
The structures of all products were established by spectroscopic techniques. The structures of  
4a, and 4i have been independently confirmed by X-ray crystal structure analyses (Figures 1-
2). In the crystal structure 4e and 4i the aryl moiety seems to be twisted out of plan.   
                    
Scheme 1. Synthesis of 1-bromopyrene 
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Scheme 2. Synthesis of 4a–i. Conditions: (i) 1 (1.0 equiv), 3a–i (1.2 equiv), K2CO3 (2.0 
equiv), Pd(OAc)2  (5 mol %), X-Phos (10 mol-%), DMF, 80 °C, 6 h. 
 
                                    Table 1. Synthesis of 4a-i 
3,4 Ar 4 (%)a 
a 4-MeC6H4 92 
b 4-(MeO)C6H4 89 
c C6H5 79 
d 4-(tBuO)C6H4 86 
e 4-ClC6H4 72 
f C6F5 76 
g 4-tBuC6H4 94 
h 2-pyridine 88 
i 4-(AcO)C6H4 77 
                                                      a Yields of isolated products 
 
1.2.2 Synthesis of acrylate substituted pyrenes  
 
Using the same protocol as above, the Heck reaction of 1-bromopyrene 2 with acrylates 5a-i 
(1.2 equiv.) gave 1-alkenylpyrenes 6a-j in 74-93% yield, (Schemes 3, Table 2). The structures 
of all products were also proved by spectroscopic techniques. The structure of 6a, has been 
independently confirmed by X-ray crystal structure analysis (Figures 3). The crystal sructure 
shows that aromatic group is in plane with the pyrene moiety.  
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Scheme 3. Synthesis of 6a–j. Conditions: (i) 1 (1.0 equiv), 5a–j (1.2 equiv), K2CO3  (2.0 
equiv), Pd(OAc)2  (5 mol %), X-Phos (10 mol %),DMF, 80 °C, 6 h. 
 
 
                                           Table 2. Synthesis of 6a-j 
5,6 R 6 (%)a 
a CO2nBu 84 
b CO2Et 87 
c CO2iOct 79 
d CO2nHex 80 
e CO2iBu 86 
f CO2tBu 93 
g CO2Me 90 
h CO2R b 88 
i CO2(CH2)CF3 83 
j CO2(CH2)2OH 74 
                                           a Yields of isolated products; b R = 2-ethylhexyl 
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Table 3. Optimization of the synthesis of 4b 
Entry Catalyst Ligand T (°C) Base t (h) Yield (%)a 
1 10%Pd(OAc)2 10%XPhos 120 Triethanolamine 12 0 
2 10%Pd(PPh3)4 - 120 K2CO3 12 0 
3 5% Pd(OAc)2 10%XPhos 110 NEt3 10 mixture 
4 5% Pd(OAc)2 10%XPhos 100 K2CO3 10 60 
5 5% Pd(OAc)2 10%XPhos 80 K2CO3 8 70 
6 5% Pd(OAc)2 10%XPhos 60-70 K2CO3 6-7 94 
 a Isolated yields 
 
 
 
 
 
Figure 1. Crystal structure of 4e 
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Figure 2. Crystal structure of 4i 
 
Figure 3. Crystal structure of 6a 
 
1.2.3 Absorption and fluorescence properties of pyrene compounds 
 
 The UV-Vis absorption spectra of compounds 4i,b,d,e and 6e (Table 4) recorded in 
acetonitrile, are shown in Figure 4. Compounds 4i and 4e (bearing electron acceptor groups) 
show a slight red shift with absorption maxima at about 375 nm and a shoulder at 390 nm. 
Compounds 4b and 4d (bearing electron donating groups) and acrylate 6e show two 
absorptions at about 275 nm and 350 nm. Parent pyrene exhibits absorption at about 275 nm.  
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Figure 4. UV-Vis spectra of 4i,b,d,e and 6e (DCM, c = 10-5 M) 
 
                     Table 4. Assigned transitions of 4i,b,d,e and 6e 
 λ1abs [nm] λ2abs [nm] λ3abs [nm] 
4j 280 293 373 
4b 268 280 347 
4d 267 279 347 
6e 266 280 347 
4e 280 293 374 
         (DCM, c = 10-5 M) 
 
The fluorescence emission spectra of 4i,b,d,e (Table 5) (excitation wavelength λex = 373 nm), 
again recorded in CH3CN, show two bands at approx. 420 nm and 440 nm (Figure 5). The 
emissions of 4b and 4d (bearing electron donating groups) are shifted to higher wavelenghths 
compared to 4i,e. The spectrum of acrylate 6e exhibits one emission at 455 nm.  
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Figure 5. Fluorescence spectra of 4i,b,d,e and 6e (DCM, c = 10-6 M) 
 
                                     
                       Table 5. Assigned transitions of 4i,b,d,e and 6e 
 λ4em [nm] λ5em [nm] λ6em [nm] 
4j 420 443 - 
4b 422 443 - 
4d 417 434 - 
6e - - 455 
4e 426 446 - 
Emissions of 4i,b,d,e and 6e measured in (DCM, c = 10-6 M) 
 
Furthermore I have carried out solvatochromic studies for the UV-Vis absorption and 
fluorescence (Figures 6-10). In the UV-Vis spectra of 4e, j, containing electron-withdrawing 
substituents, a red shift is observed for DMSO (15 nm) and DMF (10 nm) compared to 
acetonitrile. For unpolar solvents, like hexane, a slight blue shift (5 nm) is observed. On the 
other hand, a different effect is observed for pyrenes 4b and 4d containing electron-donating 
substituents. The use of hexane causes a significant red shift (20 nm). For compound 4b, a 
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new absorption band is observed at about 375 nm. For acrylate 6e, a slight red shift (10 nm) is 
observed for DMSO and a blue shift (10 nm) is observed for hexane. 
 
Figure 6. Solvatochromic effects (absorption) for 4i (c = 10-6 M) 
 
Figure 7. Solvatochromic effects (absorption) for 4b (c = 10-6 M) 
26 
 
 
 Figure 8. Solvatochromic effects (absorption) for 4d (c = 10-6 M) 
             
 
Figure 9. Solvatochromic effects (absorption) for 6e (c = 10-6 M) 
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Figure 10. Solvatochromic effects (absorption) for 4e (c = 10-6 M) 
 
The fluorescence emission spectra also show an influence of the solvent (Figures 11-15). 
Pyrenes 4e,i containming electron-withdrawing substituents, show a slight red shift (5-10 nm) 
compared to acetonitrile. For pyrenes 4b,d, containing electron-donating substituents, a red 
shift is observed for DMSO (20 nm) and for DMF (10 nm). For acyrlate 6e a slight blue shift 
(10 nm) is observed for dichloromethane, DMSO and DMF. The strongest blue shift (approx. 
30 nm) was observed for hexane, EtOAc, THF, and dioxane. Furthermore, in dioxane and 
EtOAc a new emission band appears at about 445 nm. 
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Figure 11. Solvatochromic effects (fluorescence) for 4i (c = 10-6 M) 
 
 
Figure 12. Solvatochromic effects (fluorescence) for 4b (c = 10-6 M) 
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Figure 13. Solvatochromic effects (fluorescence) for 4d (c = 10-6 M) 
 
 
Figure 14. Solvatochromic effects (fluorescence) for 6e (c = 10-6 M) 
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Figure 15. Solvatochromic effects (fluorescence) for 4e (c = 10-6 M) 
 
1.2.4 Measurements of electrochemical properties pyrene compounds 
 
Cyclo-voltammetric measurements were carried out to determine the electrochemical activity 
and to derive the potential values of the 1-alkenylpyrenes. Figure 16 shows the influence of 
different substituents on the oxidation potential. Most of the substrates exhibit two oxidation 
peaks. One of them is always located at 1.4 V, this peak is only weakly developed and it can 
also be found in the DPV of the starting material. The second oxidation peak is mostly well 
developed and is located between 1.0 and 1.2 V. The exact position of this peak depends on 
the type of substituent. For pyrenes containing electron-withdrawing substituents (4e,i) a 
slight shift to negative potential (1,05 V) is observed. For pyrenes 4b,d, containing electron-
donating substituents, a slight shift to positive potential (1,15 V) is observed. 
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Figure 16.  Oxidative DPVs of different substituted pyrenes in DMF (0.1 M TBABF4); 
working electrode: platinum 
 
 
1.2.5 Computational studies of pyrene compounds 
 
In order to get a better understanding of the geometric and electronic structure of the 
molecules, Sebastian Reimann (Group of Prof. Langer) carried out density functional theory 
(DFT) calculations, using Becke’s three parameter set with Lee-Yang-Parr modification 
(B3LYP) using a 6-31G* basis set of theory. The calculated HOMO and LUMO surfaces of 
the molecules along with their electrostatic potential maps in the ground states, the dipole 
moments and the calculated HOMO-LUMO energy gap are given in Figure 17. The 
calculations suggest that the 1-alkenylpyrenes are slightly twisted out of plane. The slight 
twisting might be a result of steric interactions and will not significantly disturb the 
conjugation. However, the X-ray crystal structures show that the pyrene moiety, the double 
bond and the phenyl ring (for products 4) are in plane in the solid state. This result suggests 
that the planar structures in the solid state might be a result of the crystal packing. In case of 
pyrene 6e, the HOMO and the LUMO are nearly fully localized on the pyrene moiety. In case 
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of 4e,i,b,d, the HOMO and the LUMO are spread all over the molecule. The localization of 
HOMO and LUMO on either side of the alkenyl linkage (with contribution from the alkene to 
both HOMO and LUMO) suggests that the alkene acts as a conjugation bridge in all the 
molecules.  
 
The electrostatic potential maps are supposed to indicate the drifting of charges in the 
molecules dependent on the type of substituents. In case of 4d the strong donor group leads to 
an increase of the charge on the alkenyl moiety. This effect is also obvious in case of 4b 
containing a weaker electron-donating group. In case of 4e, the electron-withdrawing group 
leads to a decrease of the charge on the alkenyl moiety. In case of acrylate 6e, the charge is 
mainly located on the pyrene and the carboxylate moiety which also slightly increases the 
charge on the alkenyl moiety. 
  
Compound 6e 4e 4j 4b 4d 
Potential 
    
LUMO 
     
HOMO 
    
Geometry 
     
µcalc(D) 2.535 2.218 1.694 1.951 1.563 
∆Ecalc 
HOMO-
LUMO  
3.338 3.278 3.287 3.2681 3.2912 
 
Figure 17.  DFT calculated ground-state geometries (with dipole vectors), HOMO, LUMO, 
and potential energy surfaces of 1-alkenylpyrenes 
33 
 
Inspection of the energy levels of the HOMO and LUMO of the 1-alkenylpyrenes show that 
electron donating groups (4b,d) cause a slight increase of both energy levels, while electron-
withdrawing groups (4e,j) effect a decrease of the energy levels (Figure 18). 
 
 
Figure 18. HOMO-LUMO energy levels (this energy level diagram shows the influence of 
the donor substituents on the HOMO and LUMO energies) 
 
 
1.3 Conclusions 
 
In conclusion, 1-alkenylpyrenes were prepared by Heck reaction of 1-bromopyrene with 
styrenes and acrylates. The absorption and emission spectroscopic properties of the products 
were studied. The electrochemical characteristics were also studied. The electrochemical band 
gaps are correlated with the HOMO-LUMO energy gaps derived from photophysical 
measurements and from theoretical calculations performed by density functional theory 
(DFT) calculations. The results suggest that the alkene act as a conjugation bridge in all the 
molecules. 
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Chapter 2. Synthesis of Terphenyls by Site-Selective Suzuki-Miyaura Reactions 
 
2  Synthesis of Terphenyls from Mono- and Difluorinated Bromobenzenes by Site- 
Selective Suzuki-Miyaura Reactions 
 
2.1 General Introduction 
Chemists have always been interested in finiding new methods for the formation of carbon-
carbon bonds. These reactions very much smooth the progress of the construction of complex 
molecules from simple precursors. The Grignard, Diels–Alder, and Wittig reaction have been 
of great use in this regard in the last century. But for the last three decades transition metal-
catalyzed reactions, particularly palladium(0)-catalyzed transformations, have gained 
significant value for carbon-carbon bond formation and many new ideas have been tested and 
realized.18 Currently, these reactions are being used for the synthesis of a number of natural 
products, pharmaceuticals and advanced materials.19-21 The most commonly applied 
palladium-catalyzed carbon–carbon bond forming reactions in total synthesis are, namely, the 
Heck,22 Stille,23 Suzuki,24 Sonogashira,25 Tsuji–Trost,26 and the Negishi27 reaction. The 
mechanisms of these reactions are similar. The first step is usually the oxidative addition of 
organic halides or triflates to the Pd(0) complex to form organopalladium halides. The 
following step is, in case of the Suzuki, Sonogashira and Stille reaction, often a 
transmetallation with nucleophilic compounds to give a diorganopalladium complex. This 
complex undergoes a reductive elimination to create carbon-carbon bond and regeneration of 
the catalyst. 
The Suzuki-Miyaura reaction is the reaction that gained much significance for its 
effectiveness for the cross-coupling between halides and organoboronic acids.28 Advances 
made in this field include the improvement of new catalysts and modern methods have greatly 
increased the scope of this reaction and is now considered to be a quite general procedure for 
a wide range of selective carbon-carbon bond formations.29 The scope of the reaction partners 
is not only restricted to arenes, but includes also alkyl, alkenyl and alkynyl compounds. 
 
The mechanism of the Suzuki reaction involves the oxidative addition of organic 
halides or triflates to the Pd(0) complex to form a organopalladium halide (R1-Pd(II)-X). This 
step is followed by transmetallation with a boronic acid derivative or a borane to give a 
diorganopalladium complex (R1-Pd-R2). This complex undergoes a reductive elimination with 
carbon-carbon bond formation and regeneration of the catalyst.30-33 The reactivity order of 
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aryl halides and aryl triflates which act as electrophiles, is Ar-I > Ar-Br > Ar-OTf > Ar-Cl. 
The use of base accelerates the transmetalation. This is due to the increase of the carbanion 
character of the organoborane moiety by formation of an organoborate containing a 
tetravalent boron atom. The selection of a proper catalyst plays an important role in the 
success of the desired reaction. The common palladium sources employed include, for 
example, Pd(OAc)2, PdCl2, Ph(PPh3)2Cl2, and Pd(dba)2. The use of bulky electron-rich 
ligands is often the key for a successful transformation. The ferrocenylphosphine,34 N-
heterocyclic carbenes,35 P(tBu)3,36 P(Cy)3 often give a good yields. 
 
Suzuki-Miyaura reactions37 in particular are very attractive, due to the stability of the 
precursors, boronic acids, and facility of work up. In this reaction even an alkyl group (i.e. 
sp3-hybridized C atom), as opposed to the more traditionally used vinyl or aryl groups, can be 
transferred from the organoborane component during the palladium-catalyzed coupling 
process with vinyl or aryl halides or triflates. Compared to Stille reactions,38 Suzuki–Miyaura 
couplings have a much broader scope in a potentially vast range of alkyl boranes (typically 
prepared through the regio- and chemoselective hydroboration of readily available alkene 
precursors) can be employed in the reaction.38 The interest of the chemist in this field is 
evident from the continuous developments in the use of new reaction conditions, catalysts and 
ligands.40-42  
 
2.1.1  Introduction 
Fluorinated arenes are often biologically active and thus interesting compounds which find 
many uses as pharmacologically active substances, agrochemicals, or as building blocks for 
their synthesis.43 Fluorinated molecules are increasingly used in the pharma and crop 
protection industry. This is due to the fact that strategically placed fluorine atoms often have a 
positive influence on the biological properties of active compounds.44 For this reason 
synthetic methods for the selective preparation of specifically fluorinated intermediates and 
building blocks are of high importance. 
The fluorine compounds are the least abundant natural organohalides.45 Until 1957, no 
fluorine containing drug had been developed. Since then, over 150 fluorinated drugs have 
come to market and now make about 20% of all pharmaceuticals46, with even higher figures 
for agrochemicals up to 30%.47 
A large number of known pharmaceutical and agrochemical products contain fluorinated 
arenes which enhance solubility, bioavailability and metabolic stability compared with non-
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Fluorinated analogues.48 Fast progress in this area has been fuelled by the development of 
new fluorination processes increasing the range of synthetic fluorinated building blocks 
acquiescent to functional group manipulation. The strategic use of fluorine substitution in 
drug design has culminated with the production of some of the key drugs available in the 
market.49 
The site-selectivity of these reactions is generally influenced by electronic and steric 
parameters.50 Our research group has already reported site-selective Suzuki-Miyaura (S-M) 
reactions of tetrabrominated thiophene, N-methylpyrrole, selenophene, and of other 
polyhalogenated heterocycles.51 Site-selective S-M reactions of the bis(triflate) of methyl 2,5-
dihydroxybenzoate have also been studied.52 Site-selective palladium(0)-catalyzed cross-
coupling reactions of dibromides, diiodides or bis(triflates) of fluorinated arenes have, to the 
best of our knowledge, not been reported to date. 
 
2.2 Results and discussion 
2.2.1  One pot synthesis of difluorinated ortho-terphenyls by site-selective Suzuki 
reactions of 1,2-dibromo-3,5-difluorobenzene 
In the following section, first results of my study related to S–M reactions of 1,2-dibromo-3,5-
difluorobenzene are reported. The products, difluorinated ortho-terphenyls, are not readily 
available by other methods. The S–M reaction of commercially available 1,2-dibromo-3,5-
difluorobenzene 7 with two equivalents of arylboronic acids 8a–e,h,p,s,t (Table 6) afforded 
the difluorinated ortho-terphenyls 9a–i in moderate to good yields (Scheme 4, Table 7). The 
best yields were obtained using 2.2 equivalents of the arylboronic acid, Pd(PPh3)4 (0.03 
equiv) as the catalyst, and Cs2CO3 (2.2 equiv) as the base (1,4-dioxane, 90 °C, 8 h) 
          Table 6. Aryl boronic acids 
  Ar-B(OH)2    Ar-B(OH)2 
8 Ar 8 Ar 
a C6H5 l 4-(Acetyl)C6H4 
b 4-MeC6H4 m 3,5-(Me)2C6H3 
c 2-(MeO)C6H4 n 3-ClC6H4 
d 4-(MeO)C6H4 o 4-ClC6H4 
e 4-(EtO)C6H4 p 4-FC6H4 
f 3,4-(MeO)2C6H3 q 4-CF3C6H4 
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g 2,6-(MeO)2C6H3 r 2-(MeO)C6H4 
h 2,4-(MeO)2C6H3 s 3-(MeO)C6H4 
i 4-(Vinyl)C6H4 t 3-MeC6H4 
j 4-(tBu)C6H4 u 2-Thienyl 
k 4-(tBuO)C6H4 v 2,3-(MeO)2C6H3 
 
 
 
Scheme 4. Synthesis of 9a–i. Reagents and conditions: i, 7 (1.0 equiv), 8a–e,h,p,s,t (2.2 
equiv), Cs2CO3 (2.2 equiv), Pd(PPh3)4 (3 mol%), 1,4-dioxane, 90 °C, 8 h. 
 
  Table 7. Synthesis of 9a-i 
8 9 Ar Yields of 9 (%)a 
a a C6H5 65 
b b 4-MeC6H4 45 
c c 2-(MeO)C6H4 60 
d d 4-(MeO)C6H4 70 
e e 4-(EtO)C6H4 68 
h f 2,4-(MeO)2C6H3 58 
p g 4-FC6H4 45 
s h 3-(MeO)C6H4 70 
t i 3-MeC6H4 48 
 aYields of isolated products 
 
The S–M reaction of 7 with arylboronic acids 8b-h,p (1.0 equiv) afforded the 2-bromo-3,5-
difluoro-biphenyls 10a–h in good yields and with very good site selectivity (Scheme 5, Table 
8). The formation of the opposite regioisomer was not observed. 
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Scheme 5. Synthesis of 10a–h. Reagents and conditions: i, 7 (1.0 equiv), 8b-h,p (1.0 equiv), 
Cs2CO3 (1.5 equiv), Pd(PPh3)4 (3 mol%), 1,4-dioxane, 90 °C, 9 h. 
 
     Table 8. Synthesis of 10a-h 
8 10 Ar Yields of 10 (%)a 
b a 4-MeC6H4 45 
c b 2-(MeO)C6H4 60 
d c 4-(MeO)C6H4 60 
e d 4-(EtO)C6H4 65 
f e 3,4-(MeO)2C6H3 60 
g f 2,6-(MeO)2C6H3 68 
h g 2,4-(MeO)2C6H3 67 
p h 4-FC6H4 63 
aYields of isolated products 
 
The one-pot reaction of 1,2-dibromo-3,5-difluorobenzene with two different arylboronic acids 
afforded the unsymmetrical difluorinated ortho-terphenyls 11a–g containing two different 
terminal aryl groups (Scheme 6, Table 9) 
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Scheme 6. One-pot synthesis of 11a–g. Reagents and conditions: i, 1 (1.0 equiv), 8b-d,g,h,p 
(1.0 equiv), Cs2CO3 (1.5 equiv), Pd(PPh3)4 (3 mol%), 1,4-dioxane, 90 °C, 8 h; 2) 8a-b,h,o,r 
(1.2 equiv), Cs2CO3 (1.5 equiv), 90 °C, 8 h. 
 
 
Table 9. Synthesis of 11a-g 
8 11 Ar1 Ar2 Yield of 11(%)a 
b,h a 4-MeC6H4 2,4-(MeO)2C6H3 56 
d,r b 4-(MeO)C6H4 2-MeC6H4 68 
d,a c 4-(MeO)C6H4 C6H5 70 
c,b  d 2-(MeO)C6H4 4-MeC6H4 62 
g,b e 2,6-(MeO)2C6H3 4-MeC6H4 60 
h,b  f 2,4-(MeO)2C6H3 4-MeC6H4 48 
p,o  g 4-FC6H4 4-ClC6H4 45 
aYields of isolated products 
The structures of all products were established by spectroscopic methods. The structures of 9b 
and 10f were independently confirmed by X-ray crystal structure analyses (Figure 19 and 
Figure 20). The aryl group at positon 1 of structure 9b is twisted out of plane whereas the aryl 
group at position 2 is in plane. In case of stucture 10f the aryl groups are slightly out of plane. 
40 
 
 
Figure 19. Ortep plot of 9b 
 
 
 
Figure 20. Ortep plot of 10f 
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The structure of compound 10g has also been confirmed by 2D NMR (NOESY; HMBC) 
(Figure 21). H-6 of the ring B resonating at δ = 7.08 ppm showed a clear and important 
NOESY correlation with the H-6 of ring A resonating at δ = 6.89 ppm. This proved the 
connectivtity of aryl group at C-1 of ring A. HMBC correlation of H-6 with carbon C-1 of 
ring A again confirmed that the aryl group is attached at the carbon C-1 of ring A.  
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Figure 21. 
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2.2.2 One pot synthesis of fluorinated terphenyls by site-selective Suzuki-Miyaura 
reactions of 1,4-dibromo-2-flourobenzene 
The S–M reaction of commercially available 1,4-dibromo-2-fluorobenzene 12 with 2 equiv. 
of arylboronic acids 8b,d,f,h-j,l,p,t,u afforded the fluorinated para-terphenyls 13a–k in 
moderate to good yields (Scheme 7, Table 10). The best yields were obtained using 2.2 equiv. 
of the arylboronic acid, Pd(PPh3)4 (0.03 equiv) as the catalyst and Cs2CO3 (2.2 equiv) as the 
base (1,4-dioxane, 90 °C, 8 h). The S–M reaction of 12 with arylboronic acids 8b,d,f,i,j,n,o 
(1.0 equiv) afforded the biaryls 14a–h in good yields and with very good site selectivity 
(Scheme 8, Table 11). The formation of the opposite regioisomers was not observed. 
 
 
Scheme 7. Synthesis of 13a–k. Conditions: (i) 1 (1.0 equiv), 8b,d,f,h-j,l,p,t,u (2.2 equiv), 
Cs2CO3 (2.2 equiv), Pd(PPh3)4 (3 mol %), 1,4-dioxane, 90 °C, 6–8 h. 
 
Table 10.   Synthesis of 13a-k 
8 13 Ar Yields of 13 (%)a 
b a 4-MeC6H4   60 
d b 4-(MeO)C6H4   52 
e c  4-(EtO)C6H4  65 
f d 3,4-(MeO)2C6H3  58 
h e 2,4-(MeO)2C6H3  63 
i f 4-(Vinyl)C6H4  45 
j g 4-tBuC6H4   63 
l h 4-(Acetyl)C6H4 52 
p i 4-FC6H4 48 
t j 3-MeC6H4 60 
u k 2-Thienyl 50 
   aYields of isolated products 
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Interestingly, the yields of products 15a–c are in the same range as the yields of 14a–h. This 
might be explained by the assumption that the selectivity and the yields are mainly 
determined by the first attack of the boronic acid to 12. The second attack during the synthesis 
of 15a–c only has a small influence on the yield because no problem of site-selectivity exists. 
On the other hand, the yield of products 13a–k (where no problem of site-selectivity exists) is 
in a similar range. Therefore, we believe that the chromatographic purification also has a great 
influence on the yield, due to some loss of material. For all reactions, only one 
chromatographic purification has to be carried out. Inspection of the NMR of the crude 
products 15a–c (before purification) shows that a small amount of mono-coupling and 
double-coupling product (containing two Ar1 groups) is present in most cases. In case of the 
synthesis of 14a–h, a small amount of double-coupling product is present in the crude product 
mixture. 
 
   
 Scheme 8. Synthesis of 14a–h. Conditions: (i) 12 (1.0 equiv), 8b,d-f,i,j,n,o (1.0 equiv), 
Cs2CO3 (1.5 equiv), Pd(PPh3)4 (3 mol %), 1,4-dioxane, 90 °C, 6–8 h. 
 
       Table 11. Synthesis of 14a-h 
8 14 Ar Yields of 14 (%)a 
b a 4-MeC6H4 60 
d b 4-MeOC6H4 60 
e c  4-EtO(C6H4) 68 
f d 3,4- (MeO)2C6H3 67 
i e 4-(Vinyl)C6H4 45 
j f 4-(tBu)C6H4 58 
n g 3-ClC6H4 57 
o h 4-ClC6H4 60 
aYields of isolated products  
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The one-pot reaction of 1,4-dibromo-2-fluorobenzene 12 with two different arylboronic acids 
afforded the unsymmetrical fluorinated para-terphenyls 15a–c containing two different 
terminal aryl groups (Scheme 9, Table 12). 
 
Scheme 9. One-pot synthesis of 15a-c. Conditions:1) 12 (1.0 equiv.), 8f,l,m (1.0 equiv.), 
Cs2CO3 (1.5 equiv.), Pd(PPh3)4  (3 mol-%), 1,4-dioxane, 90 °C, 8 h, 2) 8a,d,u (1.2 equiv.), 
Cs2CO3 (1. 5 equiv.), 90 °C, 8 h. 
 
   Table 12. Synthesis of 15a-c 
8 15 Ar1 Ar2 Yields of 15 (%)a 
f,u a  3,4-(MeO)2C6H3 2-Thienyl  53 
l,d b  4-(Acetyl)C6H4  4-MeOC6H4   60 
m,a c 3,5-(Me)2C6H3 C6H5 65 
aYields of isolated products 
 
The structures of all products were established by spectroscopic methods. The structures of 
14e and 13b were independently confirmed by X-ray crystal structure analyses (Figure 22 and 
Figure 23). The aryl groups of structure 14f are twisted out of plane whereas the aryl groups 
of 13c are only slightly twisted. 
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Figure 22. Ortep plot of 14f 
 
 
 
 
 
 
 
Figure 23. Ortep plot of 13c 
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2.2.3. One pot synthesis of flourinated Terphenyls by site selective Suzuki- Miyura 
reactions of 1,3-dibromo-5-flourobenzene 
The S–M reaction of commercially available 1,3-dibromo-5-fluorobenzene 16 with two 
equivalents of arylboronic acids 8a–d,q,u,v afforded the difluorinated ortho-para terphenyls 
17a–g in moderate to good yields (Scheme 10, Table 13). The best yields were obtained using 
2.2 equivalents of the arylboronic acid, Pd(PPh3)4 (0.03 equiv) as the catalyst, and Cs2CO3 
(2.2 equiv) as the base (1,4-dioxane, 90 °C, 8 h). 
 
 
Scheme 10. Synthesis of 17a–g. Conditions: (i) 16 (1.0 equiv), 8a-d,q,u,v (2.2 equiv), 
Cs2CO3 (2.2 equiv), Pd(PPh3)4 (3 mol %), 1,4-dioxane, 90 °C, 6–8 h 
 
 
   Table 13. Synthesis of 17a-g 
8 17 Ar Yields of 17(%)a 
a a  C6H5 55 
b b 4-MeC6H4 62 
c c 2-(MeO)C6H4 60 
d d  4-(MeO)C6H4 70 
q e  4-CF3C6H4 45 
u f 2-Thienyl 48 
v g 2,3-(MeO)2C6H3 58 
           aYields of isolated products 
 
 
 
47 
 
The S–M reaction of 16 with arylboronic acids 8b,d, (1.0 equiv) afforded the 3-bromo-4-
fluoro-biphenyls 18a,b in good yields and with very good site selectivity (Scheme 11, Table 
14). The formation of the opposite regioisomers was not observed. 
 
 
Scheme 11. Synthesis of 18a,b. Conditions: (i) 16 (1.0 equiv), 8b,d (1.0 equiv), Cs2CO3 (1.5 
equiv), Pd(PPh3)4 (3 mol %), 1,4-dioxane, 90 °C, 6–8 h. 
         
         Table 14. Synthesis of 18a,b 
8 18 Ar Yields of 18 (%)a 
b a 4-MeC6H4 63 
d b 4-MeOC6H4 70 
             aYields of isolated products 
 
The one-pot reaction of 1,3-dibromo-4-fluorobenzene 16 with two different arylboronic acids 
afforded the unsymmetrical fluorinated para-terphenyls 19a containing two different terminal 
aryl groups (Scheme 12, Table 15). 
 
 
Scheme 12. One-pot synthesis of 19a. Conditions :1) 16 (1.0 equiv.), 8q (1.0 equiv.), Cs2CO3 
(1.5 equiv.), Pd(PPh3)4  (3 mol-%), 1,4-dioxane, 90 °C, 8 h, 2) 8d (1.2 equiv.), Cs2CO3 (1. 5 
equiv.), 90 °C, 8 h. 
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       Table 15.  Synthesis of 19a 
8 19 Ar1 Ar2 Yield of 19a (%)a 
q,d a 4-CF3C6H4 4-(MeO)C6H4 58 
aYields of isolated products 
 
The structures of all products were established by spectroscopic methods. The site selectivity 
of 18b was confirmed by 2D NMR (Fig. 21) the structure of 17b was independently 
confirmed by x-ray crystal structure (Fig. 24). The aryl groups are twisted out of plane. 
 
Figure 24. Ortep plot of 17b 
 
2.3 Conclusions 
The site-selective formation of 10a–f and 11a–d can be explained by steric and electronic 
reasons. The first attack of palladium(0)-catalyzed cross-coupling reactions generally occurs 
at the more electron-deficient and sterically less hindered position.53,54 Position 1 of 1,2-
dibromo-3,5-difluorobenzene (7) is sterically less hindered because it is located next to a 
bromine and to a hydrogen atom while position 2 is located next to a bromine and to a 
fluorine atom (Figure 25). In addition, position 1 (located meta to the fluorine atoms) is 
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considerably more electron deficient than position 2 (located ortho and para to the fluorine 
atoms), due to the p-donating effect of the fluorine atom. 
 In fact, the 1H NMR signals of aromatic protons located ortho or para to a fluorine atom are 
generally shifted to higher field compared to the proton located in meta position.54 
 
F
F
Br
Br
more sterically hindered
less electron-deficient
less sterically hindered
more electron-deficient7  
 Figure 25. Possible explanation for the site-selectivity of cross-coupling reactions of 7 
 
So this way, we have reported site-selective Suzuki–Miyaura reactions of 1,2-dibromo-3,5-
difluorobenzene which provide a convenient approach to difluorinated ortho-terphenyls and 
2-bromo-3,5-difluoro-biphenyls. 
  
Similarly, the site-selective formation of 14a–g and 15a–b can be explained by steric and 
electronic reasons. The first attack of palladium(0)-catalyzed cross-coupling reactions 
generally occurs at the more electronic deficient and sterically less hindered position.53,54 
Position 4 of 1,4-dibromo-2-fluorobenzene (12) is sterically less hindered because it is located 
next to two hydrogen atoms while position 1 is located next to a fluorine atom (Figure 26). In 
addition, position 4 (located meta to the fluorine atom) is more electron deficient than position 
1 (located ortho to the fluorine atoms), due to the p-donating effect of the fluorine atom. In 
fact, the 1H NMR signals of aromatic protons located ortho to a fluorine atom are generally 
shifted to higher field compared to the proton located in meta position. 
 
Br
F
more sterically hindered
less electron-deficient
less sterically hindered
more electron-deficient
Br
12  
Figure 26. possible explanations for the site selectivity of cross coupling reactions of 12 
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Furthermore, we have reported site-selective Suzuki–Miyaura reactions of 1,4-dibromo-2-
fluorobenzene which provide a convenient approach to fluorinated terphenyls and biaryls.55 
Thirdly, the site-selective formation of 18a–b and 19a can be explained by steric and by 
electronic reasons. The first attack of palladium(0)-catalyzed cross-coupling reactions 
generally occurs at the less electron-deficient position.53 As per our previous knowledge we 
were expecting the attack on position 1 of 1,3-dibromo-4-fluorobenzene 16 but in this case the 
result was not according to our expectation rather it was opposite to that, in this case we 
observed the first attack on position 2 of 1,3-dibromo-4-fluorobenzene (16), which has been 
explained by NOESY correlation fig. 27A. In fact, the 1H NMR signals of aromatic protons 
located ortho or para to a fluorine atom are generally shifted to higher field.54 
So, we have also prepared site-selective Suzuki–Miyaura reactions of 1,3-dibromo-4-
fluorobenzene which provide a convenient approach to fluorinated ortho-para-terphenyls and 
3-bromo-4-fluoro-biphenyls.  
F
Br
more sterically hindered
less electron-deficient
less sterically hindered
more electron-deficient
Br
16  
Figure 27. Possible explanations for the site selectivity of cross coupling reactions of 16 
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Figure 27A. 
 
H-6 of the ring B resonating at δ = 7.39 ppm showed a clear and important NOESY 
correlation with the H-3 of ring A resonating at δ = 7.47 ppm. This proved the connectivtity 
of aryl group at C-1 of ring A.  
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Chapter 3.  Synthesis of mono and difluorinated periodobenzenes 
 
3. A Novel and Convenient Synthesis of Mono- and Difluorinated Periodobenzenes 
3.1 Introduction 
Poly- and periodinated aromatic compounds are conventionally prepared by multi-step 
procedures from the corresponding amines involving acetylation, nitration, diazotization, and 
reduction,56 which is time-consuming. The preparation of periodinated aromatic compounds 
through mercuration followed by iododemercuration with potassium triiodide has been 
reported.57 
Molecular iodine is not commonly used for iodination of aromatic compounds due to its low 
electrophilic property. To carry out the direct iodination reaction using molecular iodine 
requires an appropriate oxidizing agent to convert molecular iodine into a powerful 
electrophile.58 Preparation of periodinated aromatic compounds using molecular iodine in the 
presence of fuming sulfuric acid as an oxidizing agent has been reported. Mattern59 reported 
the preparation of periodinated aromatic compounds using molecular iodine in the presence of 
H5IO6 in sulfuric acid. Although such reported methods for the preparation of periodinated 
aromatic compounds are excellent and powerful in most cases, these methods have drawbacks 
such as the need for longer reaction time and strong acidic or severe reaction conditions to 
carry out the reaction. 
Recently, M. A. Rahman et al.60 have found that the reaction of arenes with molecular iodine 
occurs very easily in the presence of K2S2O8 as an oxidant and give iodoarenes in good yields. 
This reagent system is convenient and powerful even in the case of deactivated arenes. The 
reported periodination method is effective for the arenes bearing moderately deactivating 
groups as well as moderately activating groups.  
We have extended our studies to the direct periodination reactions of difluorinated (Table 18) 
shows the results of direct periodination of different difluorinated benzenes using the 
molecular iodine in the presence of K2S2O8 and sulfuric acid in trifluoroacetic acid (TFA) and 
1,2-dichloroethane (DCE). The outline of the periodination is illustrated in Schemes 13-16.  
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3.2 Results and Discussions 
3.2.1 Synthesis of 1,2-difluoro-3,4,5,6-tetraiodobenzene 
The reaction of commercially available 1,2-difluorobenzene 20 with five equivalents of 
molecular Iodine afforded the 1,2-difluoro-3,4,5,6-tetraiodobenzene 21 in excellent yield 
(Scheme 13, Table 16). The excellent yields were obtained using molecular Iodine in excess, 
K2S2O8 (5 equiv) as an oxidant, and H2SO4 (1.0 equiv) as an oxidizing agent (1,2-
dichloroethane(DCE) as a solvent at 80 °C for 90 h. 
 
 
Scheme 13. Synthesis of 21 Conditions: i, 20 (1 equiv.), I2 (5 equiv.), K2S2O8 (5 equiv.), 
TFA (5 equiv.), DCE, 80 °C, 90h.  
 
The product was characterized by spectroscopic methods. The signal of the carbon atom 
located ortho to the fluorine atom is strongly shifted upfield (97.3 ppm) in the 13C NMR 
spectrum, due to the anisotropic effect of iodine atom and due to the π-donating effect of the 
fluorine atom. The structure of 21 was independently confirmed by X-ray crystal structure 
analysis (Figure 28). 
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Figure 28. Ortep plot of 21 
 
3.2.2 Synthesis of 1,3-difluoro-2,4,5,6-tetraiodobenzene 
The reaction of commercially available 1,3-difluorobenzene 22 with seven equivalents of 
molecular iodine afforded the 1,3-difluoro-2,4,5,6-tetraiodobenzene 23 in good to excellent 
yield (Scheme 14, Table 16). The excellent yields were obtained using molecular Iodine in 
excess, K2S2O8 (5 equiv) as an oxidant, and H2SO4 (1.0 equiv) as an oxidizing agent (1,2-
dichloroethane (DCE) as a solvent at 70 °C for 120 h.  
 
Scheme 14. Synthesis of 23. Conditions: i, 22 (1 equiv.), I2 (7 equiv.), K2S2O8 (5 equiv.), 
TFA (5 equiv.), DCE, 70 °C, 120 h. 
 
The product was characterized by spectroscopic methods. The structure of 23 was also 
independently confirmed by X-ray crystal structure analysis (Figure 29). 
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Figure 29. Ortep plot of 23 
 
3.2.3 Synthesis of 1,4-difluoro-2,3,5,6-tetraiodobenzene 
The reaction of commercially available 1,4-difluorobenzene 24 with six equivalents of 
molecular iodine afforded the 1,4-difluoro-2,3,5,6-tetraiodobenzene 25 in good to excellent 
yield (Scheme 17, Table 18). The excellent yields were obtained using molecular iodine in 
excess, K2S2O8 (5 equiv) as an oxidant, H2SO4 (1.0 equiv) and 1,2-dichloroethane (DCE) as a 
solvent at 70 °C for 80 h.  
 
 
Scheme 15. Synthesis of 25 Conditions: i, 24 (1 equiv.), I2 (5 equiv.), K2S2O8 (5 equiv.), 
TFA (5 equiv.), DCE, 70 °C, 80h. 
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The product was characterized by spectroscopic methods. The structure of 25 was 
independently confirmed by X-ray crystal structure analysis (Figure 30). Due to the 
anisotropic effect of iodine and due to the π-donating effect of the fluorine atom, the signal of 
the carbon atom attached to the iodine atom is strongly shifted upfield (98.0 ppm) in the 13C 
NMR spectrum. 
 
 
Figure 30. Ortep plot of 25 
 
3.2.4 Synthesis of 1-fluoro-2,3,4,5,6-pentaiodobenzene61 
The reaction of commercially available fluorobenzene 26 with eight equivalents of molecular 
iodine afforded the 1-fluoro-2,3,4,5,6-pentaiodobenzene 27 in good yield (Scheme 18, Table 
18). The excellent yields were obtained using molecular iodine in excess, K2S2O8 (5 equiv) as 
an oxidant, and H2SO4 (1.0 equiv) and 1,2-dichloroethane (DCE) as a solvent at 70 °C for 80 
h. 
 
Scheme 16. Synthesis of 27 Conditions: i, 26 (1 equiv.), I2 (6 equiv.), K2S2O8 (6 equiv.), 
TFA (5 equiv.), DCE, 70 °C, 60h. 
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Similar to compound 25, the signal of the carbon atom located ortho to the fluorine atom is 
strongly shifted upfield (96.6 ppm) in the 13C NMR spectrum, due to the anisotropic effect of 
iodine atom and due to the π-donating effect of the fluorine atom. The structure of 27 was 
also independently confirmed by X-ray crystal structure analysis (Figure 31). 
 
 
Figure 31. Ortep plot of 27 
 
 
 
Table 16. Synthesis of polyiodoarenes 21-27 
Entry Arene Temp (°C) Time (h) Products Yields (%)a 
1 20 80 90 21  90 
2 22 70 120 23  88 
3 24 70 80 25  92 
4 26 70 60 27  76 
aYields of isolated products 
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3.3  Conclusion  
        In short, I have demonstrated a direct and very convenient method for the preparation of 
fluorinated polyiodobenzenes using the molecular iodine. The present periodination method is 
suitable for the synthesis of polyfunctionalized products. 
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Chapter 4. Synthesis of mono- and difluorinated polyethynylbenzenes 
 
4 Synthesis of fluorinated polyethynylbenzenes by Sonogashira reactions 
4.1 Introduction 
In current years much attention has been dedicated to polyethynylated carbon rich molecules, 
because of their potential as liquid crystals,62 non linear optical materials,63 light-harvesting 
materials,64 and building blocks for two-dimensional carbon net works.65 Star-shaped 
molecules with C6 and C3 symmetries have also attracted considerable attention in the field of 
materials science because of their divergence and extended π-conjugation.66 In particular, D6h-
symmetric hexaethynylbenzenes and related compounds have been used as core structures for 
dendritic materials,67 and functional dyes.68 Recently, hexaethynylbenzene derivatives have 
also been employed for constructing supramolecular architectures69 and reported as potential 
nonlinear optical materials for two-photon absorption (TPA) and third-order optical 
nonlinearity.70 Various functionalized hexa(arylethynyl)benzenes have been synthesized by 
different groups to date.71 The independent approaches to the differentially substituted 
hexaethynylbenzenes of C2v symmetry based on the Diels−Alder reaction of 
tetraethynylcyclopentadienones have already been reported.72 A method for the synthesis of 
hexaethynylbenzenes of D3h symmetry was also developed by Rubin.73 Recently, Anthony 
reported the synthesis of a D2h symmetric hexaethynylbenzene from 
tetrabromobenzoquinone.74 
Hydrocarbons bearing the multiple alkenyl groups have received considerable attention, due 
to their interesting physicochemical properties, as synthetic building blocks of new and 
interesting arenes, and because, of their aesthetic attraction. For example, Vollhardt and 
coworkers reported the synthesis and characterizations of hexaethynylenzenes and its 
applications to the first synthesis of the so-called archemedanes benzenes and cyclobutane 
moieties.75 In contrast to the general hydrocarbons counterparts, fluorinated multiple 
alkynylated arenes have not been yet known. Fluorinated compounds constitute an important 
class of natural products and various synthetic drugs which have come to the market and 
constitute approx. 20% all pharmaceuticals,76 with even higher figures for agrochemicals (up 
to 30%).77 The strategic use of fluorine substitution in drug design has culminated with the 
production of some of the key drugs available on the market. The synthesis of 
difluorotetraalkynylbenzenes A, B, C and fluoropentaalkynylbenzenes D has, to the best our 
knowledge, not been reprted to date (Scheme A). 
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 Scheme A. Molecules with multiple alkynyl groups 
 
Light emitting materials are applied in biological and material sciences. Conjugated organic 
systems have significant applications in various fields, such as LC (liquid crystals), FET (field 
effect transistors), OLED (organic light emitting devices), photovoltaic cells, and 3D-optical 
memory devices.79 The extended π-systems often brings extraordinary electronic and optical 
changes to the compounds. These changes may result in liquid crystalline and fluorescence 
properties.78 In this chapter, I have synthesized and optimized the reaction conditions to 
achieve convenient synthesis of Sonogashira products of monofluoro 
pentakis(arylethynyl)benzenes and 1,2-, 1,3-, 1,4-difluorotetrakis(aryl)benzenes and studied 
their UV-Vis and fluorescence properties. 
 
4.2 Results and Discussions 
As a part of our research project on the construction of extended π-electronic systems, we 
designed to develop an efficient synthesis of fluoropentakis(arylethynyl)benzene and 
difluorotetrakis(arylethynyl)benzene derivatives from polyhalogenated benzenes using the 
Sonogashira coupling reaction as a essential step. In this context, we report herein the efficient 
synthesis of polyethynyl-substituted aromatic compounds, 32a-d and the same protocol was 
appllied to the differentially substituted tetraarylethynylbenzenes, 29a-f, 30a, and 31a from 
difluoroiodobenzenes by ingenious combination with 28a-f. 
The Sonogashira reaction of 21, 23, 25, 27 with different substituted aryl acetylenes 28a-f (6 
equiv) afforded the 1,2-difluoro-3,4,5,6-tetrakis(arylethynyl)benzen 29a-f (Scheme 17, Table 
17), 1,3-difluoro-3,4,5,6-tetra(arylethynyl)benzene 30a (Scheme 18, Table 18), 1,4-difluoro-
2,3,5,6-tetra(arylethynyl)benzene 31a (Scheme 19, Table 19), 1-fluoro-2,3,4,5-
pentakis(arylethynyl)benzenes 32a-d (Scheme 20, Table 20), in 55-78% yields. During 
optimization Pd(PPh3)4 (10mol-%), Pd(OAc)2 (5 mol-% ) in the presence of PCy3 (10 mol-%) 
were initially employed, but no satisfactory results were obtained. The progress of reactions 
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were monitored at temperature (80-100 °C), as higher temperature increases the chances of 
removal of Iodine. X-Phos (10 mol%) was found to be the best catalyst. Several solvents were 
tried, but several of them did not work well, while good yields were obtained when DMF was 
used. Almost all pentakis and tetrakis-Sonogashira products were obtained in good to 
excellent yields. All structures were confirmed by spectroscopic analysis. 
 
4.2.1 Synthesis of 1,2-difluoro-3,4,5,6-tetrakis(arylethynyl)benzenes 
The Sonogashira reaction of 1,2-difluoro-3,4,5,6-tetraiodobenzene (21) with different 
substituted alkynes (28a-f) (6.0 equiv) afforded 1,2-difluoro-3,4,5,6 
tetrakis(arylethynyl)benzenes 29a-f (Scheme 17, Table 17) in 60-78% yield. 
 
21 29a-f
i
F
F
I
I
I
I
F
F
Ar
Ar
Ar
Ar
Ar
28a-f
 
Scheme 17. Synthesis of 29a–f: (i) conditions and reagents: 21(1.0 eq), 28a-f (6.0 eq), CuI (5 
mol %), X-Phos (10 mol %), Pd(OAc)2 (5 mol %), DMF (5mL), 100 °C, 72 h. 
 
             Table 17. Synthesis of 29a-f 
28 29 Ar Yields (%)a 
a  a C6H5 78  
b  b 4-MeC6H4  65 
c c  4-(MeO)C6H4  70 
d  d 4-tBuC6H4  62 
e  e 4-Propyl(C6H4)  67 
f  f n-Butyl  64 
   a isolated yields 
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4.2.2 Synthesis of 1,3-difluoro-2,4,5,6-tetrakis(arylethynyl)benzenes 
The Sonogashira reaction of 23 with the substituted acetylenes 28c (6.0 equiv.) afforded the 
1,3-difluoro-2,4,5,6-tetrakis(arylethynyl)benzen 30a (Scheme 18, Table 18) in 68 % yield. 
 
 
 
Scheme 18. Synthesis of 30a: (i) conditions and reagents: 23(1.0 eq), 28c (6.0 eq), CuI (5 mol 
%), X-Phos (10 mol %), Pd(OAc)2 (5 mol %), DMF (5mL) , 80°C, 72 h. 
 
        Table 18. Synthesis of 30a 
28 30 Ar Yields (%)a 
c a 4-(MeO)C6H4 68 
 aisolated yields 
 
4.2.3 Synthesis of 1,4-Difluoro-3,4,5,6-tetrakis(arylethynyl)benzenes 
The Sonogashira reaction of 25 with the substituted acetylenes 28c (6.0 equiv.) afforded the 
1,4-difluoro-2,3,5,6-tetrakis(arylethynyl)benzen 31a (Scheme 19, Table 19) in 78 % yield. 
 
 
Scheme 19. Synthesis of 31a: (i) conditions and reagents: 25 (1.0 eq), 28c (6.0 eq), CuI (5 
mol %), X-Phos (10 mol %), Pd(OAc)2 (5 mol %), DMF (5mL) , 80°C, 72 h. 
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Table 19. Synthesis of 31a 
28 31 Ar Yields (%)a 
c a 4-(MeO)C6H4  78 
 aisolated yields 
 
 
4.2.3 Synthesis of 1-fluoro-2,3,4,5,6-pentakis(arylethynyl)benzenes 
The Sonogashira reaction of 27 with the substituted acetylenes 28b-d,g (6.0 equiv.) afforded 
the 1-fluoro-2,3,4,5,6-tetrakis(arylethynyl)benzene 32a-d (Scheme 20, Table 20) in 55-78 % 
yields. 
 
Scheme 20. Synthesis of 32a-d: (i) conditions and reagents: 27(1.0 eq), 28b-d,g (6.0 eq), CuI 
(5 mol %), X-Phos (10 mol %), Pd(OAc)2 (5 mol %), DMF (5mL) , 80°C, 100 h. 
 
 
Table 20. Synthesis of 32a-d 
28 32 Ar Yields (%) 
b a 4-MeC6H4  69 
c b 4-(MeO)C6H4  78 
d c 4-tBuC6H4  68 
g d 2-MeC6H4  55 
a isolated yields 
 
The electronic absorption and fluorescence-emission data for compounds 29a-d (Fig. 32, 33, 
34, 35) 30a, 31a (Fig. 36) and 34b-c are listed in Table 21. The spectra were recorded in 
DCM, typically in the concentration range of 10-4-10-6 M. Typically, three absorption bands 
were observed in the region 227-333 nm for 29a-c, and a single band at 229 nm for 29d. The 
compounds 31a, 32b (Fig. 37) and 32c (Fig. 38) show well-resolved absorption bands in 
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range of 227-381. All compounds except 29d show the excellent absorption properties. The 
compounds 29a-d shows the absorptions at 309, 309, 333 and 229 nm respectively. The same 
compounds 29a-d showed the emissions at 390, 424, 396, and 352 nm respectively. The 
compound 29a and 29b both showed the absorption at same wavelength 309 nm which is bit 
unusual and it is supposed to be investigated. The compound 30a showed very good 
absorption at 317 nm and the emission at 428 nm with stock’s shift 111. The compounds 31a 
showed the absorption maxima 323 nm and the emission maxima at 440 nm with stock’s shift 
117. The compounds 32b-c showed absorptions at 346 and 336 nm, respectively, while the 
emissions were recorded at 454 and 432 nm, respectively. 
 
  
 
     Table 21. Electronic absorption and fluorescence-emission properties 
Products λabs[nm] λem[nm] Stokes Shift[nm] 
29a 309 390 81 
29b 309 424 115 
29c 333 396 63 
29d 229 352 123 
30a 317 428 111 
31a 323 440 117 
32b 346 454 108 
32c 336 432 96 
Absorpion- fluorescence measured in DCM (c = 10-5-10-6 M) 
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Figure 32. Absorption and emission spectra of compound 29a 
Figure 33. Absorption and emission spectra of compound 29b 
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Figure 34. Absorption and emission spectra of compound 29c 
Figure 35. Absorption and emission spectra of compound 29d 
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Figure 36. Absorption and emission spectra of compound 31a 
Figure 37. Absorption and emission spectra of compound 32b 
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Figure 38. Absorption and emission spectra of compound 32c 
 
 
4.3 Conclusion 
In conclusion, I have synthesized difluorotetrakis(arylethynyl)benzenes and 
monofluoropentaakis(arylethynyl)benzenes by Sonogashira coupling reactions in good to 
excellent yields. Sonogashira coupling reactions of tetraiodobenzenes and pentaiodobenzenes 
provided the corresponding products. All products showed excellent fluorescence properties. 
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Chapter 5. Synthesis of mono- and difluorinated polyarylbenzenes 
 
5 Synthesis of fluorinated polyarenes by Suzuki-Miyaura cross coupling reaction 
5.1 Introduction 
Electroluminescent materials containing differently substituted mono- and difluorine-atome 
were synthesized and characterized by IR, NMR, UV-Vis and emission spectroscopic studies. 
The electronic absorption and emission characteristics of the new functional materials were 
affected by the nature of the chromophore present.  
The chemistry of fluorine containing compounds and its derivatives has been intensively 
studied, due to their pharmacological and physical properties. Fluorine containing compounds 
are fundamental materials for the synthesis of medicines that are encountered in our daily 
lives. The detailed introduction has been been given in the chapter 2. Hydrocarbons bearing 
the multiple phenyl groups have received considerable attention, due to their interesting 
physicochemical properties, as synthetic building blocks of new and interesting arenes and 
because of their aesthetic attraction. 
The fluorinated penta and tetrafold Suzuki-Miyaura reaction have not been reported to date. 
Here I report first time the fluorinated penta and tetrafold Suzuki-Miyaura results. 
 
5.2 Results and Discussions  
Approaching to the end of our another important research project about the preparation of 
fluorinated penta and hexaphenyls, we designed to develop an efficient synthesis of 
fluoropentakis(aryl)benzenes and difluorotetrakis(aryl)benzene derivatives from 
polyhalogenated benzenes using the Suzuki-Miyaura protocol as an essential step. In this 
context, we report herein the efficient synthesis of polyephenyl-substituted aromatic 
compounds 33a-d and the same protocol was appllied to the differentially substituted 
tetra(aryl)benzenes, 34a-c, 35a-b, and 36a-b from difluorotetraiodobenzenes and 
monofluoropentaiodobenzenes by ingenious combination with (8a,b,d,j,m,s). 
The Suzuki-Miyaura reaction of 21, 23, 25, 27 with different substituted arylboronic acids 
(8a,b,d,j,m,s) (6 equiv) afforded the 1,2-difluoro-3,4,5,6-tetrakis(aryl)benzenes 33a-d 
(Scheme 21, Table 22), 1,3-difluoro-3,4,5,6-tetra(aryl)benzene 34a-c (Scheme 22, Table 23), 
1,4-difluoro-2,3,5,6-tetra(aryl)benzenes 35a-b (Scheme 23, Table 24), 1-fluoro-2,3,4,5-
pentakis(aryl)benzenes 36a-b (Scheme 24, Table 25), in 70-85% yields. 
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5.2.1 Synthesis of 1,2-difluoro-3,4,5,6-tetrakis(aryl)benzenes 
The Suzuki-Miyaura reaction of 1,2-difluoro-3,4,5,6-tetraiodobenzen 21 with substituted  
phenylboronic acids (8b,j,m,s) resulted in the formation of 33a-d (Scheme 21, Table 22) in 
good to excellent yields (70-85%). 
 
 
Scheme 21. Synthesis of 33a-d: conditions and reagents: i) 21 (1.0 equiv), 8b,j,m,s (6.0 
equiv), Pd(PPh3)4 (10 mol-%), Cs2CO3 (5equiv), DMF (5 mL),  110°C, 60 h. 
 
     Table 22. Synthesis of 33a-d  
8 33 Ar Yields (%)a 
b a 4-MeC6H4 80 
j b 4-tBuC6H4 85 
m c 3,5-(Me)2C6H3 78 
s d 3-(MeO)C6H4 72 
     aisolated yields 
 
5.2.2 Synthesis of 1,3-Difluoro-2,4,5,6-tetrakis(aryl)benzenes 
The Suzuki-Miyaura reaction of 1,3-difluoro-2,4,5,6-tetraiodobenzen 23 with substituted  
phenylboronic acids (8b,d,j) resulted in the formation of 34a-c (Scheme 22, Table 23) in good 
to excellent yields (70-80%). 
 
 
Scheme 22. Synthesis of 34a-c: conditions and reagents: i) 23 (1.0 equiv), 8b,d,j (6.0 equiv), 
Pd(PPh3)4 (10 mol-%), Cs2CO3 (5equiv), DMF (5 mL),  110°C, 80 h 
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    Table 25. Synthesis of 34a-c  
8 34 Ar Yields(%)a 
b a 4-MeC6H4 78 
d b 4-(MeO)C6H4 80 
j c 4-tBuC6H4 73 
       aisolated yields 
 
 
5.2.3 Synthesis of 1,4-Difluoro-2,3,5,6-tetrakis(aryl)benzenes 
The Suzuki-Miyaura reaction of 1,4-difluoro-2,3,5,6-tetraiodobenzen 25 with substituted  
phenylboronic acids (8a,d) resulted in the formation of 35a-b (Scheme 23, Table 24) in good 
to excellent yields (70-80%). 
 
Scheme 23. Synthesis of 35a-b: conditions and reagents: i) 25 (1.0 equiv), 8a,d (6.0 equiv), 
Pd(PPh3)4 (10 mol-%), Cs2CO3 (5equiv), DMF (5 mL),  100°C, 60 h. 
 
   Tabe 24. Synthesis of 35a-b 
8 35 Ar Yields (%)a 
a a C6H5  76 
d b 4-(MeO)C6H4  80 
    aisolated yields 
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The X-ray measuments for the compound 35a (Fig. 39) have also been performed which 
confirmed the structure independebtly. The aryl substitutents in the crystal structure 35b were 
twisted out of plan. 
 
Figure 39. Ortep plot of 35a 
 
 
5.2.4 Synthesis of 1-fluoro-2,3,4,5,6-pentakis(aryl)benzenes  
The Suzuki-Miyaura reaction of 1-fluoro-2,3,4,5,6-pentaiodobenzen 27 with substituted 
phenylboronic acids (8b,d) resulted in the formation of 36a-b (Scheme 24, Table 25) in good 
to excellent yields (70-80%). 
 
 
Scheme 24. Synthesis of 36a-b: conditions and reagents: i) 27 (1.0 equiv), 8b,d (6.0 equiv), 
Pd(PPh3)4 (10 mol-%), Cs2CO3 (5equiv), DMF (5 mL),  100°C, 100 h. 
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Table 25. Synthesis of 36a-b 
8 36 Ar Yields (%)a 
b a 4-MeC6H4  72 
d b 4-(MeO)C6H4  78 
aisolated yields 
 
The X-ray measuments for the compound 36a have also been performed which confirmed the 
structure independently (Figure 40). The aryl groups are twisted out of plane. 
 
Figure 40.  Ortep plot of 36a 
 
The electronic absorption and fluorescence-emission data for compounds 33d, 34b and 35b 
are listed in Table 26. The spectra were recorded in DCM, typically in the concentration range 
of 10-4-10-6 M. Typically, three absorption bands were observed in the region 227-330 nm for 
33d (Fig. 41) and the absorption maxima was observed at 227 nm whereas a broad shoulder at 
260 nm was also observed.  The compound 33d showed emission at 390nm. It showed a 
broader spectrum at 350-459 nm. The compounds 34b (Fig. 42) and 35b (Fig. 43) showed 
well-resolved absorption bands in range of 227-320. The compounds 34b and 35b showed 
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the absorptions at 256 and 258 nm respectively. The same compounds 34b showed the 
emission at 374 nm the spectrum showed also a broader emission at 350-450 nm. The 
compound 35b showed the emissions at 375 and 380 nm respectively, which is unusual and 
supposed to be investigated.  
 
 
   Table 41. Electronic absorption and fluorescence-emission properties 
Products λabs[nm] 
 
λem[nm] 
 
Stokes Shift[nm] 
33d 227 390 163 
34b 256 374 118 
35b 258 375, 380 117, 122 
Absorpion- fluorescence measured in DCM (c = 10-5-10-6 M) 
 
 
 
Figure 41. Absorption and emission spectra of compound 33d 
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Figure 42. Absorption and emission spectra of compound 34b 
 
 
Figure 43. Absorption and emission spectra of compound 35b 
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5.3 Conclusion 
In conclusion, I have synthesized difluorotetrakis(aryl)benzenes and 
monofluoropentaakis(aryl)benzenes by Suzuki–Miyaura (S–M) reactions in good to high 
yields. Suzuki–Miyaura (S–M) reactionsof tetraiodobenzenes and pentaiodobenzenes 
provided the corresponding products. All products showed good absorption and fluorescence 
properties.  
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6 Abstract 
 
The palladium(0)-catalyzed Heck cross-coupling reactions of 1-bromopyrene with styrenes 
and acrylates provided functionalized alkenylpyrenes. The effect of the temperature on the 
product distribution was studied. Suzuki-Miyaura cross coupling reactions of different 
substituted di- and mono-fluorobenzenes with different arylboronic acids afforded fluoro-
substituted terphenyls with excellent site-selectivity. The first attack occurred at the more 
electronically deficient and sterically less hindered positions. Sonogashira and Suzuki-
Miyaura coupling reactions of 1,2-difluoro-, 1,3-difluoro-, and 1,4-difluoro-tetraiodobenzenes 
and of fluoro-pentaiodobenzene afforded  tetra- and penta-alkynylated and arylated benzene 
derivatives. The fluorescence properties of various pyrene and benzene derivatives was 
studied.  
 
Die Palladium(0) katalysierte Heck-Reaktion von 1-Brompyren mit Styrolen bzw. Acrylaten 
lieferte funktionalisierte Alkenylpyrene. Der Temperatureinfluss bei der Produktbildung 
wurde untersucht. Suzuki-Miyaura Kreuzkupplungen von unterschiedlich substituierten di- 
und mono-Fluorobenzenen mit verschiedenen Boronsäuren lieferte fluorsubstituierte 
Terphenyle mit hervorragender Seitenselektivität. Der erste Angriff fand an der 
elektronenärmeren und sterisch weniger gehinderten Position statt. Sonogashira und Suzuki-
Miyaura Kupplungsreaktionen von 1,2-Difluoro-, 1,3-Difluoro- und 1,4-Difluoro-
tetraiodobenzen sowie 1-Fluoro-pentaiodobenzen ergaben die entsprechenden 4-fach bzw. 5-
fach alkinylierten bzw. arylierten Produkte. Die Fluoreszenzeigenschaften der Pyrene und 
vieler Benzenderivate wurden untersucht. 
. 
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General Scheme. Palladium(0)-catalyzed reactions developed in this thesis. 
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7 Experimental Section 
 
7.1 General: Equipment, Chemicals and Work techniques 
1H NMR Spectroscopy:  
Bruker: AM 250, Bruker ARX 300, Bruker ARX 500; δ = 0.00 ppm for Tetramethylsilane; δ 
= 7.26 ppm for (CDCl3); Characterization of the signal fragmen- tations: s = singlet, d = 
doublet, dd = double of doublet, t = triplet, q = quartet, m = multiplet, br = broadly. All 
coupling constants are indicated as (J). 2D NMR techniques (NOESY, COSY, HMQC, and 
HMBC) were used for the confirmation of structure. 
 
13C NMR Spectroscopy: 
 Bruker: AM 250, (62.9 MHz); Bruker: ARX 300, (75 MHz), Bruker: ARX 500, (125 MHz) 
Ref: 29.84 ± 0.01 ppm and 206.26 ± 0.13 ppm δ = 77.00 ppm for CDCl3. The multiplicity of 
the carbon atoms was determined by the DEPT 135 and APT technique (APT = Attached 
Proton Test) and quoted as CH3, CH2, CH and C for primary, secondary, tertiary and 
quaternary carbon atoms. Characterization of the signal fragmentations: quart = quartet the 
multiplicity of the signals was determined by the DEPT recording technology and/or the APT 
recording technology. 
 
Mass Spectroscopy: 
AMD MS40, Varian MAT CH 7, MAT 731 (EI, 70 eV), Intecta AMD 402 (EI, 70 eV and 
CI), Finnigan MAT 95 (CI, 200 eV).  
 
High Resolution mass spectroscopy:  
Finnigan MAT 95 or Varian MAT 311; Bruker FT 
CIR, AMD 402 (AMD Intectra). 
 
Infrared spectroscopy (IR):  
Bruker IFS 66 (FT IR), Nicolet 205 FT IR; Nicolet Protege 460, Nicolet 360 Smart 
Orbit  (ATR); KBr, KAP, Nujol, and ATR; Peaks are given following assignments: w = 
weak, m = medium, s = strong, br = broad. 
80 
 
Elemental Analysis  
LECO CHNS-932, Thermoquest Flash EA 1112.  
 
X-ray crystal structure analysis:  
Crystallographic data were collected on a Bruker X8Apex, Diffractometer with CCD-Kamera 
(MoKa und Graphit Monochromator, = 0.71073 Å). The structures were solved by direct 
methods using SHELXS-97 and refined against F2 on all data by full matrix least-squares 
with SHELXL-97. 
 
Melting points:  
Micro heating table HMK 67/1825 Kuestner (Büchi apparatus). 
 
Column chromatography:  
Chromatography was performed over Merck silica gel 60 (0,063 -0,200 mm, 70 - 230 mesh) 
as normal and/or over mesh silica gel 60 (0,040 - 0,063 mm, 200 -400 mesh) as Flash 
Chromatography. All solvent were distilled before use. 
 
Thin Layer Chromatography (TLC):  
Merck DC finished foils silica gel 60 F254 on aluminum foil and Macherey finished 
foils Alugram® Sil G/UV254. Detection under UV light with 254 nm and/or 366 nm without 
dipping reagent, as well as with anisaldehyde sulfuric acid reagent (1 mL anisaldehyde 
consisting in 100 mL stock solution of 85% methanol, 14% acetic acid and 1% sulfuric acid). 
 
7.2  Synthesis of 1-Alkenylpyrenes by Heck Coupling Reaction  
General procedure for synthesis of (E)-pyren-3-yl-acrylates: Palladium (II) acetate (5 mol 
%) and XPhos (10 mol %) were placed under Argon atmosphere in a pressure tube and 5 mL 
of DMF was added. After stirring for 15 min, 1-bromopyrene 2, the acrylate 5 and 
triehtylamine were added. Subsequently, the mixture was heated at 90 °C for 6 h. To the 
mixture were added water and CH2Cl2 (20 mL each) and the organic and the aqueous layer 
were separated. The latter was extracted with CH2Cl2 (2 × 20 mL). The combined organic 
layers were dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue 
was purified by a column chromatography (hexane/ethylacetate). 
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7.3 Synthesis of 1-bromopyrene17 (2): To a stirred solution of pyrene (2.02 g, 10.0 
mmol) in chloroform (100 mL), NBS (2.40 g, 12.0 mmol) was added slowly. 
The reaction mixture was stirred at room temperature for 24 h while its 
progress was monitored by TLC. After the completion of monobromination, 
the solvent was removed under reduced pressure and the crude product was 
taken in DCM (2*200 mL) and washed with water and dried over anhydrous sodium sulfate. 
The pure product was isolated by careful column chromatography on silica gel using n-hexane 
as eluent to get pure 1-bromopyrene as a light brown solid. 
 
7.4 Synthesis of ethenylpyrenes. To a stirred solution of Pd(OAc)2 (5 mol%) and XPhos 
(10 mol%) in DMF was added a solution of styrenes (0.53 mmol) and 1-bromopyrene (100 
mg, 0.35 mmol). Then K2CO3 (98 mg, 0.71 mmol) was added and kept stirring at 70 °C for 6 
h. after the completion of reaction, the solvent was removed under the reduced pressure on 
rotary evaporator and the crude product was taken in DCM and washed with water and dries 
over anhydrous sodium sulphate. The pure product was isolated by careful column 
chromatography on silica gel as yellow solids. 
 
(E)-1-(4-Methylstyryl)pyrene (4a): Starting with 1 (100 mg, 0.35 mmol), 3a (62.8 mg, 0.53 
mmol),  Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), X-Phos (10 
mol%, 16.0 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) in DMF 
(5 ml), 5a was isolated as a yellow solid (104 mg, 92%). Mp 138-
140 °C. 1H NMR (300 MHz, CDCl3): δ = 2.33 (s, 3H, CH3), 7.17 (d, 
J = 8.00 Hz, 2H, Ph), 7.25 (d, J = 16.12 Hz, 1H, CH), 7.51 (d, J = 
8.00 Hz, 2H, Ph), 7.89-8.10 (m, 8H, Py), 8.23 (d, J = 8.00 Hz, 1H, CH), 8.41 (d, J = 9.28 Hz, 
1H). 13C NMR (62.89 MHz, CDCl3): δ  = 20.3 (CH3), 122.1 (C), 122.6 (C), 123.6 (CH), 123.9 
(CH), 124.1 (C), 124.2 (C), 124.9 (CH), 125.6 (2CH), 126.1 (CH), 126.4 (C), 126.5 (C), 
127.3 (CH), 127.7 (CH), 128.5 (2CH), 129.7 (CH), 129.9 (C), 130.5 (C), 130.8 (CH), 131.1 
(CH), 133.9 (CH), 136.7 (CH). IR (ATR, cm−1): ν~  = 3043 (w), 2962 (w), 2914 (w), 2854 
(w), 2732 (w), 1908 (w), 1778 (w), 1600 (w), 1567 (w), 1512 (w), 1462 (w), 1434 (w), 1378 
(w), 1316 (w), 1260 (w), 1205 (w), 1159 (w), 1108 (w), 1048 (w), 1019 (w), 963 (m), 907 
(w), 863 (w), 837 (m), 807 (m), 751 (w), 715 (w), 679 (w), 604 (w), 543 (w). MS (EI, 70 eV): 
m/z (%) = 318 (100) [M]+, 317 (67), 304 (10), 302 (38), 300 (16), 226 (21), 151 (20), 150 
(12), 69 (11). HRMS (EI) calcd for C25H18 [M+H]+: 318.14030 found 318.139964. 
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(E)-1-(4-Methoxystyryl)pyrene (4b): Starting with 1 (100 mg, 0.35 mmol), 3b (71.3 mg, 
0.53 mmol),  Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), X-Phos 
(10 mol%, 16.0 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) in 
DMF (5 ml), 4b was isolated as a yellow solid (105 mg, 89%). 
Mp 147-149 °C. 1H NMR (300 MHz, CDCl3): δ = 3.81 (s, 3H, 
OCH3), 6.90 (d, J = 8.80 Hz, 2H, Ph), 7.24 (d, J = 15.97 Hz, 1H, 
CH), 7.56 (d, J = 8.80 Hz, 2H, Ph), 7.89-8.11 (m, 8H, Py), 8.24 (d, J = 8.15 Hz, 1H), 8.43 (d, 
J = 9.18 Hz). 13C NMR (62.89 MHz, CDCl3) :δ = 55.4 (OCH3), 114.2 (2CH), 123.2 (CH), 
123.5 (CH), 123.6 (CH), 124.9 (CH), 125.1 (CH), 125.2 (CH), 126.0 (CH), 127.1 (CH), 127.4 
(CH), 127.5 (CH), 128.0 (2CH), 128.2 (C), 128.8 (C), 130.6 (C), 130.9 (C), 131.0 (C), 131.4 
(CH), 131.6 (C), 132.3 (C), 132.5 (C), 159.5 (C). IR (ATR, cm−1): ν~ =3042 (w), 2999 (w), 
2965 (w), 2932 (w), 2837 (w), 1598 (m), 1537 (m), 1510 (m), 1455 (m), 1415 (m), 1325 (m), 
1301 (m), 1263 (m), 1203 (m), 1174 (m), 1108 (m), 1072 (m), 1025 (s), 964 (s), 947 (m), 893 
(w), 843 (s), 815 (s), 765 (m), 722 (m), 707 (s), 638 (m), 605 (m), 566 (m), 544 (m). MS (EI, 
70 eV): m/z (%) = 334 (100) [M]+, 333 (28), 318 (18), 303 (17), 291 (17), 290 (14), 289 (36), 
226 (14), 145 (10), 111 (11), 97 (18), 95 (13), 85 (15), 83 (20), 81 (24), 71 (25), 57 (38), 55 
(25), 43 (22), 41 (21). HRMS (EI) calcd. for C25H18O1 [M+H]+: 334.13522; found 
334.134251. 
 
(E)-1-Styrylpyrene (4c): Starting with 1 (100 mg, 0.35 mmol), 3c (55.6 mg, 0.53 mmol),  
Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), X-Phos (10 mol%, 16 mg, 
0.035 mmol), K2CO3  (98 mg, 0.71 mmol) in DMF (5 ml), 4c was 
isolated as a yellow oil. (85 mg, 79%). 1H NMR (300 MHz, CDCl3): δ = 
7.22-7.39 (M, 5H, Ph), 7.60-7.63 (m, 2H, Py), 7.89-8.15 (m, 7H, Py), 
8.25 (d, J = 8.40 Hz, 1H, CH), 8.42 (d, J = 9.20 Hz, 1H, CH). 13C NMR 
(62.89 MHz, CDCl3): δ = 123.5 (CH), 123.7 (CH), 124.3 (C), 124.9 (CH), 125.0 (CH), 125.3 
(CH), 125.7 (CH), 126.3 (CH), 126.4 (CH), 126.5 (C), 126.6 (CH), 126.7 (CH), 126.8 (C), 
127.1 (CH), 127.2 (CH), 127.3 (CH), 127.4 (CH), 127.8 (CH), 129.9 (CH), 130.0 (C), 130.5 
(C), 130.8 (CH), 130.9 (C). IR (ATR, cm−1): ν~  = 3080 (w), 2998 (w), 2956 (w), 2836 (w), 
1736 (w), 1609 (s), 1586 (s), 1508 (s), 1454 (s), 1425 (m), 1401 (m), 1372 (w), 1303 (s), 1255 
(m), 1184 (w), 1158 (s), 1145 (s),  1092 (s), 1032 (s), 996 (s), 925 (m), 861 (w), 834 (m), 818 
(s) 796 (m), 736 (w), 718 (w), 663 (w), 607 (w), 587 (m). MS (EI, 70 eV): m/z (%) = 304 
(100) [M]+, 303 (80), 302 (29), 300 (14), 226 (15), 151 (17). HRMS (EI) calcd. for C24H16 
[M+H]+: 304.12465; found 304.124431. 
OMe
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(E)-1-(4-tert-Butoxystyryl)pyrene (4d): Starting with 1 (100 mg, 0.35 mmol), 3d (93.8 mg, 
0.53 mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), X-Phos 
(10 mol%, 16 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) in 
DMF (5 ml), 4d was isolated as a yellow solid ( 115 mg, 86%). 
Mp 122-124 °C. 1H NMR (300 MHz, CDCl3): δ = 1.34 (s, 9H, 
t-BuO), 7.05 (d, J = 8.59 Hz, 2H, Ph), 7.28 (d, J = 16.05 Hz, 
1H, CH), 7.57 (d, J = 8.59 Hz, 2H, Ph), 7.95-8.15 (m, 8H, Py), 8.25 (d, J = 8.22  Hz, 1H, CH), 
8.45 (d, J = 9.41 Hz, 1H, CH). 13C NMR (62.89 MHz, CDCl3): δ = 28.9 (OCH3), 123.1 (CH), 
123.6 (CH), 123.4 (2CH), 124.5 (CH), 12 4.9 (2CH), 125.0 (C), 125 (C), 125.2 (CH), 125.9 
(CH), 127.1 (CH), 127.5 (2CH), 127.4 (2CH), 128.2 (C), 130.7 (C), 130.9 (C), 131.4 (2CH), 
131.5 (C) 132.1 (C), 132.9 (C),   155.4 (CO). IR (ATR, cm−1): ν~  = 3038 (w), 2974 (m), 2929 
(w), 2870 (w), 1712 (w), 1680 (w), 1598 (m), 1504 (s), 1458 (w), 1415 (w), 1364 (m), 1296 
(w), 1238 (s), 1157 (s), 1101 (w), 1012 (w), 958 (m), 894 (m), 840 (s), 756 (w), 713 (m), 641 
(w), 608 (w), 552 (w), 539 (m). MS (EI, 70 eV): m/z (%) = 376 (16) [M]+, 2360 (14), 321 
(32), 320 (100), 319 (62), 303 (13), 289 (29), 1226 (33). HRMS (EI) calcd. for C28H24O1 
[M+H]+: 376.18217; found 376.181427. 
 
(E)-1-(4-Chlorostyryl)pyrene (4e): Starting with 1 (100 mg, 0.35 mmol), 3e (73.7 mg, 0.53 
mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), X-Phos (10 mol%, 
16 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) in DMF (5 ml), 4e 
was isolated as a yellow solid (86 mg, 72%). Mp 149-151 °C. 1H 
NMR (300 MHz, CDCl3): δ = 7.30 (d, J = 16.21 Hz, 1H, CH), 7.40 
(d, J = 8.40 Hz, 2H, Py), 7.61 (d, J = 8.40 Hz, 2H, Py), 7.99-8.21 (m, 
8H, Py), 8.30 (d, J = 7.99 Hz, 1H, Py), 8.48 (d, J = 9.28 Hz, 1H). 13C NMR (62.89 MHz, 
CDCl3): δ = 122.8 (CH), 123.0 (CH), 125.1 (2CH), 125.4 (CH), 125.9 (CH), 126.2 (CH), 
127.3 (CH), 127.4 (CH), 127.6 (CH), 127.7 (2CH), 128.4 (C),128.7 (C) 128.9 (2CH), 130.3 
(C), 130.8 (CH), 130.9 (C), 130.4 (C), 130.5 (C), 132.4 (C), 133.3 (C), 136.2 (C). IR (ATR, 
cm−1): ν~  = 3044 (w), 3013 (w), 2958 (w), 2857 (w), 1923 (w), 1859 (w), 1796 (w), 1724 (w), 
1681 (w), 1620 (w), 1584 (w), 1504 (w), 1488 (m), 1414 (w), 1317 (w), 1240 (w), 1185 (w), 
1112 (w), 1089 (m), 1009 (m), 956 (s), 939 (s), 862 (w), 837 (s), 800 (s), 753 (m), 713 (s), 
676 (m), 605 (s), 553 (m), 536 (s). MS (EI, 70 eV): m/z (%) = 338 (100) [M]+, 337 (31), 303 
(22), 302 (22), 301 (13, 300 (13), 299 (16), 227 (12), 226 (17), 225 (12), 207 (15), 151 (27), 
O
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150 (20), 149 (24), 136 (12). HRMS (EI) calcd for C24H15Cl [M+H]+: 338.08568; found 
338.085035. 
(E)-1-(Perfluorostyryl)pyrene (4f): Starting with 1 (100 mg, 0.35 mmol), 3f (103 mg, 0.53 
mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), X-Phos (10 mol%, 
16 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) in DMF (5 ml), 4f 
was isolated as a yellow solid (106 mg, 76%). Mp 208-210 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.21 (d, J = 16.47 Hz, 1H, CH), 
8.04-8.24 (m, 7H, Py), 8.32 (d, J = 8.10 Hz, 1H Py), 8.41 (d, J = 9.47 
Hz, 1H), 8.54 (d, J = 16.47 Hz, 1H, CH). 13C NMR (62.89 MHz, CDCl3): δ = 12.6 (C), 123.4 
(CH), 124.9 (C), 125.0 (2C), 125.5 (CH), 125.7 (CH), 126.1 (CH), 127.3 (CH), 127.4 (2C), 
127.7 (C), 127.9 (CH), 128.3 (CH), 128.8 (2CH), 130.8 (2CH), 130.9 (2C), 131.4 (C), 132.4 
(2C), 167.0 (C). 19F: δ = -142.22 (2CF), -155.8 (2CF), -162.4 (CF). ). IR (ATR, cm−1): ν~  
= 3024 (w), 2961 (w), 2920 (w), 2875 (w), 1698 (m), 1617 (m), 1599 (m), 1435 (w), 1361 
(w), 1276 (m), 1088 (s), 1036 (w), 979 (w), 838 (s). MS (EI, 70 eV): m/z (%) = 394 (100) 
[M]+, 393 (58), 392 (17), 374 (13), 226 (12). HRMS (EI) calcd for C24H11F5 [M+H]+: 
394.07754; found 394.076693. 
 
(E)-1-(4-tert-Butylstyryl)pyrene (4g): Starting with 1 (100 mg, 0.35 mmol), 3g (85.2 mg, 
0.53 mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), X-Phos 
(10 mol%, 16 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) in 
DMF (5 ml), 4g was isolated as a yellow solid (120 mg, 94%). Mp 
125-127 °C. 1H NMR (300 MHz, CDCl3): δ = 1.29 (s, 9H, CH3) 
7.24 (d, J = 16.14 Hz, 1H, CH), 7.37 (d, J = 8.36, 2H, Ph), 7.53 
(d, J = 8.36 Hz, 2H, Ph), 7.87-8.08 (m, 8H, Py), 8.20 (d, J = 8.10 Hz, 1H, CH), 8.38 (d, J = 
9.33 Hz, 1H, CH). 13C NMR (75 MHz, CDCl3): δ = 31.4 (3CH3), 34.8 (C), 123.15 (CH), 
123.71 (CH), 125.03 (CH), 125.06 (CH), 125.13 (C), 125.19 (CH), 125.28 (CH), 125.82 
(CH), 126.02 (2CH), 126.54 (2CH), 127.22 (CH), 127.54 (CH), 127.56 (CH), 128.38 (C), 
130.78 (C), 131.02, (CH),  131.60, 131.77, 132.23 (C), 135.07 (C), 151.12 (C). IR (ATR, 
cm−1): ν~  = 3040 (w), 2952 (w), 2900 (w), 2864 (w), 1598 (w), 1513 (w), 1461 (w), 1413 (w), 
1361 (w), 1267 (w), 1201 (w), 1137 (w), 1090 (w), 1022 (w), 962 (w), 904 (w), 863 (w), 836 
(m), 773 (w), 710 (m), 611 (w), 556 (m). GC-MS (EI, 70 eV): m/z (%): 360 (100) [M]+, 346 
(14), 345 (56), 329 (10), 304 (16), 303(68), 302 (24), 228 (16), 227 (90), 226 (40), 215 (18), 
151 (46), 150 (22). HRMS (EI) calcd for C28H24 [M]+: 360.18725; found 360.186333. 
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(E)-2-(2-(Pyren-1-yl)vinyl)pyridine (4h): Starting with 1 (100 mg, 0.35 mmol), 3h (55.9 
mg, 0.53 mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), X-Phos (10 
mol%, 16 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) in DMF (5 ml), 
4h was isolated as a yellow solid ( 95 mg, 88%). Mp 107-109 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.13 (dd, J = 4.82, 7.70 Hz, 1H, CH), 
7.34 (d, J = 15.85 Hz, 1H, CH), 7.43 (d, J = 7.85 Hz, 1H, CH), 7. 7.65 (t, J = 7.70 Hz, 1H, 
CH), 7.92 (t, J = 7.70 Hz, 1H, CH), 7.99-8.12 (m, 6H, CH), 8.30 (d, J = 8.30 Hz, 1H, CH), 
8.53 (d, J = 9.21 Hz, 1H, CH), 8.63 (d, J = 4.53 Hz, 1H, CH), 8.72 (d, J = 15.85 Hz, 1H, CH). 
13C NMR (62.89 MHz, CDCl3) :δ = 122.3 (CH), 122.6 (CH), 123.3 (CH), 123.8 (CH), 124.3 
(C), 124.8 (C), 125.1 (C), 125.2 (CH), 125.3 (CH), 125.5 (CH), 126.1 (CH), 127.4 (C), 127.4 
(CH), 127.5 (C), 127.6 (CH), 127.8 (CH), 129.5 (C), 129.8 (CH), 130.5 (CH), 131.1 (C), 
131.5 (C), 136.8 (CH), 149.7 (CH). IR (ATR, cm−1): ν~  = 3044 (w), 2923 (m), 2551 (w), 1730 
(w), 1678 (w), 1622 (w), 1581 (s), 1506 (w), 1467 (s), 1360 (w), 1300 (w), 1243 (w), 1186 
(w), 1108 (w), 1049 (w), 991 (w), 965 (w), 894 (w), 841 (s), 793 (w), 740 (w), 679 (w), 607 
(w), 539 (w). MS (EI, 70 eV): m/z (%) = 305 (68) [M]+, 304 (100), 230 (14), 226 (26), 152 
(29), 97 (10). HRMs (EI) calcd. for C23H15N1 [M+H]+: 305.11990; found 305.24472 
 
(E)-4-(Pyren-1-yl)vinylphenyl acetate (4i): Starting with 1 (100 mg, 0.35 mmol), 3i (86.3 
mg, 0.53 mmol),  Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), X-
Phos (10 mol%, 16 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) 
in DMF (5 ml), 4i was isolated as a yellow solid (99 mg, 77%). Mp 
150-152 °C. 1H NMR (300 MHz, CDCl3): δ = 2.33 (s, 3H, CH3), 
7.14 (d, J = 8.71Hz, 2H, Ar), 7.28 (d, J = 16.19 Hz, 1H, Ar), 7.65 
(d, J = 8.71  Hz, 2H, Ar), 7.94-8.03 (m, 3H, Ar), 8.06-8.17 (m, 5H, Ar), 8.25 (d, J = 8.12 Hz, 
1H, Ar), 8.42 (d, J = 9.25 Hz, 1H, Ar). 13C NMR (62.89 MHz, CDCl3): δ = 21.2 (CH3), 121.9 
(2CH), 122.9 (CH), 123.6 (CH), 124.9 (C), 125.0 (2CH), 125.1 (2CH), 125.3 (C), 125.9 
(2CH), 127.2 (CH), 127.4 (CH), 127.6 (3CH), 128.3 (C), 130.7 (CH), 130.9 (C), 131.5 (C), 
131.7 (C), 135.6 (C), 150.2 (C), 169.5 (CO). IR (ATR, cm−1): ν~  = 3473 (w), 3042 (w), 2992 
(w), 2849 (w), 1742 (s), 1714 (s), 1661 (m), 1597 (m), 1538 (w), 1505 (m), 1463 (w), 1415 
(m), 1368 (m), 1322 (w), 1262 (w), 1221 (s), 1188 (s), 1137 (s), 1092 (m), 1041 (m), 968 (w), 
914 (s), 863 (m), 810 (s), 761 (s), 710 (s), 657 (s), 612 (s), 562 (m), 534 (m). MS (EI, 70 eV): 
m/z (%) = 362 (38) [M]+, 321 (16), 320 (81), 319 (37), 289 (19), 226 (15), 43 (100). HRMS 
(EI) calcd.for C26H18O2 [M+H]+: 362.13013; found 362.129652. 
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7.5 Synthesis of acrylate substituted pyrenes. 
Starting with 2 (100 mg, 0.35 mmol), 5a-e (0.53 mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 
mmol), X-Phos (10 mol%, 16 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) in DMF (5 ml), 
was stirred at 80 °C for 6-7 h. The reaction mixture was diluted with dichloromethane and 
washed with water. The combined organic layers were evaporated and column 
chromatography was performed with n-hexane:ethyle acetate(4:1). The products were isolated 
as yellow solids.  
 
(E)-Butyl-3-(pyren-1-yl)acrylate (6a): Starting with 1 (100 mg, 0.35 mmol), 5a (68 mg, 0.53 
mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), X-Phos (10 
mol%, 16 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) in 
DMF (5 ml), 6a was isolated as a luminous yellow oil (98 mg, 
84%). 1H NMR (300 MHz, CDCl3): δ = 1.01 (t, J = 7.4 Hz, 3H, 
CH3), 1.50 (sext, J = 7.2 Hz 2H, CH2), 1.77 (p, J = 6.8 Hz, 2H, 
CH2), 4.31 (t, J = 6.7 Hz, 2H, OCH2), 7.83 (d, J = 7.84 Hz, 3H, CH), 7.89-8.00 (m, 4H, Py), 
8.03-8.12 (m, 4H, Py), 8.13-8.23 (m, 2H, Ar). 13C NMR (62.89 MHz, CDCl3): δ=13.2 (CH3), 
27.6 (CH2), 35.1 (CH2), 59.6 (OCH2), 121.9 (CH), 123.8 (CH), 123.9 (2CH), 124.8 (CH), 
125.8 (CH), 126.0 (CH), 126.4 (CH), 126.5 (CH), 127.5 (C), 127.7 (CH), 129.1 (C), 129.8 
(CH), 130.3 (C), 133.5 (C), 135.9 (C), 140.3 (C), 171.9 (CO). IR (ATR, cm−1): ν~  = 3433 (w), 
3039 (w), 2955 (w), 2869 (w), 2135 (w), 1920 (w), 1796 (w), 1720 (s), 1619 (m), 1594 (m), 
1537 (w), 1487 (w), 1434 (w), 1381 (w), 1312 (m), 1274 (m), 1200 (m), 1162 (s), 1061 (m), 
973 (m), 900 (w), 838 (s), 795 (m), 731 (m), 680 (m), 635 (m), 594 (m), 538 (m). MS (EI, 70 
eV): m/z (%) = 328 (61) [M]+, 255 (19), 227 (100), 226 (85), 225 (12), 224 (12), 113 (18). 
HRMS (EI) calcd.for C23H20O2 [M+H]+: 328.14578; found 328.145349. 
 
(E)-Ethyl-3-(pyren-1-yl)acrylate (6b): Starting with 1) (100.0 mg, 0.355 mmol), (5b) ( 53.2 
mg, 0.532 mmol),  Pd(OAc)2 (5mol%, 4.33 mg, 0.017 mmol), X-Phos 
Ligand (10mol%, 16.0 mg, 0.035 mmol), K2CO3 (98.0 mg, 0.71 
mmol) in DMF (5 ml), (6b) was isolated as a  yellow solid (92.0 mg, 
87%). Mp 94-96 °C. 1H NMR (300 MHz, CDCl3): δ = 1.34 (t, J = 
6.98 Hz, 3H, CH3), 4.29 (q, J = 14.3 Hz, 2H, CH2), 6.26 (d, J = 15.74 Hz, 1H, CH), 7.92-8.12 
(m, 8H, Py), 8.34 (d, J = 9.23 Hz, 1H, Py), 8.75 (d, J = 15.74 Hz, 1H, CH). 13C NMR (62.89 
MHz, CDCl3): δ = 30.9 (CH3), 61.2 (0CH2), 120.3 (CH), 122.5 (CH), 122.9 (C), 124.1 (CH), 
124.6 (C), 124.8 (CH), 125.0 (CH), 125.7 (CH), 125.8 (C), 125.9 (CH), 126.2 (CH), 127.3 
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(CH), 127.4 (C), 128.3 (C), 128.4 (CH), 128.5 (C), 129.7 (C), 130.7 (C), 131.3 (C), 132.6 (C), 
141.3 (CH), 167.1 (CO). IR (ATR, cm−1): ν~ = 3041 (w), 2977 (w), 2925 (w), 2904 (w), 2852 
(w), 1731 (w), 1705 (m), 1619 (m), 1538 (w), 1479 (w), 1442 (m), 1391 (w), 1340 (w), 1277 
(m), 1210 (m), 1156 (s), 1107 (m), 1053 (m), 971 (m), 897 (m), 837 (s), 788 (m), 748 (m), 
700 (m), 616 (m), 593 (m). MS (EI, 70 eV): m/z (%) = 300(64) [M]+, 255 (16), 227 (100), 226 
(86), 224 (13), 113 (27) HRMs (EI) calcd. for C21H16O2 [M+H]+: 300.114633; found 
300.11448 
 
(E)-6-Methylheptyl-3-(pyrene-1-yl)acrylate (6c): Starting with 1 (100 mg, 0.35 mmol), 5c 
(98 mg, 0.53 mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 
mmol), X-Phos (10 mol%, 16 mg, 0.035 mmol), K2CO3 
(98 mg, 0.71 mmol) in DMF (5 ml), 6c was isolated as a 
yellow oil (107 mg, 79%). 1H NMR (300 MHz, CDCl3): 
δ = 0.76-0.90 (m, 8H), 1.19-1.37 (m, 7H, CH2), 4.13-4.16 (m, 2H, OCH3), 7.91-8.22 (m, 9H, 
Py), 8.39 (d, J = 9.15 Hz, 1H, CH), 9.75 (d, J = 15.63 Hz, 1H, CH). 13C NMR (75 MHz, 
CDCl3): δ = 10.1 (CH3), 14.1 (CH3), 23.0 (CH2), 23.8 (CH2), 28.9 (CH2), 30.4 (CH2), 38.7 
(CH), 68.2 (OCH2), 120.4 (CH), 122.5(CH), 124.2 (CH), 125.1 (CH), 125.8 (CH), 126.0 
(CH), 126.3 (CH), 127.3 (CH), 128.3 (C), 128.5 (CH), 128.8 (CH), 129.7 (C), 130.7 (C), 
130.9 (CH), 131.3 (C), 132.5, (C),  132.7 (C), 141.3 (C), 167.8 (CO). IR (ATR, cm−1): ν~  = 
3435 (w), 3041 (w), 2955 (w), 2870 (w), 2731 (m), 1722 (s), 1621 (m), 1584 (w), 1510 (w), 
1460 (m), 1416 (w), 1312 (m), 1270 (s), 1209 (m), 1163 (m), 1120 (m), 1070 (m), 1039 (m), 
975 (m), 866 (m), 841 (s), 741 (m), 705 (m), 651 (w), 609 (w), 538 (w). HRMS (EI) calcd. for 
C27H28O2 [M]+: 384.20838; found 384.207745. 
 
(E)-Hexyl-3-(pyren-1-yl)acrylate (6d): Starting with 1 (100 mg, 0.35 mmol), 5d (82.9 mg, 
0.53 mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), X-
Phos (10 mol%, 16.0 mg, 0.035 mmol), K2CO3 (98 mg, 
0.71 mmol) in DMF (5 ml), 6d was isolated as a yellow oil 
(101 mg, 80%). 1H NMR (300 MHz, CDCl3): δ = 0.86 (t, J 
= 7.1 Hz 3H, CH3), 1.26-1.41 (m, 6H, CH2), 1.70 (p, J = 6.7 Hz 2H, CH2), 4.22 (t, J = 6.76, 
2H, OCH2), 6.62 (d, J = 15.73, 1H, CH), 7.90-8.19 (m, 8H, py), 8.38 (d, 3J = 9.41 Hz, 1H, 
CH), 8.73 (d, J = 15.73 Hz, 1H, CH). 13C NMR (75 MHz, CDCl3): δ = 14.1 (CH3), 22.6 
(CH2), 25.8 (CH2), 28.8 (CH2), 31.6 (CH2), 64.9 (OCH2), 120.4 (CH), 122.5 (CH), 124.2 
(CH), 124.6 (C), 124.9 (CH), 125.0 (CH),  125.8 (CH), 126.0 (CH), 126.3 (CH), 127.2 (C), 
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127.3 (CH), 128.3 (C), 128.5 (CH), 129.7 (C), 130.7 (C), 131.3 (C), 132.7,(C), 141.3 (CH), 
167.3 (CO). IR (ATR, cm−1): ν~  = 3040 (w), 2952 (m), 2926 (m), 2855 (w), 1918 (w), 1707 
(s), 1620 (m), 1478 (w), 1416 (w), 1368 (w), 1313 (m), 1241 (m), 1162 (s), 1053 (m), 975 
(m), 840 (s), 794 (w), 716 (w), 680 (w), 609 (w), 536 (w). GC-MS (EI, 70 eV): m/z (%) = 356 
(44) [M]+, 167 (36), 149 (100), 228 (19), 227 (100). HRMS (EI) calcd. for C25H24O2 [M]+: 
356.17708; found 356.176071. 
 
(E)-iso-Butyl 3-(pyren-3-yl)acrylate (6e): Starting with 1 (100 mg, 0.35 mmol), 5e (76 mg, 
0.53 mmol), Pd(OAc)2 (5 mol %,4.3 mg, 0.017 mmol), X-Phos (10 
mol%, 16 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) in DMF (5 
ml), 6e was isolated as a luminous yellow oil (100 mg, 86%). 1H 
NMR (300 MHz, CDCl3): δ = 0.97 (d, J = 6.6 Hz, 6H, CH3), 2.05-
1.99 (m, 1H, CH), 4.00 (d, J = 6.6 Hz, 2H, CH2), 6.61 (d, J = 15.6 Hz, 1H, CH), 7.89 (d, J = 
15.5 Hz, 1H, CH), 7.91-8.15 (m, 7H, CH), 8.31 (d, J = 8.4 Hz, 1H, CH), 8.70 (d, J = 15.8 Hz, 
1H, CH). 13C NMR (75 MHz, CDCl3): δ = 19.3 (CH3), 19.3 (CH3), 28.0 (CH), 70.9 (CH2), 
120.3 (CH), 122.4 (CH), 124.2 (CH), 124.6 (C), 124.9 (C), 125.0 (CH), 125.8 (CH), 125.9 
(CH), 126.3 (CH), 127.3 (CH), 128.3 (C), 128.5 (CH), 128.6 (CH), 129.7, 130.7, 131.3, 132.7 
(C), 141.3 (CH), 167.3 (CO). IR (ATR, cm−1): ν~  = 3040 (w), 2958 (w), 2872 (w), 1703 (m), 
1619 (m), 1595 (m), 1466 (w), 1374 (w), 1240 (m), 1153 (s), 1013 (m), 971 (m), 839 (s), 755 
(m), 704 (m), 679 (w), 488 (w).GC-MS (EI, 70 eV): m/z (%) = 328 [M]+, 255 (31), 249 (30), 
228 (23), 227 (100), 226 (96), 225 (12), 224 (16), 113 (15). Anal. calcd. for C23 H20O2 
(328.40): C, 84.12; H, 6.14. Found: C, 83.67; H, 6.241. HRMS (EI) calcd. for C23 H20O2 
[M]+: 328.14578; found 328.145716. 
 
(E)-tert-Butyl 3-(pyren-3-yl)acrylate (6f): Starting with 1 (100 mg, 0.35 mmol), 5f (76. mg, 
0.53 mmol), Pd(OAc)2 (5 mol %, 4.3 mg, 0.017 mmol), X-Phos (10 
mol %, 16 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) in DMF (5 
ml), 6f was isolated as a luminous yellow oil (108 g, 93%). 1H NMR 
(300 MHz, CDCl3): δ = 0.97 (s, 9H, CH3), 6.55 (d, J = 15.9 Hz, 1H, 
CH), 7.96 (d, J = 15.6 Hz, 1H, CH), 7.97-8.18 (m, 7H, CH), 8.37 (d, J = 9.0 Hz, 1H, CH), 
8.69 (d, J = 15.8 Hz, 1H, CH). 13C NMR (75 MHz, CDCl3): δ = 28.4 (CH3, t-Bu), 80.7 (C, t-
Bu), 122.3 (CH), 124.2 (CH), 124.8 (C), 124.9 (C), 125.0 (CH), 125.7 (CH), 125.9 (CH), 
126.3 (CH), 127.4 (CH), 128.4 (C), 128.5 (CH), 128.8 (CH), 128.9 (CH), 129.6, 130.8, 131.4, 
132.5 (C), 140.3 (CH), 166.5 (CO). IR (ATR, cm−1): ν~  = 3042 (w), 2959 (w), 2928 (w), 2859 
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(w), 1705 (m), 1621 (m), 1596 (m), 1458 (w), 1390 (w), 1276 (s), 1143 (s), 1070 (m), 1039 
(w), 976 (m), 840 (s), 743 (w), 706 (m), 680 (w). GC-MS (EI, 70 eV): m/z (%) = 328 [M]+, 
(44), 255 (26), 248 (30), 228 (19), 227 (100), 226 (88), 225 (17), 224 (22). HRMS (EI): calcd. 
for C23H20O2 [M]+: 328.14578; found 328.145734. 
 
(E)-Methyl-3-(pyren-3-yl)acrylate (6g): Starting with 1 (100 mg, 0.35 mmol), 5g (46 mg, 
0.53 mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), X-Phos Ligand 
(10 mol%, 16 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 mmol) in DMF (5 
ml), 6g was isolated as a yellow solid (91.mg, 90%). Mp 135-137 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.82 (s, 3H, OCH3), 6.62 (d, J = 15.6 
Hz, 1H, CH), 7.92-8.19 (m, 8H, CH), 8.39 (d, J = 9.3 Hz, 1H, CH), 8.75 (d, J = 15.9 Hz, 1H, 
CH). 13C NMR (75 MHz, CDCl3): δ = 51.9 (OCH3),  119.8 (CH), 122.5 (CH), 124.2 (CH), 
124.7 (C), 124.9 (C), 125.1 (CH), 125.9 (CH), 126.0 (CH), 126.3 (CH), 127.4 (CH), 128.2 
(C), 128.6 (CH), 128.9 (CH), 129.8 (C), 130.7 (C), 131.3 (C), 132.8 (C), 141.6 (CH), 167.6 
(CO). IR (ATR, cm−1): ν~  = 3072 (w), 3043 (w), 2956 (w), 2927 (w), 2859 (w), 1700 (s), 
1611 (m), 1592 (w), 1433 (m), 1368 (m), 1273 (m), 1121 (m), 1071 (m), 982 (m), 838 (s), 
760 (m), 707 (m), 677 (w). GC-MS (EI, 70 eV): m/z (%) = 286 (58) [M]+, 255 (14), 228 (18), 
227 (100), 226 (93), 225 (15), 224 (18), 200 (8), 113 (26), 112 (12). HRMS (EI) calcd. for 
C20H14O2 [M]+: 286.09883; found 286.098350. 
 
(E)-2-Ethylhexyl-3-(pyren-3-yl)acrylate (6h): Starting with 1 (100 mg, 0.35 mmol), 5h (111 
mg, 0.53 mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 
mmol), X-Phos (10 mol%, 16 mg, 0.03 mmol), K2CO3 (98 
mg, 0.71 mmol) in DMF (5 ml), 6h was isolated as a 
yellow oil (120 mg, 88%). 1H NMR (300 MHz, CDCl3): δ 
= 0.81-0.90 (m, 6H, CH3), 1.23-1.46 (m, 8H, CH2), 1.65-
1.71 (m, 1H, CH), 4.15 (d, J = 6.3 Hz, 2H, OCH2), 6.66 (d, J = 15.6 Hz, 1H, CH), 7.85-8.07 
(m, 8H, CH), 8.24 (d, J = 8.7 Hz, 1H, CH), 8.75 (d, J = 15.8 Hz, 1H, CH). 13C NMR (75 
MHz, CDCl3): δ = 11.2 (CH3), 14.2 (CH3), 23.0, 23.8, 29.1, 30.6 (CH2), 39.0 (CH-chain), 
67.2 (OCH2), 120.4 (CH), 122.5 (CH), 124.2 (CH), 124.7 (C), 124.9 (C), 125.1 (CH), 125.8 
(CH), 126.0 (CH), 126.3 (CH), 127.4 (CH), 128.3 (C), 128.6 (CH), 128.6 (CH), 129.7, 130.7, 
131.4, 132.7 (C), 141.3 (CH), 167.4 (CO). IR (ATR, cm−1): ν~ = 3041 (w), 2956 (w), 2925 
(w), 2857 (w), 1709 (m), 1620 (m), 1595 (m), 1459 (w), 1379 (w), 1275 (m), 1162 (s), 1030 
(w), 975 (w), 840 (s), 756 (w), 705 (m), 680 (w). GC-MS (EI, 70 eV): m/z (%) = 384 (100) 
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[M]+, 272 (17), 255 (36), 248 (30), 228 (24), 227 (88), 226 (78), 225 (10), 224 (10). Anal. 
calcd. for C27 H28O2: C, 84.34. H, 7.34. Found: C, 83.89. H, 7.652. HRMS (EI) calcd. for 
C27H28O2[M]+: 384.20838; found 384.208096. 
 
(E)-2,2,2-Trifluoroethyl-3-(pyren-3-yl)acrylate (6i): Starting with 1 (100 mg, 0.35 mmol), 
5i (67 mg, 0.532 mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 
mmol), X-Phos (10 mol%, 16 mg, 0.035 mmol), K2CO3 (98 mg, 
0.71 mmol) in DMF (5 ml), 6i was isolated as a luminous yellow 
solid (105 mg, 83%). Mp 118-120 °C. 1H NMR (300 MHz, 
CDCl3): δ = 4.75 (q, 3J = 9.0 Hz, 2H, OCH2CF3), 6.66 (d, 3J = 15.0 Hz, 1H, CH), 8.08-8.37 
(m, 8H, CH), 8.24 (d, 3J = 9.0 Hz, 1H, CH), 8.99 (d, 3J = 15.0 Hz, 1H, CH). 13C NMR (75 
MHz, CDCl3): δ = 68.1 (OCH2), 117.6 (CH), 122.5 (CH), 124.3 (CH), 124.7 (C), 124.7 (C), 
125.0 (CH), 125.2 (CH), 126.1 (CH), 126.3 (CH), 126.4 (CH), 127.4 (CH), 128.6 (C), 128.9 
(CH), 129.9, 131.8, 133.5, 133.7 (C), 143.8 (CH), 166.9 (CO). IR (ATR, cm−1): ν~  = 3045 
(w), 2956 (w), 2922 (w), 2852 (w), 1718 (m), 1614 (m), 1538 (m), 1441 (w), 1371 (w), 1267 
(m), 1138 (s), 1054 (w), 973 (w), 839 (s), 755 (w), 701 (m), 678 (w). GC-MS (EI, 70 eV): m/z 
(%) = 354 (90) [M]+, 255 (23), 228 (19), 227 (100), 226 (92), 225 (15), 224 (17), 113 (34), 
112 (13). HRMS (EI, 70 eV) calcd. for C21H13F3O2 [M]+: 354.08622 found 354.086153. 
 
(E)-2-Hydroxyethyl-3-(pyren-3-yl)acrylate (6j): Starting with 1 (100 mg, 0.35 mmol), 5j 
(56 mg, 0.53 mmol), Pd(OAc)2 (5 mol%, 4.3 mg, 0.017 mmol), 
X-Phos (10 mol%, 16 mg, 0.035 mmol), K2CO3 (98 mg, 0.71 
mmol) in DMF (5 ml), 6j was isolated as a yellow solid (84 mg, 
74%). Mp 132-134 °C. 1H NMR (300 MHz, CDCl3): δ = 1.99 (s, 
1H, OH), 3.86-3.89 (m, 2H, CH2), 4.33-4.37 (m, 2H, CH2), 6.63 
(d, J = 15.9 Hz, 1H, CH), 7.89-8.01 (m, 8H, CH), 8.38 (d, J = 8.6 Hz, 1H, CH), 8.74 (d, J = 
15.9 Hz, 1H, CH). 13C NMR (75 MHz, CDCl3): δ = 61.6, 66.4 (CH2), 119.4 (CH), 122.4 
(CH), 124.2 (CH), 124.3 (CH), 124.6 (C), 124.7 (C), 125.1 (CH), 125.9 (CH), 126.1 (CH), 
126.3 (CH), 127.3 (CH), 128.7 (CH), 130.7, 130.9, 131.3, 132.6, 132.9 (C), 142.3 (CH), 
167.5 (CO). IR (ATR, cm−1): ν~  = 3024 (w), 2961 (w), 2920 (w), 2875 (w), 1698 (m), 1617 
(m), 1599 (m), 1435 (w), 1361 (w), 1276 (m), 1088 (s), 1036 (w), 979 (w), 838 (s), 760 (w), 
703 (m), 678 (w). GC-MS (EI, 70 eV): m/z (%) = 316 (63) [M]+, 255 (28), 248 (30), 228 (20), 
227 (98), 226 (100), 225 (13), 224 (15), 113 (24). Anal. calcd. for C21H16O3; C, 79.73. H, 
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5.10. Found: C, 79.52. H, 5.334. HRMS (EI) calcd. for C21H16O3 [M]+: 316.10940; found 
316.108872. 
 
7.6 Synthesis of terphenyls from mono- and difluorinated bromobenzenes by site-
selective Suzuki-Miyaura reactions 
General Procedure for Suzuki Reactions (9a-I, 10a-h) 
A 1,4-dioxane solution (4 mL per 0.3 mmol of 7) of 7, Cs2CO3, Pd(PPh3)4, and arylboronic 
acid 8 was stirred at 90 °C for 6 or 8 h. After cooling to r.t. the organic and the aqueous layer 
were separated and the latter was extracted with CH2Cl2. The combined organic layers were 
dried (Na2SO4), filtered, and the filtrate was concentrated in vacuo. The residue was purified 
by column chromatography. 
 
1,2-Diphenyl-3,5-difluorobenzene (9a): Starting with 7 (100 mg, 0.37 mmol), Cs2CO3 (263 
mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), Phenylboronic acid (98 mg, 0.81 
mmol), and 1,4-dioxane (4 mL), 9a was isolated as a colorless solid (62 
mg, 65%). Mp 70–72 °C. 1H NMR (300 MHz, CDCl3): δ = 6.87-6.94 (m, 
1H, ArH), 6.96–7.00 (m, 1H, ArH), 7.04-7.10 (m, 4H, ArH), 7.16–7.24 
(m, 6H, ArH). 13C NMR (62.89 MHz, CDCl3): 13C NMR (62.89 MHz, CDCl3): δ = 102.7 (d, 
J = 27.9 Hz, CH), 112.9 (d, J = 3.1 Hz, CH), 127.2 (2CH), 127.8 (2CH), 127.9 (2CH), 129.6 
(2CH), 131.0 (2CH), 133.4 (C), 139.4 (t, J = 2.1 Hz, C), 144.4 (d, J = 9.18 Hz, C), 160.0 (dd, 
J = 247.2 12.3 Hz, CF), 161.3 (dd, J = 248.2, 12.6 Hz, CF).  19F NMR (282.4 MHz, CDCl3): δ 
= –110.61 (CF), –111.64 (CF). IR (ATR, cm−1): ν̃ = 3065 (w), 3027 (w), 2923 (w), 2852 (w), 
1617 (m), 1589 (m), 1537 (w), 1498 (w), 1465 (m), 1438 (m), 1413 (m), 1328 (m), 1265 (w), 
1204 (w), 1155 (w), 1139 (m), 1101 (m), 1038 (w), 997 (m), 918 (w), 874 (w), 866 (m), 840 
(m), 780 (m), 766 (s), 716 (w), 697 (s), 632 (m), 597 (m), 557 (m). MS (EI, 70 eV): m/z (%) = 
266 (100) [M]+, 264 (14), 251 (36), 244 (26), 238(10). HRMS (EI) calcd. for C18H12F2 [M]+: 
266.09016; found 266.090819. 
 
1,2-Di(4´-methylphenyl)-3,5-difluorobenzene (9b): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 4-
methylphenylboronic acid (110 mg, 0.81 mmol) and 1,4-dioxane (4 mL), 
9b was isolated as a colorless solid (48 mg, 45%). Mp 68-70 °C. 1H 
NMR (300 MHz, CDCl3): δ = 2.38 (s, 3H, CH3) 2.40 (s, 3H, CH3), 6.92-
6.96 (m, 2H, ArH), 7.02-7.06 (m, 4H, ArH), 7.08-7.10 (m, 4H, ArH). 13C NMR (75 MHz, 
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CDCl3): δ = 21.1, (CH3) 21.3 (CH3), 102.6 (t, J = 24.8 Hz, CH), 112.9 (d, J = 18.5 Hz, CH), 
124.4 (d, J = 12.5 Hz, CH), 128.8 (4CH), 129.8 (4CH), 130.8 (2C), 136.7 (2C), 144.4 (dd, J = 
4.5, 4.5 Hz, C), 159.1 (dd, J = 246.1, 11.8 Hz, CF), 160.1 (dd, J  = 247.2, 12.6 Hz, CF).19F 
NMR (282 MHz, CDCl3): δ = −110.24 (CF), −111.73 (CF). IR (ATR, cm−1): ν̃ = 3027 (w), 
2973 (w), 2923 (w), 2865 (w), 1905 (w), 1611 (w),  1587 (w), 1514 (w), 1453 (w), 1399 (w), 
1335 (w), 1267 (w), 1202 (w), 1141 (w), 1111 (w), 1098 (w), 997 (w), 945 (w), 844 (w), 815 
(w), 756 (w), 716 (w), 665 (w), 623 (w), 599 (w), 520 (m). MS (EI, 70 eV): m/z (%) = 294 
(100) [M]+, 293 (13), 280 (18), 275 (12), 265(14). HRMS (EI) calcd. for C20H16F2 [M]+: 
294.12146; found 294.121005. 
 
1,2-Di(2´-methoxyphenyl)-3,5-difluorobenzene (9c): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 2-
methoxyphenylboronic acid (123 mg, 0.81 mmol), and 1,4-dioxane (4 
mL), 9c was isolated as a colorless solid (71 mg, 60%). Mp 111–113 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.42 (s, 3H, OCH3), 3.55 (s, 3H, OCH3), 
6.60 (dd, J = 8.3, 0.7 Hz, 1H, ArH), 6.67–6.88 (m, 6H, ArH), 6.94 (dd, J = 
7.5, 1.7 Hz, 1H, ArH), 7.05–7.12 (m, 2H, ArH). 13C NMR (62.89 MHz, CDCl3): δ = 54.9 
(OCH3), 55.2 (OCH3), 102.6 (t, J  = 26.5 Hz, CH), 110.2 (CH), 110.3 (CH), 113.2 (dd, J = 
21.2, 3.5 Hz, CH), 119.7 (CH), 119.9 (CH), 122.1 (dd, J = 17.1, 3.8 Hz, C), 123.1 (C), 128.6 
(t, J = 2.1 Hz, C), 128.90 (CH), 128.92 (CH), 131.0 (CH), 131.7 (CH), 141.9 (t, J = 4.9 Hz, 
C), 156.0 (C), 157.0 (C), 160.1 (dd, J = 247.2, 12.8 Hz, CF), 161.6 (dd, JcF = 247.2, 13.3 Hz, 
CF). 19F NMR (282.4 MHz, CDCl3): δ = –112.82 (CF), –118.20 (CF). IR (ATR): ν̃ = 3067 
(w), 2956 (w), 2926 (w), 2835 (w), 1616 (w), 1596 (w), 1503 (w), 1494 (w), 1455 (w), 1421 
(w), 1338 (w), 1287 (w), 1247 (m), 1201 (w), 1180 (w), 1120 (w), 1089 (w), 1024 (m), 928 
(w), 877 (w), 865 (w), 800 (w), 755 (w), 744 (m), 701 (w), 635 (w), 586 (m), 537 (w) cm-1. 
MS (EI, 70 eV): m/z (%) = 326 (100) [M]+, 295 (12), 251 (21), 238 (10). HRMS (EI) calcd. 
for C20H16O2F2 [M]+: 326.11129; found 326.11090. 
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1,2-Di(4-methoxyphenyl)-3,5-difluorobenzene (9d): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 2-
methoxyphenylboronic acid (123 mg, 0.81 mmol), and 1,4-dioxane 
(4 mL), 9d was isolated as a colorless oil (58 mg, 70%). 1H NMR 
(300 MHz, CDCl3): δ = 3.59 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 
6.61-6.95 (m, 10H, ArH). 13C NMR (62.89 MHz, CDCl3): δ = 55.0 
(OCH3), 55.2 (OCH3), 102.6 (dd, J = 29.3, 2.02 Hz, 2CH), 113.4 (d, J = 2.86 Hz, 2CH), 114.2 
(2CH), 125.8 (C), 127.7 (CH), 130.7 (2CH), 131.9 (t, J = 2.91 Hz, CH), 132.0 (CH), 144.0 
(dd, J = 9.57, 4.16 Hz, C), 158.7 (d, J = 10.8 Hz, C), 160.3 (dd, JCF = 247.0, 12.9 Hz, CF), 
161.6 (dd, JCF = 248.1, 14.5 Hz, CF). 19F NMR (282.4 MHz, CDCl3): δ = –110.45 (CF), –
111.95 (CF). IR (ATR): ν̃ = 3076 (w), 3035 (w), 2955 (w), 2933 (w), 2836 (w), 2537 (w), 
2047 (w), 1887 (w), 1726 (w), 1607 (s), 1587 (s), 1512 (s), 1461 (s), 1439 (s), 1402 (m), 1335 
(w), 1289 (m), 1242 (s), 1204 (m), 1175 (s), 1139 (s), 1098 (s), 1034 (s), 997 (s), 874 (m), 
827 (s), 799 (s), 760 (m), 732 (m), 665 (w), 585 (s), 543 (s) cm-1. MS (EI, 70 eV): m/z (%) = 
326 (100) [M]+, 251 (21), 239 (11), 238 (11). HRMS (EI) calcd. for C20H16O2F2 [M]+: 
326.11129; found 326.111300 
 
1,2-Di(4´-ethoxyphenyl)-3,5-difluorobenzene (9e): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 4-
ethoxyphenylboronic acid (135 mg, 0.81 mmol), and 1,4-dioxane (4 
mL) 9e was isolated as a colorless solid (88 mg, 68%). Mp 69–71 
°C. 1H NMR (300 MHz, CDCl3): δ = 1.36-1.43 (m, 4H, CH2), 3.94-
4.03 (m, 6H, OCH3), 6.69-7.01 (m, 10H, ArH). 13C NMR (62.89 
MHz, CDCl3): δ = 14.8 (CH3), 14.9 (CH3), 63.2 (OCH2), 63.3 (OCH2), 102.3 (t, J = 26.5 Hz, 
CH), 112. (dd, J = 21.8, 3.6 Hz, CH), 113.9 (2CH), 114.0 (2CH), 114.7 (2CH), 125.6 (C), 
127.7 (C), 130.7 (2CH), 131.0 (C), 132.2 (C), 157.9 (C), 158.1 (C), 160.0 (dd, JCF = 249.2, 
12.6 Hz, CF), 161.1 (dd, JCF = 249.2, 13.3 Hz, CF). 19F NMR (282.4 MHz, CDCl3): δ = –
110.09 (CF), –112.02 (CF). IR (ATR, cm−1): ν̃ = 3062 (w), 3036 (w), 2975 (w), 2929 (w), 
2873 (w), 1730 (w), 1605 (m), 1586 (m), 1511 (m), 1460 (m), 1432 (m), 1393 (m), 1335 (w), 
1285 (m), 1239 (s), 1177 (m), 1110 (m), 1046 (m), 997 (m), 934 (w), 867 (m), 819 (s), 758 
(m), 647 (w), 616 (m), 594 (w), 559 (m), 536 (m). MS (EI, 70 eV): m/z (%) = 354 (100) [M]+, 
326 (21), 298 (30), 297 (22), 251 (24). HRMS (EI) calcd. for C22H20O2F2 [M]+: 354.14259; 
found 354.142299 
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1,2-Di(2´,4´-dimethoxyphenyl)-3,5-difluorobenzene (9f): Starting with 7 (100 mg, 0.37 
mmol), Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 2,4-
dimethoxyphenylboronic acid (148 mg, 0.81 mmol), and 1,4-
dioxane (4 mL), 9f was isolated as a colorless solid (81 mg, 58%). 
Mp 96–98 °C. 1H NMR (300 MHz, CDCl3): δ = 3.44 (s, 3H, OCH3), 
3.56 (s, 3H, OCH3), 3.68 (s, 3H, OCH3), 3.69 (s, 3H, OCH3), 6.20-
6.30 (m,3H, ArH), 6.72-6.85 (m,3H, ArH), 7.29-7.42 (m,1H, ArH), 761-766 (m,1H, ArH). 
13C NMR (62.89 MHz, CDCl3): δ = 55.0 (OCH3), 55.2 (OCH3), 55.3 (OCH3), 55.4 (OCH3), 
98.1 (d, J = 12.7 Hz, CH), 98.9 (C), 102.4 (d, J = 109.9 Hz, C), 103.8 (d, J = 16.3 Hz, CH), 
113.2 (d, J = 14.5 Hz, C), 113.8 (d, J = 16.5 Hz, CH), 115.8 (C), 121.2 (t, J = 9.25 Hz, C), 
127.9 (t, J = 21.7 Hz, H), 130.2 (C), 131.4 (CH), 131.9 (C), 134.7 (t, J = 25.5 Hz, CH), 157.5 
(d, J = 245.5 Hz, CF), 160.0 (C), 160.3 (C). 19F NMR (282.4 MHz, CDCl3): δ = –110.09 
(CF), –113.03 (CF). IR (ATR, cm−1): ν̃ = 3054 (w), 2997 (w), 2921 (w), 2851 (w), 1607 (w), 
1579 (w), 1508 (w), 1461 (w), 1435 (w), 1410 (w), 1337 (w), 1280 (w), 1205 (m), 1156 (m), 
1124 (w), 1092 (m), 1030 (m), 981 (w), 935 (w), 830 (w), 647 (w), 723 (w), 692 (w), 613 (w), 
588 (w), 540 (w). MS (EI, 70 eV): m/z (%) = 386 (100) [M]+, 355 (11). HRMS (EI) calcd. for 
C22H20O4F2 [M]+: 386.13242; found 386.132496 
 
1,2-Di(4´-Fluorophenyl)-3,5-difluorobenzene (9g): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 4-
fluorophenylboronic acid (114 mg, 0.81 mmol), and 1,4-dioxane (4 
mL), 9g was isolated as a colorless solid (49 mg, 45%). Mp 96–98 °C. 
1H NMR (300 MHz, CDCl3): δ = 6.79-6.88 (m, 1H, ArH), 6.96–7.09 
(m, 1H, ArH), 7.22-7.45 (m, 8H, ArH).13C NMR (62.89 MHz, CDCl3): 
δ = 103.9 (d, J = 3.09 Hz, C), 113.5 (t, J = 3.2 Hz, CH), 115.1 (CH), 115.6 (CH), 115.9 (CH), 
128.2 (CH), 128.5 (CH), 128.6 (d, J = 2.7 Hz, CH), 128.9 (CH), 129.0 (CH), 130.5 (CH), 
130.7 (C), 133.7 (CH), 136.1 (d, J = 216.5 Hz, CF), 136.6 (d, J = 255.4 Hz, CF), 138.4 (C), 
153.5 (d, J = 234.7 Hz, CF), 157.6 (d, J = 245.8 Hz, CF). 19F NMR (282.4 MHz, CDCl3): δ = 
–98.84 (CF), –109.67 (CF), –111.15 (CF), –115.15 (CF). IR (ATR, cm−1): ν̃ = 3084 (w), 3050 
(w), 2925 (w), 1903 (w), 1619 (w), 1587 (m), 1494 (m), 1474 (m), 1424 (m), 1348 (m), 1279 
(w), 1222 (m), 1157 (m), 1113 (m), 1088 (s), 1029 (w), 1001 (s), 943 (w), 847 (m), 811 (s), 
723 (m), 701 (m), 626 (m), 605 (s), 545 (m). MS (EI, 70 eV); m/z (%) = 302 (100) [M]+, 282 
(18). HRMS (EI) calcd. for C18H10OF4 [M]+: 302.07131; found 302.070651. 
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1,2-Di(3-methoxyphenyl)-3,5-difluorobenzene (9h): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 3-
methoxyphenylboronic acid (123 mg, 0.81 mmol), and 1,4-dioxane (4 
mL), 9h was isolated as a colorless solid (58 mg, 70%). Mp 118–120 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.43 (s, 3H, OCH3), 3.57 (s, 3H, 
OCH3), 6.61 (d, J = 7.69 Hz, 1H, ArH), 6.66-6.97 (m, 7H, ArH), 7.06-
713 (m, 2H, ArH). 13C NMR (62.89 MHz, CDCl3): δ = 55.4 (OCH3), 55.9 
(OCH3), 102.6 (t,. J = 26.4 Hz, C), 110.4 (CH), 113.1 (d, J = 3.6 Hz, CH), 119.2 (d, J = 16.5 
Hz, CH) 123.1 (C), 128.6 (t, J = 2.9 Hz, CH), 130.0 (C), 131.0 (2CH), 156.0 (C), 157.0 (C), 
159.0 (dd, JCF = 247.4, 14.31 Hz, CF), 161.7 (dd, JCF = 247.4, 14.31 Hz, CF). 19F NMR 
(282.4 MHz, CDCl3): δ = –110.45 (CF), –111.95 (CF). IR (ATR): ν̃ = 3055 (w), 2922 (w), 
2851 (w), 1726 (w), 1618 (w), 1590 (w), 1580 (w), 1494 (w), 1436 (m), 1377 (w), 1336 (w), 
1277 (w), 1245 (w), 1177 (m), 1117 (s), 1091 (m), 1026 (m), 996 (m), 877 (w), 838 (w), 798 
(w), 747 (s), 720 (s), 692 (s), 637 (m), 587 (w), 538 (s) cm-1. MS (EI, 70 eV); m/z (%) = 326 
(100) [M]+, 295 (13), 251 (22), 238 (11). HRMS (EI) calcd. for C20H16O2F2 [M]+: 326.11129; 
found 326.110991. 
 
1,2-Di(3-methylphenyl)-3,5-difluorobenzene (9i): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 3-
methylphenylboronic acid (110 mg, 0.81 mmol) and 1,4-dioxane (4 mL), 
9i was isolated as a colorless solid (51 mg, 48%). Mp 73-75 °C. 1H NMR 
(300 MHz, CDCl3): δ = 2.38 (s, 3H, CH3) 2.40 (s, 3H, CH3), 6.92-6.96 (m, 
2H, ArH), 7.02-7.06 (m, 4H, ArH), 7.08-7.10 (m, 4H, ArH). 13C NMR (75 
MHz, CDCl3): δ = 21.1, 21.3 (ArCH3), 102.6 (t, J = 24.8 Hz, CH), 112.9 
(d, J = 18.5 Hz, CH), 124.4 (d, J = 12.5 Hz, C), 128.8 (4CH), 129.8 (4CH), 130.8 (2C), 136.7 
(2C), 144.4 (dd, J = 4.5, 4.5 Hz, C), 159.1 (dd, 1JCF = 246.1, 11.8 Hz, CF), 160.1 (dd, 1JCF = 
247.2, 12.6 Hz, CF).19F NMR (282 MHz, CDCl3): δ = −110.69 (CF), −112.19 (CF). IR (ATR, 
cm−1): ν̃ = 3087 (w), 3052 (w), 2974 (w), 2923 (w), 2865 (w), 1905 (w), 1610 (w),  1587 (m), 
1514 (w), 1453 (w), 1398 (w), 1335 (m), 1310 (w), 1277 (w), 1201 (w), 1141 (m), 1111 (w), 
1097 (m), 997 (m), 968 (w), 870 (m), 844 (m), 815 (s), 756 (w), 726 (m), 664 (w), 623 (m), 
598 (w), 530 (w). MS (EI, 70 eV): m/z (%) = 294 (100) [M]+, 293 (12), 280 (18), 279 (87), 
278 (22), 277 (11), 265(14), 264 (45), 259 (10), 257 (10). HRMS (EI) calcd. for C20H16F2 
[M]+: 294.12146; found 294.121750. 
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2-Bromo-3,5-difluoro-4`-methylbiphenyl (10a): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (119 mg, 0.37 mmol), Pd(PPh3)4 (3 mol%), 4-
methylphenylboronic acid (50 mg, 0.37 mmol), and 1,4-dioxane (4 
mL), 10a was isolated as a colorless solid (46 mg, 45%). Mp 68–70 °C. 
1H NMR (300 MHz, CDCl3): δ = 6.85–6.92 (m, 2H, Ar), 7.23–67.29 
(m, 4H, Ar). 13C NMR (75.46 MHz, CDCl3): δ = 21.3 (CH3), 103.5 (t, J 
= 26.6 Hz, CH), 104.9 (dd, J = 20.1, 4.3 Hz, CH), 113.8 (dd, J = 22.6, 3.7 Hz, C), 128.9 (CH), 
129.0 (CH), 136.3 (t, J = 2.8 Hz, C), 138.4 (C), 159.6 (dd, JCF = 248.1, 13.2 Hz, CF), 159.9 
(CH), 161.6 (dd, JCF = 249.4, 13.6 Hz, CF). 19F NMR (282.4 MHz, CDCl3): δ = –98.94 (CF), 
–111.30 (CF). IR (ATR): ν̃ = 3086 (w), 3028 (w), 2989 (w), 2921 (w), 2856 (w), 1914 (w), 
1747 (w), 1666 (w), 1604 (w), 1584 (m), 1514 (m), 1468 (w), 1421 (m), 1398 (m), 1350 (m), 
1278 (w), 1205 (w), 1183 (w), 1139 (m), 1111 (m), 1042 (w), 998 (m), 949 (w), 870 (m), 818 
(s), 782 (m), 710 (m), 641 (w), 606 (m), 597 (m), 579 (m). MS (EI, 70 eV): m/z (%) = 284 
(97) [M]+ (81Br), 283 (22), 282 (100) (79Br), 201 (67), 183(53). HRMS (EI) calcd. for C13H9 
79BrF2 [M]+: 281.98502; found 281.170318. 
 
2-Bromo-3,5-difluoro-2`-methoxybiphenyl (10b): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (119 mg, 0.37 mmol), Pd(PPh3)4 (3 mol%), 2-
methoxyphenylboronic acid (56 mg, 0.37 mmol), and 1,4-dioxane (4 mL), 
10b was isolated as a colorless oil (65 mg, 60%). 1H NMR (300 MHz, 
CDCl3): δ = 3.68 (s, 3H, OCH3), 6.75-6.81 (m, 1H, ArH), 6.86-6.95 (m, 
2H, ArH), 7.03 (dd, J = 7.45, 2.00 Hz, 1H, ArH), 7.27-74 (m, 1H, ArH), 7.55-7.62 (m, 1H, 
ArH). 13C NMR (62.89 MHz, CDCl3): δ = 55.6 (OCH3), 103.6 (t, J = 27.4 Hz, CH), 106.5 (q, 
J = 20.7 Hz, CH), 111.0 (C), 114.2 (dd, J = 3.71 Hz, C), 120.5 (CH), 128.5 (CH), 130.3 (d, J 
= 26.2 Hz, C), 132.2 (CH), 156.4 (C), 159.2 (dd, JCF = 247.6, 13.4 Hz, CF), 161.3 (dd, JCF = 
248.3, 12.7 Hz, CF). 19F NMR (282.4 MHz, CDCl3): δ = –100.33 (CF), –111.80 (CF). IR 
(ATR): ν̃ = 3090 (w), 3056 (w), 3016 (w), 2936 (w), 2835 (w), 1614 (m), 1580 (m), 1495 (m), 
1434 (s), 1345 (m), 1296 (m), 1241 (s), 1196 (m), 1119 (s), 1071 (w), 1022 (s), 996 (s), 939 
(w), 873 (s), 844 (s), 779 (w), 751 (s), 719 (s), 692 (s), 639 (m), 596 (s), 538 (s) cm-1. MS (EI, 
70 eV): m/z (%) = 300 (37) [M]+, (81Br), 298 (79Br) (37), 219 (33), 205 (12), 204 (100), 188 
(14), 175 (21). HRMS (EI) calcd. for C13H9O79BrF2 [M]+: 297.97994; found 297.980349, 
C13H9O81BrF2 [M]+: 299.97789; found 299.978435. 
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2-Bromo-3,5-difluoro-4`-methoxybiphenyl (10c): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 4-
methoxyphenylboronic acid (56 mg, 0.37 mmol), and 1,4-dioxane (4 
mL), 10c was isolated as a colorless solid (65 mg, 60%). Mp 61–62 
°C. 1H NMR (300 MHz, CDCl3): δ = 3.86 (s, 3H, OCH3), 6.84-6.98 
(m, 4H, ArH), 7.30-7.35 (m, 2H, ArH). 13C NMR (62.89 MHz, CDCl3): δ = 55.3 (OCH3), 
103.6 (t, J = 26.8 Hz, CH), 113.6 (2CH), 113.9 (d, J = 3.58 Hz, CH), 114.4 (C), 115.1 (C), 
130.4 (2CH), 131.5 (t, J = 2.2 Hz, C), 145.3 (d, J = 8.3 Hz, C) 159.6 (C), 160.0 (dd, JCF = 
238.0, 13.4 Hz, CF), 161.4 (dd, JCF = 248.3, 12.7 Hz, CF). 19F NMR (282.4 MHz, CDCl3): δ 
= –98.86 (CF), –111.35 (CF). IR (ATR): ν̃ = 3094 (w), 3013 (w), 2964 (w), 2914 (w), 2836 
(w), 1889 (w), 1604 (s), 1588 (s), 1514 (s), 1496 (m), 1445 (m), 1377 (m), 1292 (m), 1244 (s), 
1205 (m), 1183 (s), 1140 (m), 1071 (w), 1029 (m), 998 (s), 937 (w), 870 (s), 833 (s), 799 (m), 
753 (m), 708 (w), 679 (m), 641 (m), 600 (s), 569 (s) cm-1. MS (EI, 70 eV): m/z (%) = 300 
(100) [M]+ (81Br), 299 (14), 298 (98) (79Br), 285 (12), 283 (12), 257 (18), 255 (18), 188 (11), 
176 (32), 175 (39). HRMS (EI) calcd. for C13H9O79BrF2 [M]+: 297.97994; found 297.979859 
C13H9O81BrF2 [M]+: 299.97789; found 299.977797. 
 
2-Bromo-3,5-difluoro-4`-ethoxybiphenyl (10d): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (119 mg, 0.37 mmol), Pd(PPh3)4 (3 mol%), 4-
ethoxyphenylboronic acid (61 mg, 0.37 mmol), and 1,4-dioxane (4 
mL), 10d was isolated as a colorless solid (74 mg, 65%). Mp 111–113 
°C. 1H NMR (300 MHz, CDCl3): δ = 1.44 (t, J = 6.95 Hz, 3H, CH3), 
4.07 (q, J = 6.95, 3H, OCH3), 3.55 (s, 3H, OCH3), 6.83–6.97 (m, 3H, ArH), 7.28–7.34 (m, 
3H, ArH). 13C NMR (62.89 MHz, CDCl3): δ = 14.8 (CH3), 63.5 (OCH2), 103.2 (t, J = 27.0 
Hz, CH), 113.5 (d, J = 4.0 Hz, CH), 113.7 (dd, J = 22.2, 3.4 Hz, C), 114.1 (2CH), 128.4 (d, J 
= 6.9 Hz,CH), 128.7 (CH), 130.4 (CH), 133.7 (CH), 141.3 (d, J = 9.4 Hz, C), 159.0 (C), 159.3 
(dd, JCF = 247.9, 13.3 Hz, CF), 161.3 (dd, JCF = 249.5, 13.3 Hz, CF). 19F NMR (282.4 MHz, 
CDCl3): δ = –101.8 (CF), –112.5 (CF). IR (ATR): ν̃ = 3067 (w), 2956 (w), 2926 (w), 2835 
(w), 1616 (w), 1596 (w), 1503 (w), 1494 (w), 1455 (w), 1421 (w), 1338 (w), 1287 (w), 1247 
(m), 1201 (w), 1180 (w), 1120 (w), 1089 (w), 1024 (m), 928 (w), 877 (w), 865 (w), 800 (w), 
755 (w), 744 (m), 701 (w), 635 (w), 586 (m), 537 (w) cm-1. MS (EI, 70 eV): m/z (%) = 312 
(61) (79Br) [M]+, 287 (12), 286 (98), 284 (100), 204(10). HRMS (EI) calcd. for 
C14H11O81BrF2 [M]+: 313.99354; found 313.993486 
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2-Bromo-3,5-difluoro-3`,4`-dimethoxybiphenyl (10e): Starting with 7 (100 mg, 0.37 
mmol), Cs2CO3 (119 mg, 0.37 mmol), Pd(PPh3)4 (3 mol%), 3,4-
dimethoxyphenylboronic acid (67 mg, 0.37 mmol), and 1,4-
dioxane (4 mL), 10e was isolated as a colorless solid (72 mg, 
60%). Mp 110–112 °C. 1H NMR (300 MHz, CDCl3): δ = 3.84 (s, 
3H, OCH3), 3.87 (s, 3H, OCH3), 6.78–6.88 (m, 5H, ArH). 13C 
NMR (75.46 MHz, CDCl3): δ = 55.9 (OCH3), 56.0 (OCH3), 103.4 (t, J = 27.2 Hz, CH), 110.7 
(CH), 112.5 (CH), 113.8 (dd, J = 22.7, 3.41 Hz, CH), 121.7 (CH), 131.1 (C), 148.4 (C), 149.1 
(C), 158.2 (C), 158.4 (C), 159.22 (dd, J = 248.0, 13.7 Hz, CF), 161.3 (dd, J = 248.6, 13.2 Hz, 
CF). 19F NMR (282.4 MHz, CDCl3): δ = –98.7 (CF), –111.6 (CF). IR (ATR): ν̃ = 3062 (w), 
3016 (w), 2961 (w), 2848 (w), 1607 (w), 1579 (w), 1518 (w), 1468 (w), 1437 (w), 1398 (w), 
1323 (w), 1283 (w), 1235 (w), 1188 (w), 1137 (w), 1108 (w), 1044 (w), 999 (w), 911 (w), 865 
(w), 828 (w), 790 (w), 730 (w), 666 (w), 628 (w), 597 (w), 556 (w). MS (EI, 70 eV): m/z (%) 
= 330 (81Br) (97) [M]+, 329 (15), 328 (79Br) (100), 287 (16), 206(62), 191 (12), 188 (19). 
HRMS (EI) calcd. for C14H11O281BrF2 [M]+: 329.98845; found 329.988725. 
 
2-Bromo-3,5-difluoro-2',6'-dimethoxybiphenyl (10f): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (263  mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 2,6-
dimethoxyphenylboronic acid (67 mg, 0.37 mmol) and 1,4-dioxane (4 
mL), 10f was isolated as a colorless solid (82 mg, 68%). Mp 121-123 °C. 
1H NMR (300 MHz, CDCl3): δ =3.76 (s, 6H, OCH3), 6.66 (d, J = 8.4 Hz, 
2H, CH), 6.81-6.89 (m, 2H, CH), 7.41 (t, J = 9.0, 1H, ArH). 13C NMR (75 MHz, CDCl3): δ = 
55.9 (2OCH3), 103.0 (C), 103.4 (t, J = 26.6 Hz, CH), 103.9 (2CH), 114.0 (C), 114.8 (d, J = 
4.5 Hz, CH), 130.1 (CH), 138.2 (C), 157.2 (2C), 157.4 (dd, JCF = 247.0 Hz, 12.9 Hz, CF), 
160.3 (dd, JCF = 247.6 Hz, 12.1 Hz, CF). 19F NMR (282 MHz, CDCl3): δ = −101.15 (CF), 
−112.73 (CF). IR (ATR, cm−1): ν̃ = 3086 (w), 3017 (w), 2959 (m), 2838 (w), 1590(s), 1472 
(s), 1416 (m), 1110 (s), 867 (s), 778 (s), 724 (s), 599 (s). GC-MS (EI, 70 eV): m/z (%) = 328 
[M]+, (37), 249 (11), 234 (100), 219 (16), 191 (16), 175 (12), 163 (6). ESI-HRMS calcd. for 
C14H12BrF2O2 [M+H]+: 328.9983; found 328.9983. 
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2-Bromo-3,5-difluoro-2`,4`-dimethoxybiphenyl (10g): Starting with 1 (100 mg, 0.37 
mmol), Cs2CO3 (119 mg, 0.37 mmol), Pd(PPh3)4 (3 mol%), 2,4-
dimethoxyphenylboronic acid (67 mg, 0.37 mmol), and 1,4-dioxane 
(4 mL), 10g was isolated as a colorless solid (81 mg, 67%). Mp 64–
66 °C. 1H NMR (300 MHz, CDCl3): δ = 3.75 (s, 3H, OCH3), 3.89 (s, 
3 H, OCH3), 6.53–6.57 (m, 2H, Ar), 6.82–6.88 (m, 2H, Ar), 7.04 (d, J = 8.9 Hz, 1H, Ar). 13C 
NMR (75.46 MHz, CDCl3): δ = 55.4 (OCH3), 55.6 (OCH3), 98.7 (CH), 103.4 (t, J = 26.6 Hz, 
CH), 104 (CH), 106.9 (dd, J = 20.4, 4.0 Hz, C), 114.5 (dd, J = 22.3, 3.3 Hz, CH), 121.0 (t, J = 
2.2, C), 131.1 (CH), 142.9 (d, J = 9.8 Hz, C), 157.4 (C), 159.22 (dd, JCF = 248.0, 13.7 Hz, 
CF), 161.3 (dd, JCF = 248.6, 13.2 Hz, CF) 161.4 (C). 19F NMR (282.4 MHz, CDCl3): δ = –
100.5 (CF), –112.4 (CF). IR (ATR): ν̃ = 3079 (w), 3002 (w), 2958 (w), 2937 (w), 2836 (w), 
1692 (s), 1785 (s), 1509 (s), 1463 (m), 1447 (m), 1468 (w), 1435 (s), 1345 (w), 1304 (s), 1281 
(m), 1256 (m), 1206 (s), 1146 (m), 1127 (s), 1101 (s), 1031 (s), 997 (s), 924 (m), 833 (s), 796 
(m), 716 (w), 637 (w), 599 (s), 587 (m) cm–1. MS (EI, 70 eV): m/z (%) = 330 (81Br) (95) [M]+, 
328 (81Br) (93), 329 (15), 331 (14), 235 (15), 234 (100), 219 (35), 204(12), 191 (20), 175 
(26), 163 (13). ESI-HRMS calcd. for C14H1279BrF2O2 [M+H]+: 328.9983; found 328.9979. 
 
2-Bromo-3,5-difluoro-4-fluorobiphenyl (10h): Starting with 7 (100 mg, 0.37 mmol), 
Cs2CO3 (263  mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 4-
fluorophenylboronic acid (52 mg, 0.37 mmol) and 1,4-dioxane (4 mL), 
10h was isolated as a colorless solid (66 mg, 63%). Mp 146-148 °C. 
1H NMR (300 MHz, CDCl3): δ = 6.74-6.80 (m, 2H, CH), 6.96-7.12 
(m, 2H, CH), 7.20-7.26 (m, 2H, CH). 13C NMR (75 MHz, CDCl3): δ = 
103.8 (t, J = 27.0 Hz, CH), 104.9 (d, J = 25.0 Hz, CBr), 103.4 (CH), 113.6 (dd, J = 19.5 Hz, J 
= 3.0, CH), 115.2 (CH), 130.9 (CH), 131.04 (CH), 135.1 (C), 144.6 (C), 157.9 (dd, 1JCF = 
248.0 Hz, 3JCF =12.9 Hz, CF), 161.3 (dd, 1JCF = 248.6 Hz, 3JCF = 12.8 Hz, CF), 161.1 (d, 
1JCF= 245.0 Hz, CF).19F NMR (282 MHz, CDCl3): δ = -98.53 (CF), -110.91 (CF), -112.80 
(CF). IR (ATR, cm−1): ν̃ = 3340 (w), 2921 (w), 2852 (w), 1904 (w), 1711 (w), 1470 (w), 1455 
(w), 1388 (w), 1087 (s), 1002 (s), 811 (s), 701 (m), 625 (w), 544 (m). GC-MS (EI, 70 eV): 
m/z (%) = 286 (100) (81Br) [M]+, 207 (23), 206 (77), 188 (11), 187 (20), 186 (13), 103 (11), 
93 (5). HRMS (EI, 70 eV) calcd. for C12H6BrF3 [M]+: 285.95995; found 285.959530 and 
calcd for C12H681BrF3 [M]+: 287.95790; found 287.957528. 
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General Procedure for the Synthesis of 11a–g 
The reaction was carried out in a pressure tube. To a dioxane suspension (4 mL) of 7 (200 mg, 
0.74 mmol), Pd(PPh3)4 (3 mol%), and Ar1B(OH)2 (0.74 mmol) was added Cs2CO3 (359 mg, 
1.11 mmol), and the resultant solution was degassed by bubbling argon through the solution 
for 10 min. The mixture was heated at 90 °C under Argon atmosphere for 8 h. The mixture 
was cooled to 20 °C and Ar2B(OH)2 (0.89 mmol) and Cs2CO3 (359 mg, 1.11 mmol) was 
added. The reaction mixtures were heated under Argon atmosphere for 6 h at 100 °C. They 
were diluted with H2O and extracted with CH2Cl2 (3 × 50 mL). The combined organic layers 
were dried (Na2SO4), filtered, and the filtrate was concentrated in vacuo. The residue was 
purified by flash chromatography (silica gel, EtOAc: hexane = 1:4). 
 
1-(4´-Methylphenyl)-2-(2´´,4´´-dimethoyphenyl)-3,5-difluorobenzene (11a): Starting with 
7 (200 mg, 0.74 mmol), Cs2CO3 (359 mg, 1.11 mmol), Pd(PPh3)4 (3 
mol%), 4-methylboronic acid (100 mg, 0.74 mmol), 2,4-
dimethoxyphenylboronic (161 mg, 0.88 mmol), 1,4-dioxane (4 mL), 
and 11a was isolated as a colorless highly viscous oil (140 mg, 
56%). 1H NMR (300 MHz, CDCl3): δ = 2.19 (s, 3H, CH3), 3.32 (s, 
3H, OCH3), 3.69 (s, 3H, OCH3), 6.17 (d, J = 2.3 Hz, 1H, Ar), 6.32 (dd, J = 8.3, 2.3 Hz, 1 H, 
Ar), 6.74–6.83 (m, 2H, Ar), 6.86–6.91 (m, 5H, Ar). 13C NMR (62.89 MHz, CDCl3): δ = 21.2 
(CH3), 55.0 (OCH3), 55.3 (OCH3), 98.4 (CH), 102.5 (t, J = 26.3 Hz, CH), 104.1 (CH), 113.6 
(dd, J = 21.9, 3.6 Hz, CH), 121.5 (t, J = 2.8 Hz, C), 125.7 (dd, J = 15.3, 3.6 Hz, C), 128.1 
(2CH), 130.0 (2CH), 131.1 (C), 131.6 (CH), 136.4 (C), 141.2 (dd, J = 9.6, 4.5 Hz, C), 157.0 
(C), 159.8 (dd, JCF = 246.8, 13.0 Hz, CF), 160.6 (C), 161.1 (dd, JCF = 247.1, 13.4 Hz, C). 19F 
NMR (282.4 MHz, CDCl3): δ = –111.86 (CF), –112.9 (CF). IR (ATR): ν̃ = 3080 (w), 2998 
(w), 2956 (w), 2836 (w), 1736 (w), 1609 (s), 1586 (s), 1508 (s), 1454 (s), 1425 (m), 1401 (m), 
1372 (w), 1303 (s), 1255 (m), 1184 (w), 1158 (s), 1145 (s), 1092 (s), 1032 (s), 996 (s), 925 
(m), 861 (w), 834 (m), 818 (s)796 (m), 736 (w), 718 (w), 663 (w), 607 (w), 587 (m) cm–1. MS 
(EI, 70 eV): m/z (%) = 340 (100) [M]+, 294 (11), 265 (13), 238 (12). ESI-HRMS calcd. for 
C21H19F2O2 [M+H]+: 341.1348; found 341.1348. 
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1-(4`-Methoxyphenyl)-2-(2´´-methylphenyl)-3,5-difluorobenzene (11b): Starting with 7 
(200 mg, 0.74 mmol), Cs2CO3 (359 mg, 1.11 mmol), Pd(PPh3)4 (3 
mol%), 4-methoxyphenylboronic (112 mg, 0.74 mmol), 1,4-dioxane 
(4 mL), and 2-methylphenylboronic acid (121 mg, 0.89 mmol), 11b 
was isolated as a colorless oil (155 mg, 68%). 1H NMR (300 MHz, 
CDCl3): δ = 2.14 (s, 3H, CH3), 3.32 (s, 3H, OCH3), 6.72-6.88 (m, 6H, ArH), 6.93-6.97 (m, 
1H, ArH), 7.06–7.23 (m, 2H, ArH), 7.23–7.37 (m, 1H, ArH). 13C NMR (62.89 MHz, CDCl3): 
δ = 21.2 (CH3), 55.0 (OCH3), 102.8 (CH), 110.7 (t, J = 26.3 Hz, CH), 115.0 (CH), 120.3 
(CH), 128.0 (CH), 128.1 (CH), 129.2 (CH), 130.10 (CH), 131.2 (C), 133.6 (C), 156.0 (C), 
157.7 (C), 159.2 (C), 159.6 (d, J = 13.8 Hz, C), 159.9 (dd, JCF = 248.0, 13.0 Hz, CF), 161.1 
(dd, JCF = 247.0, 13.4 Hz, C). 19F NMR (282.4 MHz, CDCl3): δ = –111.86 (CF), –112.9 (CF). 
IR (ATR): ν̃ = 3082 (w), 3053 (w), 3008 (w), 2978 (w), 2928 (w), 2835 (w), 1600 (m), 1558 
(w), 1495 (m), 1445 (m), 1394 (m), 1333 (m), 1283 (m), 1241 (s), 1201 (m), 1159 (m), 1091 
(m), 1025 (m), 995 (m), 937 (m), 893 (w), 837 (m), 803 (m), 782 (m), 742 (m), 700 (m), 640 
(m), 573 (m), 541 (m), 530 (m). MS (EI, 70 eV): m/z (%) = 310 (100) [M]+, 295 (24), 279 
(29), 264 (27), 262(10). HRMS (EI) calcd. for C20H16OF2 [M]+: 310.11637; found 
310.115566 
 
1-(4`-Methoxyphenyl)-2-phenyl-3,5-difluorobenzene (11c): Starting with 7 (200 mg, 0.74 
mmol), Cs2CO3 (359 mg, 1.11 mmol), Pd(PPh3)4 (3 mol%), 4-
methoxyphenylboronic (112 mg, 0.74 mmol), 1,4-dioxane (4 mL), 
and phenylboronic acid (107 mg, 0.89 mmol), 11c was isolated as a 
colorless oil (152 mg, 70%). 1H NMR (300 MHz, CDCl3): δ = 3.68 
(s, 3H, OCH3), 6.64 (dt, J = 9.13 Hz, 2H, ArH), 6.76-6.83 (m, 1H, 
ArH), 6.88-6.94 (m, 3H, ArH), 6.97–7.04 (m, 2H, ArH), 7.11–7.18 (m, 3H, ArH). 13C NMR 
(62.89 MHz, CDCl3): δ = 55.2 (OCH3), 102.4 (d, J = 27.5 Hz, CH), 112.7 (d, J = 3.72 Hz, C), 
112.9 (d, J = 3.72 Hz, C), 113.4 (CH), 124.2 (d, J = 3.50 Hz, C), 124.4 (d, J = 3.50 Hz, CH), 
125.6 (C), 127.2 (CH), 129.6 (CH), 130.7 (CH), 130.9 (CH), 131.7 (t, J = 2.74 Hz, C), 132.0 
(C), 133.7 (C), 144.0 (d, J = 4.73 Hz, C), 144.1 (d, J = 4.73 Hz, C), 158.8 (C), 160.1 (dd, JCF 
= 247.2, 12.6 Hz, CF), 161.6 (dd, JCF = 248.4, 13.4 Hz, C). 19F NMR (282.4 MHz, CDCl3): δ 
= –110.40 (CF), –111.44 (CF). IR (ATR): ν̃ = 3061 (w), 3032 (w), 3000 (w), 2956 (w), 2929 
(w), 2836 (w), 2541 (w), 1885 (w),1725 (w), 1608 (s), 1588 (s), 1514 (s), 1461 (m), 1405 (m), 
1335 (m), 1291 (m), 1245 (s), 1204 (m), 1176 (s), 1139 (s), 1100 (s), 1072 (m), 1034 (m), 998 
(s), 915 (w), 873 (m), 829 (s), 773 (s), 746 (m), 711 (m), 698 (s), 647 (w), 610 (w), 586 (s), 
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556 (s), 543 (m). MS (EI, 70 eV): m/z (%) = 296 (100) [M]+, 295 (19), 265 (16), 264 (11), 
263(10), 238 (15), 233 (16). HRMS (EI) calcd. for C19H14OF2 [M]+: 296.10072; found 
296.099982. 
 
1-(2`-Methoxyphenyl)-2-(4´´-methylphenyl)-3,5-difluorobenzene (11d): Starting with 7 
(200 mg, 0.74 mmol), Cs2CO3 (359 mg, 1.11 mmol), Pd(PPh3)4 (3 
mol%), 2-methylphenylboronic (100 mg, 0.74 mmol), 1,4-dioxane (4 
mL), and 4-methylphenylboronic acid (123 mg, 0.89 mmol), 11d was 
isolated as a colorless solid (142 mg, 62%). Mp 67-69 °C. 1H NMR 
(300 MHz, CDCl3): δ = 2.14 (s, 3H, CH3), 3.32 (s, 3H, OCH3), 6.72-
6.88 (m, 6H, ArH), 6.93-6.97 (m, 1H, ArH), 7.06–7.23 (m, 2H, ArH), 7.23–7.37 (m, 1H, 
ArH). 13C NMR (62.89 MHz, CDCl3): δ = 21.2 (CH3), 55.0 (OCH3), 102.8 (CH), 110.7 (t, J = 
26.3 Hz, CH), 115.0 (CH), 120.3 (CH), 128.0 (CH), 128.1 (CH), 129.2 (CH), 130.10 (CH), 
131.2 (C), 133.6 (C), 156.0 (C), 157.7 (C), 159.2 (C), 159.6 (d, J = 13.8 Hz, C), 159.9 (dd, JCF 
= 248.0, 13.0 Hz, CF), 161.1 (dd, JCF = 247.0, 13.4 Hz, C). 19F NMR (282.4 MHz, CDCl3): δ 
= –111.86 (CF), –112.9 (CF). IR (ATR): ν̃ = 3082 (w), 3053 (w), 3008 (w), 2978 (w), 2928 
(w), 2835 (w), 1600 (m), 1558 (w), 1495 (m), 1445 (m), 1394 (m), 1333 (m), 1283 (m), 1241 
(s), 1201 (m), 1159 (m), 1091 (m), 1025 (m), 995 (m), 937 (m), 893 (w), 837 (m), 803 (m), 
782 (m), 742 (m), 700 (m), 640 (m), 573 (m), 541 (m), 530 (m). MS (EI, 70 eV): m/z (%) = 
310 (100) [M]+, 295 (24), 279 (29), 264 (27), 262(10). HRMS (EI) calcd. for C20H16OF2 [M]+: 
310.11637; found 310.115566. 
 
1-(2´,6´-Dimethoxyphenyl)-2-(4´´-methylphenyl)-3,5-difluorobenzene (11e): Starting with 
7 (200 mg, 0.74 mmol), Cs2CO3 (359 mg, 1.11 mmol), Pd(PPh3)4 (3 
mol%), 2,6-dimethoxyphenylboronic (134 mg, 0.74 mmol), 1,4-dioxane 
(4 mL), and 4-methylboronic acid (121 mg, 0.89 mmol), 11e was 
isolated as a colorless highly viscous oil (150 mg, 60%). 1H NMR (300 
MHz, CDCl3): δ = 2.19 (s, 3H, CH3), 3.32 (s, 3H, OCH3), 3.69 (s, 3H, 
OCH3), 6.17 (d, J = 2.64 Hz, 1H, Ar), 6.34 (dd, J = 8.4, 2.9 Hz, 1 H, Ar), 6.74–6.93 (m, 7H, 
Ar). 13C NMR (62.89 MHz, CDCl3): δ = 21.2 (CH3), 55.0 (OCH3), 55.3 (OCH3), 98.4 (CH), 
102.6 (t, J = 27.3 Hz, CH), 104.1 (CH), 113.6 (dd, J = 20.8, 3.7 Hz, CH), 121.5 (q, J = 3.71 
Hz, C), 125.7 (dd, J = 15.3, 4.0 Hz, C), 128.2 (2CH), 128.6 (d, J = 19.8 Hz C), 130.1 (CH), 
131.1 (CH), 136.4 (C), 141.2 (dd, J = 9.6, 4.5 Hz, C), 157.0 (C), 159.8 (dd, JCF = 248.3, 13.2 
Hz, CF), 161.1 (dd, JCF = 248.3, 13.2 Hz, CF). 19F NMR (282.4 MHz, CDCl3): δ = –111.52 
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(CF), –112.49 (CF). IR (ATR): ν̃ = 3081 (w), 3054 (w) 2999 (w), 2956 (w), 2835 (w), 1609 
(s), 1586 (s), 1508 (s), 1454 (s), 1436 (m), 1425 (m), 1401 (m), 1335 (w), 1303 (s), 1265 (m), 
1207 (s), 1184 (w), 1158 (s), 1145 (s), 1092 (s), 1031 (s), 996 (s), 936 (m), 861 (m), 834 (m), 
818 (s), 796 (s), 733 (m), 663 (m), 608 (m), 587 (m), 530 (m) cm–1. MS (EI, 70 eV): m/z (%) 
= 340 (100) [M]+, 294 (11), 265 (14), 238 (11). HRMS(EI) calcd. for C21H19F2O2 [M]+: 
340.12694; found 340.126828. 
 
1-(2´,4´-Dimethoxyphenyl)-2-(4´´-methylphenyl)-3,5-difluorobenzene (11f): Starting with 
7 (200 mg, 0.74 mmol), Cs2CO3 (359 mg, 1.11 mmol), Pd(PPh3)4 (3 
mol%), 2,4-dimethoxyphenylboronic (134 mg, 0.74 mmol), 1,4-
dioxane (4 mL), and 4-methylboronic acid (121 mg, 0.89 mmol), 
11f was isolated as a colorless highly viscous oil (121 mg, 48%). 1H 
NMR (300 MHz, CDCl3): δ = 2.19 (s, 3H, CH3), 3.32 (s, 3H, 
OCH3), 3.69 (s, 3H, OCH3), 6.17 (d, J = 2.3 Hz, 1H, Ar), 6.32 (dd, J = 8.3, 2.3 Hz, 1 H, Ar), 
6.74–6.83 (m, 2H, Ar), 6.86–6.91 (m, 5H, Ar). 13C NMR (62.89 MHz, CDCl3): δ = 21.2 
(CH3), 55.0 (OCH3), 55.3 (OCH3), 98.4 (CH), 102.5 (t, J = 26.3 Hz, CH), 104.1 (CH), 113.6 
(dd, J = 21.9, 3.6 Hz, CH), 121.5 (t, J = 2.8 Hz, C), 125.7 (dd, J = 15.3, 3.6 Hz, C), 128.1 
(2CH), 130.0 (2CH), 131.1 (C), 131.6 (CH), 136.4 (C), 141.2 (dd, J = 9.6, 4.5 Hz, C), 157.0 
(C), 159.8 (dd, JCF = 246.8, 13.0 Hz, CF), 160.6 (C), 161.1 (dd, JCF = 247.1, 13.4 Hz, C). 19F 
NMR (282.4 MHz, CDCl3): δ = –111.86 (CF), –112.9 (CF). IR (ATR): ν̃ = 3080 (w), 2998 
(w), 2956 (w), 2836 (w), 1736 (w), 1609 (s), 1586 (s), 1508 (s), 1454 (s), 1425 (m), 1401 (m), 
1372 (w), 1303 (s), 1255 (m), 1184 (w), 1158 (s), 1145 (s), 1092 (s), 1032 (s), 996 (s), 925 
(m), 861 (w), 834 (m), 818 (s), 796 (m), 736 (w), 718 (w), 663 (w), 607 (w), 587 (m) cm–1. 
MS (EI, 70 eV): m/z (%) = 340 (100) [M]+, 294 (11), 265 (13), 238 (12). ESI-HRMS calcd. 
for C21H19F2O2 [M+H]+: 341.1348; found 341.1348 
 
1-(4´-Fluorophenyl)-2-(4´´-chlorophenyl)-3,5-difluorobenzene (11g): Starting with 1 (200 
mg, 0.74 mmol), Cs2CO3 (359 mg, 1.11 mmol), Pd(PPh3)4 (3 mol%), 
4-fluorophenylboronic (103 mg, 0.74 mmol), 1,4-dioxane (4 mL), and 
4-chlorophenylboronic acid (138 mg, 0.89 mmol), 11g was isolated as 
colorless highly viscous oil (106 mg, 45%) 1H NMR (300 MHz, 
CDCl3): δ = 6.93-7.13 (m, 8H, ArH), 7.23-7.32 (m, 2H, ArH). 13C 
NMR (75 MHz, CDCl3): δ = 102.8 (t, JCF = 3.5 Hz, CH), 103.2 (t, JCF = 3.5 Hz, CH), 103.6 (t, 
JCF = 3.51 Hz, CH), 112.6 (dd, JCF = 20.4, 4.2 Hz, CH), 115.3 (dd, JCF = 20.7, 4.9 Hz, CH), 
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123.4 (t, JCF = 2.8 Hz, CH), 128.5 (m, CH), 130.9 (CH), 131.2 (CH), 132.3 (C), 135.9 (dd, 
JCF= 238.1, 14.6 Hz, CF), 143.4 (C), 160.1 (dd, 1JCF = 245.1, 14.6 Hz, CF), 161.9 (dd, 1JCF = 
251.2, 13.6 Hz, CF).19F NMR (282 MHz, CDCl3): δ = −110.46 (CF), −110.99 (CF), −114.19 
(CF). IR (ATR, cm−1): ν̃ = 3086 (w), 3052 (w), 1896 (w), 1606 (m), 1582 (s), 1511 (s), 1457 
(s), 1392 (m), 1336 (m), 1298 (w), 1222 (s), 1159 (m), 1119 (m), 1091 (s), 1015 (m), 960 (w), 
901 (w), 872 (m), 827 (s), 758 (m), 712 (w), 645 (w), 595 (m), 576 (s), 532 (m). MS (EI, 70 
eV): m/z (%) = 318 (100) [M]+, 284 (11), 283 (66), 282 (54), 280 (18), 264 (12), 263 (53). 
HRMS (EI) calcd for C18H10ClF3 [M]+: 318.04176; found 318.041545. 
 
General procedure for Suzuki–Miyaura reactions(13a-k, 14a-h): A 1,4-dioxane solution 
(4 mL per 0.3 mmol of 12) of 12, Cs2CO3, Pd(PPh3)4 and arylboronic acid 8 were stirred at 90 
°C for 6 or 8 h. After cooling to room temperature, the organic and the aqueous layers were 
separated and the latter was extracted with CH2Cl2. The combined organic layers were dried 
(Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was purified by 
column chromatography. 
 
1,4-Di(4´-methylphenyl)-2-fluorobenzene (13a): Starting with 12 (100 mg, 0.39 mmol), 
Cs2CO3 (190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 4-methylphenylboronic acid 
(106 mg, 0.78 mmol) and 1,4-dioxane (4 mL), 13a was isolated as a colorless solid 
(65 mg, 60%). Mp 178-180 °C. 1H NMR (300 MHz, CDCl3): δ = 2.33 (s, 6H, 
CH3), 7.15-7.18 (m, 4H, CH), 7.20-7.31 (m, 3H, CH), 7.31-7.35 (m, 4H, CH). 
13C NMR (75 MHz, CDCl3): δ = 21.2, 21.3 (CH3), 114.4 (d, J = 24.0 Hz, CH), 
122.7 (d, J = 12.0 Hz, CH), 126.8, 126.8 (CH), 127.4 (d, J = 13.5 Hz, C), 128.8, 
128.9 (CH), 129.3 (CH), 129.7 (CH), 130.9 (d, J = 4.5 Hz, CH), 132.7 (C), 136.7 
(C), 137.6, 137.6 (C), 137.8, 137.8 (C), 142.0 (d, J = 7.5 Hz, C), 160.1 (d, 1JCF = 
246.0 Hz, CF). 19F NMR (282 MHz, CDCl3): δ = -115.21. IR (ATR, cm−1): ν̃ = 2916 (w), 
1912 (w), 1614 (w), 1570 (w), 1545 (w), 1484 (w), 1392 (w), 1118 (M), 1133 (m), 1041 (m), 
1005 (w), 948 (w), 890 (w), 844 (w), 807 (w), 731 (w), 646 (w), 557 (m), 496 (w), 455 (w). 
GC-MS (EI, 70 eV): m/z (%) = 276 (100) [M]+, 275 (13), 239 (5), 183 (7), 137 (4). HRMS 
(EI, 70 eV) calcd. for C20H17F [M]+: 276.13008; found 276.130318. 
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1,4-Di(4´-methoxyphenyl)-2-fluorobenzene (13b): Starting with 12 (100 mg, 0.39 mmol), 
Cs2CO3 (190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 4-methoxyphenylboronic acid 
(106 mg, 0.78 mmol) and 1,4-dioxane (4 mL), 13b was isolated as a light yellow 
solid (42 mg, 52%). Mp 182-184 °C. 1H NMR (300 MHz, CDCl3): δ = 3.79 (s, 
6H, OCH3), 6.91-6.94 (m, 4H, CH), 7.19-7.29 (m, 3H, CH), 7.36-7.46 (m, 4H, 
CH). 13C NMR (75 MHz, CDCl3): δ = 55.4, 55.4 (OCH3), 114.0, 114.0 (CH), 
114.3, 114.3 (CH) 114.4 (d, J = 20.0 Hz, CH), 122.4 (d, J = 3.0 Hz, CH), 128.2, 
128.2 (CH), 130.1 (d, J = 3.0, 2C, CH), 130.7 (d, J = 4.5 Hz, CH), 130.9, 130.9 
(C), 132.1, 132.1 (C), 142.0 (d, J = 7.5 Hz, C), 158.6 (d, 1JCF = 248.0 Hz, CF), 
159.2, 159.6 (C). 19F NMR (282 MHz, CDCl3): δ = -114.88. IR (ATR, cm−1): ν̃ = 3035 (w), 
3016 (w), 2960 (w), 2933 (w), 2909 (w), 2836 (w),1605 (s), 1578 (m), 1476 (m), 1391 (m), 
1292 (m), 1030 (m), 871 (m), 807 (s), 6963 (w), 578 (m), 522 (m), 456 (m). GC-MS (EI, 70 
eV); m/z (%) = 308 (100) [M]+, 293 (40), 265 (11), 222 (10), 154 (7), 133 (5). HRMS (EI) 
calcd. for C20H17FO2 [M]+: 308.12071; found 308.120220. 
 
1,4-Di(4`-ethoxyphenyl)-2-fluorobenzene (13c): Starting with 12 (100 mg, 0.39 mmol), 
Cs2CO3 (190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 4-ethoxyphenylboronic acid 
(64 mg, 0.39 mmol) and 1,4-dioxane (4 mL), 13c was isolated as a colorless solid 
(86 mg, 65%). Mp 96-98 °C. 1H NMR (300 MHz, CDCl3): δ = 1.39 (t, J = 7.2 Hz, 
6H, CH3), 3.99 (q, J = 6.89 Hz, 4H, OCH2), 6.85-6.91 (m, 4H, CH), 7.21-7.28 (m, 
3H, CH), 7.36-7.50 (m, 4H, CH). 13C NMR (75 MHz, CDCl3): δ = 14.9 (2CH3), 
63.6 (2OCH2), 106.8 (d, J = 22.0 Hz, C), 114.5 (d, J = 16.5 Hz, CH), 114.7 (CH), 
115.0 (CH), 123.4 (d, J = 3.8 Hz, CH), 127.7 (CH), 128.0 (CH), 131.3 (C), 133.6 
(CH), 133.9 (C), 144.1 (C), 159.2 (d, 1JCF = 247.0 Hz, C). 19F NMR (282 MHz, 
CDCl3): δ = -114.92. IR (ATR, cm−1): ν̃ = 2958 (w), 2935 (w), 2838 (w), 1897 (w), 1597 (m), 
1474 (s), 1243 (s), 1180(m), 1027 (s), 805 (s), 751 (m), 692 (m), 412 (w). GC-MS (EI, 70 
eV): m/z (%) = 336 (100) [M]+, 307 (22), 280 (32), 279 (15), 251 (14). HRMS (EI) calcd. for 
C22H21FO2 [M]+: 336.15201; found 336.151958.  
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1,4-Di(3`,4`-dimethoxyphenyl)-2-fluorobenzene (13d): Starting with 12 (100 mg, 0.39 
mmol), Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 3,4-
dimethoxyphenylboronic acid (141 mg, 0.78 mmol) and 1,4-dioxane (4 
mL), 13d was isolated as a colourless oil (84 mg, 58%). 1H NMR (300 
MHz, CDCl3): δ = 3.84 (s, 6H, OCH3), 3.85 (s, 3H, OCH3), 3.88 (s, 3H, 
OCH3), 6.24-6.65 (m, 1H, ArH), 6.86-6.91 (m, 2H, ArH), 6.99 (m, 3H, 
ArH), 7.23–7.42 (m, 3H, ArH). 13C NMR (75.46 MHz, CDCl3): δ = 55.8 
(OCH3), 55.9 (2OCH3), 56.5 (OCH3), 100.5 (CH), 100.7 (CH), 110.1 
(CH), 111.3 (d, J = 19.9 Hz, CH), 112.3 (t, J = 3.5 Hz, CH), 114. (d, J = 
23.9 Hz, CH), 119.3 (CH), 128.2 (C), 130.6 (d, J = 4.3 Hz, CH), 132.4 (d, J = 2.4 Hz, C), 
134.7 (C), 141.7 (d, J = 8.1 Hz, C), 143.1 (C), 148.8 (d, J = 3.23 Hz, C), 149.1 (C), 149.3 (C), 
159.9 (d, J = 247.1 Hz, CF). 19F NMR (282.4 MHz, CDCl3): δ = -117.7 (CF). IR (ATR, cm-
1): ν̃ = 3103 (w), 3072 (w), 2996 (w), 2931 (w), 2833 (w), 2732 (w), 2700 (w), 2583 (w), 
2551 (w), 2457 (w), 2400 (w), 2353 (w), 2277 (w), 2052 (w), 1907 (w), 1797 (w), 1737 (w), 
1621 (w), 1578 (m), 1536 (w), 1498 (w), 1467 (s), 1426 (s), 1404 (s), 1354 (w), 1318 (m), 
1259 (s), 1226 (s), 1197 (m), 1137 (m), 1104 (s), 1084 (m), 1035 (m), 1001 (s), 966 (m), 920 
(m), 879 (m), 850 (m), 820 (s), 787 (s), 744 (s), 692 (s), 657 (m), 606 (m), 570 (m), 536 (m). 
MS (EI, 70 eV): m/z (%) = 368 (100) [M]+, 338 (35). HRMS (EI) calcd. for C22H21O4F [M]+: 
368.14184; found 368.14198. 
 
1,4-Di(2`,4`-dimethoxyphenyl)-2-fluorobenzene (13e): Starting with 12 (100 mg, 0.39 
mmol), Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 2,4-
dimethoxyphenylboronic acid (141 mg, 0.78 mmol) and 1,4-dioxane (4 
mL), 13e was isolated as a colourless semi solid (91 mg, 63%). 1H NMR 
(300 MHz, CDCl3): δ = 3.60 (s, 3H, OCH3), 3.63 (s, 3H, OCH3), 3.85 (s, 
3H, OCH3), 3.86 (s, 3H, OCH3), 6.86-6.95 (m, 4H, ArH), 7.03.-7.09 (m, 
2H, ArH), 7.28–7.34 (m, 3H, ArH). 13C NMR (75.46 MHz, CDCl3): δ = 
55.9 (OCH3), 56.0 (OCH3), 60.7 (OCH3),  60.8 (OCH3), 112.0 (CH), 112.4 
(CH), 122.5 (CH), 123.3 (d, J = 2.6 Hz, CH), 123.7 (CH), 124.2  (CH), 
124.6 (d, J = 3.9 Hz, C), 130.1 (C), 131.4 (d, J = 3.7 Hz, CH), 134.5 (d, J = 2.0 Hz, C), 139.4 
(d, J = 8.3 Hz, C), 146.9 (d, J = 52.3 Hz, C), 153.1 (d, J = 29.3 Hz, C), 159.4 (d, J = 247.2 Hz, 
CF). 19F NMR (282.4 MHz, CDCl3): δ = -114.8 (CF). IR (ATR, cm-1): ν̃ = 3103 (w), 3058 
(w), 3006 (w), 2962 (w), 2838 (w), 1621 (w), 1598 (w), 1579 (w), 1515 (w), 1402 (w), 1316 
(w), 1264 (m), 1199 (w), 1133 (w), 1113 (m), 1085 (m), 1019 (w), 934 (w), 875 (w), 824 (w),  
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787 (m), 734 (m), 651 (w), 581 (w), 535 (m). MS (EI, 70 eV): m/z (%) = 368 (100) [M]+, 338 
(36). HRMS (EI) calcd. for C22H21O4F1 [M]+: 368.14184; found 368.124183. 
 
1,4-Di(4´-vinylebutylphenyl)-2-fluorobenzene (13f): Starting with 12 (100 mg, 0.39 mmol), 
Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (115 
mg, 0.78 mmol) and 1,4-dioxane (4 mL), 13f was isolated as a colourless solid (53 
mg, 45%). Mp stable upto 375 °C. 1H NMR (300 MHz, CDCl3): δ = 5.23 (dt, J = 
10.87 Hz, 2H, CH2), 5.75 (q, J = 17.7, 2H, CH2), 6.70 (q, J = 17.6 Hz, 2H, CH), 
7.30–7.54 (m, 11H, ArH). 13C NMR (75.46 MHz, CDCl3): δ = 29.6 (CH3), 114.3 
(CH), 126.3 (2CH), 126.8 (2CH), 127.0 (2CH), 129.0 (2CH), 129.7 (2CH), 130.8 
(d, J = 3.89 Hz, C), 133.1 (C), 136.2 (C), 136.4 (C), 136.9 (C), 137.2 (t, J =  2.39 
Hz, C), 153.1 (d, JCF = 237.0 Hz, CF). 19F NMR (282.4 MHz, CDCl3): d -117.50 
(CF). IR (ATR, cm-1): ν̃ = 2922 (m), 2852 (m), 1740 (w), 1696 (w), 1604 (w), 
1547 (w), 1486 (w), 1395 (w), 1242 (w), 1185 (w), 1134 (w), 1045 (w), 1006 (w), 893 (w), 
878 (w), 814 (w), 771 (w), 700 (w), 580 (w), 548 (w). MS (EI, 70 eV): m/z (%) = 300 (100) 
[M]+. HRMS (EI) calcd. for C22H17F [M]+: 300.13088; found 300.130205. 
 
1,4-Di(4´-tert-butylphenyl)-2-fluorobenzene (13g): Starting with 12 (100 mg, 0.39 mmol), 
Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 4-tert-butylphenylboronic 
acid (138 mg, 0.78 mmol) and 1,4-dioxane (4 mL), 13g was isolated as a 
colourless solid (89 mg, 63%). Mp 184–186 °C. 1H NMR (300 MHz, CDCl3): δ = 
1.29 (s, 18H, CH3), 7.30 (dd, J = 12.1, 1.6 Hz, 1H, ArH), 7.36–7.42 (m, 6H, ArH), 
7.45–7.50 (m, 4H, ArH). 13C NMR (75.46 MHz, CDCl3): δ = 31.3 (CH3), 34.6 
(C), 111.3 (CH), 114.3 (d, J = 23.9 Hz, CH), 122.7 (d, J  = 3.2 Hz, CH), 125.4 
(2CH), 125.9 (2CH), 126.6 (2CH), 127.3 (d, J = 13.6 Hz, C), 128.6 (d, J = 3.2 Hz, 
CH), 130.8 (d, J = 4.3 Hz, C), 132.6 (d, J = 1.4 Hz, CH), 136.7 (d, J = 1.9 Hz, C), 
141.8 (C), 141.9 (C), 150.8 (d, JCF = 19.3 Hz, C), 160.1 (d, JCF = 247 Hz, C). 19F 
NMR (282.4 MHz, CDCl3): δ = 117.97 (CF). IR (ATR, cm-1): ν̃ = 3033 (w), 2950 
(m), 2860 (w), 2705 (w), 2163 (w), 1977 (w), 1910 (w), 1741 (w), 1616 (w), 1543 (w), 1486 
(m), 1428 (w), 1394 (m), 1305 (w), 1261 (m), 1200 (w), 1187 (m), 1122 (w), 1045 (w), 1004 
(w), 948 (w), 894 (m), 816 (s), 829 (w), 750 (w), 675 (w), 586 (m), 548 (m). MS (EI, 70 eV): 
m/z (%) = 360 (54) [M]+, 346 (26), 345 (100), 137 (12). HRMS (EI) calcd for C26H29F[M]+: 
360.22478; found 360.224193. 
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1,4-Di(4`-Acetylphenyl)-2-fluorobenzene (13h): Starting with 12 (100 mg, 0.39 mmol), 
Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 4-Acetylphenylboronic acid 
(127 mg, 0.78 mmol) and 1,4-dioxane (4 mL), 13h was isolated as a colorless 
solid (68 mg, 52%). Mp 178-180 °C. 1H NMR (300 MHz, CDCl3): δ = 2.58 (s, 
6H, CH3), 7.37-7.53 (m, 3H, ArH), 7.61-7.66 (m, 4H, ArH), 7.97-8.00 (m, 4H, 
ArH). 13C NMR (75.46 MHz, CDCl3): δ = 26.7 (CH3), 29.7 (CH3), 114.8 (CH), 
115. (d, J = 2.3 Hz, CH), 123.3 (d, J = 3.6 Hz, CH), 127.31 (2CH), 128.6 (2CH), 
129.0 (CH), 129.2 (CH), 130.9 (CH), 131.9 (d, J = 4.3 Hz, CH), 136.3 (C), 136.5 
(C), 139.9 (d, J = 1.3 Hz, C), 141.8 (d, J = 7.8 Hz, C), 143.6 (d, J = 1.8 Hz, C), 
160.6 (d, J = 249.5 Hz, CF), 197.6 (CO), 197.8 (CO). 19F NMR (282.4 MHz, 
CDCl3): δ = -116.6 (CF). IR (ATR, cm-1): ν̃ = 3039 (w), 2921 (w), 2852 (w), 2387 (w), 2325 
(w), 1731 (w), 1678 (m), 1602 (w), 1563 (w), 1520 (w), 1484 (w), 1423 (w), 1392 (w), 1357 
(w), 1289 (w), 1264 (m), 1184 (m), 1112 (w), 1052 (w), 1005 (w), 961 (w), 877 (w), 811 (m), 
754 (w), 691 (w), 623 (m), 592 (m) 531 (w). MS (EI, 70 eV): m/z (%) = 332 (51) [M]+, 318 
(22), 317 (100), 244 (11). HRMS (EI) calcd. for C22H17FO2 [M]+: 332.12126; found 
332.12776. 
 
1,3-Di(4`-fluorphenyl-5-fluorobenzene (13i): Starting with 12 (100 mg, 0.37 mmol), 
Cs2CO3 (263  mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 4-fluoromethylphenylboronic 
acid (109 mg, 0.78 mmol) and 1,4-dioxane (4 mL), 13i was isolated as a colorless 
solid (54 mg, 48%). Mp 145-149 °C. 1H NMR (300 MHz, CDCl3): δ = 7.03-7.09 
(m, 2H, ArH), 7.24-7.29 (m, 1H, ArH), 7.32-7.36 (m, 4H, ArH), 7.41-7.50 (m, 4H, 
ArH). 13C NMR (75 MHz, CDCl3): δ = 114.5 (dd, J = 24.2, 3.8 Hz, CH), 115.5 (d, 
J = 21.5 Hz, CH), 115.9 (d, J = 21.4, Hz, CH), 122.8 (t, J = 3.2 Hz, CH), 128.2 
(CH), 128.8 (CH), 129.2 (CH), 130.5 (d, J = 3.34 Hz, CH), 130.7 (dd, J = 8.2, 3.3 
Hz, CH), 130.9 (d, J = 3.3 Hz, CH), 131.3 (CH), 133.7 (d, J = 1.1 Hz, C), 134.2 (d, 
J = 4.9 Hz, C), 137.8 (d, J = 1.7 Hz, C), 141.1 (d, J = 8.3 Hz, C), 159.9 (d, JCF = 248.2 Hz, 
CF), 162.5 (d, JCF = 247.6 Hz, CF), 168.8, (d, JCF= 247.7 Hz, CF). 19F NMR (282 MHz, 
CDCl3): δ = -114.2.5, -117.3, -117.6 (CF). IR (ATR, cm−1): ν̃ = 3070 (w), 3041 (w), 2953 (w), 
2917 (w), 2849 (w), 1907 (w), 1602 (w), 1595 (w), 1524 (w), 1480 (m), 1429 (w), 1387 (w), 
1298 (w), 1224 (m), 1163 (m), 1094 (w), 1006 (w), 967 (w), 892 (m), 833 (m), 809 (s), 751 
(w), 709 (w), 690 (w), 613 (w), 577 (m), 546 (w). MS (EI, 70 eV); m/z (%) = 284 (100) [M]+. 
HRMS (EI) calcd. for C18H11F3 [M]+: 284.08074; found 284.1082698. 
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1,4-Di(3´-methylphenyl)-2-fluorobenzene (13j): Starting with 12 (100 mg, 0.39 mmol), 
Cs2CO3 (190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 3-methylphenylboronic acid 
(106 mg, 0.78 mmol) and 1,4-dioxane (4 mL), 13j was isolated as a colorless 
solid (65 mg, 60%). Mp 180-182 °C. 1H NMR (300 MHz, CDCl3): δ = 2.33 (s, 
6H, CH3), 7.19 (d, J = 8.1 Hz, 4H, ArH), 7.26-7.37 (m, 2H, ArH), 7.42 (t, J = 
7.2 Hz, 5H, ArH). 13C NMR (75 MHz, CDCl3): δ = 21.1, 21.2 (CH3), 114.1 (d, 
J= 23.8 Hz, CH), 122.6 (d, J = 3.2 Hz, CH), 126.8, (2CH), 127.5 (d, J = 3.2 Hz, 
C), 128.7 (d, J = 3.2 Hz, 2CH), 129.2, (2CH), 129.6 (2CH), 130.7 (d, J = 4.0 Hz, CH), 132.6 
(C), 136.7 (d, J = 18.0 Hz, C), 137.5 (d, J = 14.6 Hz, C), 147.9 (d, J = 8.2 Hz, C), 160.0, (d, J 
= 246.8 Hz, CF). 19F NMR (282 MHz, CDCl3): δ = -117.97. IR (ATR, cm−1): ν̃ = 3027 (w), 
2917 (w), 2853 (w), 2735 (w), 1914 (w), 1614 (w), 1569 (w), 1547 (w), 1423 (w), 1392 (w), 
1296 (w), 1215 (w), 1182 (w), 1133 (w), 1042 (w), 1005 (w), 947 (w), 890 (w), 869 (w), 807 
(m), 731 (w), 647 (w), 557 (w), 556 (w). GC-MS (EI, 70 eV); m/z (%) = 276 (100) [M]+, 275 
(11). HRMS (EI) calcd. for C20H17F [M]+: 276.13008; found 276.131090. 
 
1,4-Di(2-thienyl)-2-fluorobenzene (13k): Starting with 12 (100 mg, 0.39 mmol), Cs2CO3 
(190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 2-thienylboronic acid (49 mg, 0.39 
mmol) and 1,4-dioxane (4 mL), 13k was isolated as a colourless solid (51 mg, 
50%). Mp 94-96 °C. 1H NMR (300 MHz, CDCl3): δ = 7.00-7.06 (m, 2H, ArH), 
7.22-7.34 (m, 5H, ArH), 7.41–7.43 (m, 1H, ArH), 7.52–7.57 (m, 1H, ArH). 13C 
NMR (75.46 MHz, CDCl3): δ = 113.4 (d, J = 24.5 Hz, CH), 121.1 (d, J = 13.5 Hz, 
C), 121.8 (d, J = 3.1 Hz, CH), 123.8 (CH), 125.6 (CH), 125.8 (d, J = 4.5 Hz, CH), 
126.3 (d, J = 7.1 Hz, CH), 127.8 (CH), 128.3 (CH), 129.0 (d, J = 4.2 Hz, CH), 134.9 (d, J =  
9.4 Hz, C), 136.9 (d, J = 3.87 Hz, C), 142.6 (d, J = 2.9 Hz, C), 159.2 (d, JCF = 250.2 Hz, CF). 
19F NMR (282.4 MHz, CDCl3): δ = -107.4 (CF). IR (ATR, cm-1): ν̃ = 3100 (w), 3074 (w), 
2961 (w), 2854 (w), 1799 (w), 1606 (w), 1553 (w), 1483 (m), 1419 (m), 1354 (w), 1289 (w), 
1259 (m), 1207 (w), 1135 (w), 1058 (m), 1015 (m), 945 (w), 866 (m), 805 (s), 692 (s), 630 
(m), 579 (w), 550 (m), 528 (m). GC-MS (EI, 70 eV): m/z (%) = 260 (100) [M+], 215 (12). 
HRMS (EI) calcd. for C14H9FS2 [M]+: 260.01242; found 260.012690. 
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1-Bromo-4(4´-methylphenyl)-2-fluorobenzene (14a): Starting with 12 (100 mg, 0.39 
mmol), Cs2CO3 (190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 4-
methylphenylboronic acid (53 mg, 0.39 mmol) and 1,4-dioxane (4 mL), 14a was 
isolated as a colourless solid (63 mg, 60%). Mp 81-83 °C. 1H NMR (300 MHz, 
CDCl3): δ = 2.25 (s, 3H, CH3), 7.05-7.09 (m, 3H, ArH), 7.14–7.18 (m, 1H, ArH), 
7.26–7.29 (m, 2H, ArH), 7.40 (dd, J = 1.5 Hz, 1H, ArH). 13C NMR (75.46 MHz, 
CDCl3): δ = 21.1 (CH3), 107.4 (d, J = 27.3 Hz, C), 114.8 (d, J = 22.5 Hz, CH), 
123.3 (d, J = 3.3 Hz, CH), 126.7 (2CH), 129.7 (2CH), 133.6 (CH), 136.1 (d, J = 1.6 Hz, C), 
138.2 (C), 142.6 (d, J = 7.1 Hz, C), 159.3 (d, JCF = 246.2 Hz, CF). 19F NMR (282.4 MHz, 
CDCl3): δ = -107.4 (CF). IR (ATR, cm-1): ν̃ = 3027 (w), 2918 (w), 2852 (w), 2732 (w), 2602 
(w), 2496 (w), 1907 (w), 1599 (w), 1556 (w), 1472 (w), 1417 (w), 1390 (w), 1301 (w), 1262 
(w), 1197 (w), 1137 (w), 1055 (w), 1019 (w), 944 (w), 871 (w), 801 (m), 693 (w), 643 (w), 
594 (w), 546 (w), 529 (w). MS (EI, 70 eV): m/z (%) = 266 (100) (81Br) [M]+, 265 (25), 264 
(98) (79Br), 263 (12), 185 (17), 184 (19), 183 (48), 170 (18), 165 (26). HRMS (EI) calcd. for 
C13H10BrF [M]+: 263.99444; found 263.994605. HRMS (EI); calcd. for C13H1081BrF [M]+: 
265.99240; found 265.992813. 
 
1-Bromo-4(4´-methoxyphenyl)-2-fluorobenzene (14b): Starting with 12 (100 mg, 0.39 
mmol), Cs2CO3 (190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 4-
methoxyphenylboronic acid (59.3 mg, 0.39 mmol) and 1,4-dioxane (4 mL), 14b 
was isolated as a colorless oil (67 mg, 60%). 1H NMR (300 MHz, CDCl3): δ = 
3.77 (s, 3H, OCH3), 6.90 (td, J = 8.85, 2.18 Hz, 2H, ArH), 7.20–7.27 (m, 3H, 
ArH), 7.34–7.39 (m, 2H, ArH). 13C NMR (75.46 MHz, CDCl3): δ = 55.3 (OCH3), 
114.1 (2CH), 119.6 (d, J = 25.9 Hz, CH), 120.5 (d, J = 9.5 Hz, C), 127.6 (d, J = 
3.70 Hz, C), 128.5 (d, J = 12.4 Hz, CH), 129.9 (d, J = 2.8 Hz, CH), 131.4 (d, J = 4.07 Hz, 
CH), 131.9 (d, J = 2.77 Hz, C), 132.1 (d, J = 9.8 Hz, CH), 159.4 (C), 159.5 (d, JCF = 251 Hz, 
C). 19F NMR (282.4 MHz, CDCl3): δ = -115.31 (CF). IR (ATR, cm-1): ν̃ = 3067 (w), 2999 
(w), 2922 (w), 2835 (w), 2712 (w), 2550 (w), 2158 (w), 2048 (w), 1980 (w), 1891 (w), 1607 
(m), 1518 (m), 1477 (s), 1390 (m), 1264 (m), 1247 (s), 1178 (s), 1112 (m), 1037 (m), 963 (w), 
869 (s), 807 (s), 719 (m), 636 (w), 570 (m), 539 (s). MS (EI, 70 eV): m/z (%) = 281 (13) [M]+, 
280 (100), 267 (30), 265 (31), 239 (29), 158 (15), 157 (35). HRMS (EI) calcd. for 
C13H10OBrF [M]+: 281.98731; found 281.987694. 
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1-Bromo-4(4´-ethoxyphenyl)-2-fluorbenzene (14c): Starting with 12 (100 mg, 0.39 mmol), 
Cs2CO3 (190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 4-ethoxyphenylboronic acid 
(64.7 mg, 0.39 mmol) and 1,4-dioxane (4 mL), 14c was isolated as a colorless 
solid (79 mg, 68%). Mp 76-78 °C. 1H NMR (300 MHz, CDCl3): δ = 1.37 (t, J = 
7.2 Hz, 3H, CH3), 3.99 (q, J = 6.9 Hz, 2H, OCH2), 6.85-6.91 (m, 2H, CH), 7.21-
7.28 (m, 3H, CH), 7.36-7.50 (m, 2H, CH). 13C NMR (75 MHz, CDCl3): δ = 14.9 
(CH3), 63.6 (OCH2), 106.8 (d, J = 22.0 Hz, C), 114.5 (d, J = 16.5 Hz, CH), 114.7 
(CH), 115.0 (CH), 123.4 (d, J = 3.8 Hz, CH), 127.7 (CH), 128.0 (CH), 131.3 (C), 133.6 (CH), 
133.9 (C), 144.1 (C), 159.2 (d, 1JCF = 247.0 Hz, C). 19F NMR (282 MHz, CDCl3): δ = -
114.92. IR (ATR, cm−1): ν̃ = 2958 (w), 2935 (w), 2838 (w), 1897 (w), 1597 (m), 1474 (s), 
1243 (s), 1180(m), 1027 (s), 805 (s), 751 (m), 692 (m), 412 (w).  GC-MS (EI, 70 eV): m/z (%) 
= 294 (78) [M]+, 268 (100), 239 (22), 211 (20), 157 (32), 133 (12), 106 (10). HRMS (EI) 
calcd. for C14H12BrFO [M]+: 294.00556; found 294.005131. 
 
1-Bromo-4(3´,4´-di-methoxyphenyl)-2-fluorbenzene (14d): Starting with 12 (100 mg, 0.39 
mmol), Cs2CO3 (190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 3,4-
dimethoxyphenylboronic acid (71.0 mg, 0.39 mmol) and 1,4-dioxane (4 mL), 
14d was isolated as a colorless oil (82 mg, 67%). 1H NMR (300 MHz, 
CDCl3): δ = 3.84 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 6.86-6.89 (m, 1H, CH), 
6.96-6.99 (m, 3H, CH), 7.18-7.23 (m, 2H, CH). 13C NMR (75 MHz, CDCl3): 
δ = 55.9, 56.0 (OCH3), 110.0 (C), 111.2, 112.1 (CH), 112.1 (CH), 119.7 (d, J 
= 3.7 Hz, CH), 121.3 (CH), 121.4 (d, J = 3.0 Hz, CH), 127.6 (CH), 131.5 (C), 131.6 (C), 
149.8 (COCH3), 149.9 (COCH3), 158.9 (d, 1JCF = 247.0 Hz, CF). 19F NMR (282 MHz, 
CDCl3): δ = -115.11. IR (ATR, cm−1): ν̃ = 2960 (w), 2936 (w), 1599 (m), 1581 (m), 1475 (m), 
1339 (m), 1243 (m), 1180 (m), 1028 (s), 891 (s), 871 (m), 834 (m), 752 (m), 693 (m), 640 
(w), 597 (w), 542 (m), 412 (m). GC-MS (EI, 70 eV): m/z (%) = 310 (100) [M]+, 295 (18), 269 
(16), 267 (18), 188 (66), 173 (11), 157 (15), 145 (18), 106 (8). HRMS (EI) calcd. for 
C14H12BrFO2 [M] +: 310.00047; found 310.000984. 
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1-Bromo-4(4´-vinylphenyl)-2-fluorobenzene (14e): Starting with 12 (100 mg, 0.39 mmol), 
Cs2CO3 (190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 4-vinylphenylboronic acid (57 
mg, 0.39 mmol) and 1,4-dioxane (4 mL), 14e was isolated as a colorless solid. (49 
mg, 45%). Mp 338-340 °C. 1H NMR (300 MHz, CDCl3): δ = 5.03 (d, J = 2.3 Hz, 
1H, CH), 5.58 (d, J = 4.3 Hz, 1H, CH), 6.52 (q, J = 3.7 Hz, 1H, CH), 7.00-7.13 (m, 
3H, ArH), 7.23-7.35 (m, 4H, ArH). 13C NMR (75.46 MHz, CDCl3): δ = 114.5 
(CH), 114.9 (CH), 123.5 (d, J = 4.3 Hz, CH), 126.4 (CH), 126.8 (CH), 126.9 (CH), 
128.9 (d, J = 3.2 Hz, CH), 133.7 (CH), 136.1 (CH), 136.3 (d, J = 19.6 C), 137.5 (C), 137.6 (d, 
J = 2.4 Hz, C), 142.1 (d, J = 7.4 Hz, C), 159.4 (d, JCF = 243.3 Hz, CF). 19F NMR (282.4 MHz, 
CDCl3): δ = -107.1 (CF). IR (ATR, cm-1): ν̃ = 2922 (w), 2852 (w), 2368 (w), 2165 (w), 2046 
(w), 1977 (w), 1711 (m), 1605 (w), 1573 (w), 1521 (w), 1486 (w), 1432 (w), 1359 (m), 1301 
(w), 1219 (m), 1186 (w), 1116 (w), 1090 (w), 1006 (w), 989 (w), 905 (w), 878 (w), 814 (m), 
771 (w), 721 (w), 668 (w), 622 (w), 578 (w), 529 (w). MS (EI, 70 eV); m/z (%) = 278 (96) 
(81Br) [M]+, 276 (100), 277 (18), 196 (41), 170 (14), 158. HRMS (EI) calcd. for C14H1081BrF 
[M]+: 277.99240; found 277.992413. 
 
 
1-Bromo-4(4´-tert-butylphenyl)-2-fluorobenzene (14f): Starting with 12 (100 mg, 0.39 
mmol), Cs2CO3 (190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 4-tert-
butylphenylboronic acid (46 mg, 0.39 mmol) and 1,4-dioxane (4 mL), 14f was 
isolated as a colorless solid. (70 mg, 58%). Mp 75-77 °C. 1H NMR (300 MHz, 
CDCl3): δ = 1.14 (s, 9H, CH3), 7.02-7.38 (m, 7H, ArH). 13C NMR (75.46 MHz, 
CDCl3): δ = 31.2 (CH3), 34.7 (C), 114.8 (d, J = 22.1 Hz, CH), 123.6 (d, J = 3.2 Hz, 
CH), 125.6 (CH), 125.9 (CH), 126.5 (CH), 128.5 (d, J = 3.51 Hz, CH), 131.6 (t, J 
= 3.7 Hz, C), 133.6 (CH), 136.1 (d, J = 2.3 Hz, C), 142.7 (d, J = 6.9 Hz, C), 151.4 
(C), 159.3 (d, JCF = 246.7 Hz, CF). 19F NMR (282.4 MHz, CDCl3): δ =-115.01 (CF). IR 
(ATR, cm-1): ν̃ = 3066 (w), 2960 (w), 2927 (w), 2866 (w), 2718 (w), 1915 (w), 1892 (w), 
1599 (w), 1519 (w), 1477 (m), 1387 (m), 1266 (m), 1245 (m), 1196 (m), 1109 (m), 1053 (m), 
967 (w), 873 (m), 810 (s), 716 (w), 643 (w), 575 (m), 545 (s). MS (EI, 70 eV): m/z (%) = 308 
(33) (81Br) [M]+, 306 (32), 293 (100), 292 (16), 291 (99), 265 (17), 212 (15), 183 (18). HRMS 
(EI) calcd. for C16H1681BrF [M]+: 308.03935; found 308.039487 
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1-Bromo-4(3´-chlorophenyl)-2-fluorobenzene (14g) : Starting with 12 (100 mg, 0.39 
mmol), Cs2CO3 (190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 3-chlorophenylboronic 
acid (60 mg, 0.39 mmol) and 1,4-dioxane (4 mL), 14g was isolated as a colourless 
solid (56 mg, 50%). Mp 94-95 °C. 1H NMR (300 MHz, CDCl3): δ = 7.21 (d, J = 
8.7 Hz, 1H, ArH), 7.25-7.33 (m, 2H, ArH), 7.35-7.39 (m, 4H, ArH). 13C NMR 
(75.46 MHz, CDCl3): δ = 119.8 (d, J = 25.5 Hz, CH), 128.8 (CH), 129.1 (CH), 
130.0 (CH), 131.1 (CH), 133.2 (C), 134.2 (C), 135.5 (C), 146.0 (C), 160.1 (d, J = 245.1 Hz, 
CF), 161.1 (C). 19F NMR (282.4 MHz, CDCl3): δ = -115.0 (CF). IR (ATR, cm-1): ν̃ = 2954 
(w), 2919 (m), 2850 (m), 1737 (w), 1591 (w), 1555 (w), 1501 (w), 1473 (m), 1411 (w), 1302 
(w), 1275 (w), 1213 (w), 1125 (w), 1088 (m), 1018 (m), 888 (m), 837 (m), 807 (s), 749 (m), 
701 (w), 630 (m), 582 (m), 543 (w). MS (EI, 70 eV); m/z (%) = 286 (100) (81Br) [M]+, 285 
(10), 284 (77) (79Br), 170 (54), 169 (11). HRMS (EI) calcd. for C12H7BrClF [M]+: 283.93982; 
found 283.987663. HRMS (EI) calcd. for C12H781BrClF [M]+: 285.93687; found 285.937585. 
 
 
1-Bromo-4(4´-chlorophenyl)-2-fluorobenzene (14h): Starting with 12 (100 mg, 0.39 mmol), 
Cs2CO3 (190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 4-chlorophenylboronic acid 
(60 mg, 0.39 mmol) and 1,4-dioxane (4 mL), 14h was isolated as a colourless solid 
(68 mg, 60%). Mp 94-95 °C. 1H NMR (300 MHz, CDCl3): δ = 7.19-7.24 (m, 1H, 
ArH), 7.31 (dd, J = 12.6, 1.8 Hz, 1H, ArH), -7.41-7.49 (m, 4H, ArH), 7.50 (dd, J = 
8.1, 1.2 Hz, 1H, ArH). 13C NMR (75.46 MHz, CDCl3): δ = 108.3 (d, J = 20.9 Hz, 
C), 114.9 (d, J = 23.1 Hz, CH), 123.7 (d, J = 3.3 Hz, CH), 128.2 (2CH), 129.2 
(2CH), 133.9 (CH), 134.4 (C), 137.4 (C), 141.4 (d, J = 7.1 Hz, C), 159.4 (d, JCF = 247.7 Hz, 
CF). 19F NMR (282.4 MHz, CDCl3): δ = -106.8 (CF). IR (ATR, cm-1): ν̃ = 2954 (w), 2919 
(m), 2850 (m), 1737 (w), 1591 (w), 1555 (w), 1501 (w), 1473 (m), 1411 (w), 1302 (w), 1275 
(w), 1213 (w), 1125 (w), 1088 (m), 1018 (m), 888 (m), 837 (m), 807 (s), 749 (m), 701 (w), 
630 (m), 582 (m), 543 (w). MS (EI, 70 eV): m/z (%) = 286 (100) (81Br) [M]+, 284 (77) (79Br), 
170 (54), 169 (11). HRMS (EI) calcd for C12H779BrClF [M]+: 283.93982; found 283.939663. 
HRMS (EI) calcd. for C12H781BrClF [M]+: 285.93687; found 285.987585. 
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General procedure for the synthesis of 15a–c. 
The reaction was carried out in a pressure tube. To a dioxane suspension (4 mL) of 12 (200 
mg, 0.79 mmol), Pd(PPh3)4 (3 mol%) and Ar1B(OH)2 (0.79 mmol) was added Cs2CO3 (385 
mg, 1.18 mmol), and the resultant solution was degassed by bubbling argon through the 
solution for 10 min. The mixture was heated at 90 °C under Argon atmosphere for 8 h. The 
mixture was cooled to 20 °C and Ar2B(OH)2 (0.95 mmol) and Cs2CO3 (385 mg, 1.18 mmol) 
was added. The reaction mixtures were heated under Argon atmosphere for 6 h at 100 °C. 
They were diluted with water and extracted with CH2Cl2 (3 * 50 mL). The combined organic 
layers were dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue 
was purified by flash chromatography (silica gel, EtOAc/ hexane = 1:4). 
 
1-(3´,4´-Dimethoxyphenyl)-4-(2-thienyl)-2-fluorobenzene (15a): Starting with 12 (200 mg, 
0.79 mmol), Cs2CO3 (385 g, 1.81 mmol), Pd(PPh3)4 (3 mol%), 3,4-
dimethoxyyphenylboronic acid (143 mg, 0.79 mmol) and 1,4-dioxane (4 mL) 
and 2-thienylphenylboronic acid (121 mg, 0.95 mmol), 15a was isolated as a 
colorless solid (131 mg, 53%). Mp 94-96 °C. 1H NMR (300 MHz, CDCl3): δ = 
3.81 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 6.85-7.17 (m, 5H, ArCH), 7.21-7.52 
(m, 4H, ArH). 13C NMR (75 MHz, CDCl3): δ = 56.0 (OCH3), 56.1 (OCH3), 
107.2 (d, J = 20.0 CH), 110.0 (CH), 110.3 (CH), 111.5 (d, J = 4.5 Hz, CH), 
113.6 (dd, J = 21.4, 7.1 Hz, J = 2.4 Hz, C), 114.7 (d, J = 22.6 Hz, CH), 119.4 (CH), 119.5 (C), 
122.4 (t, J = 2.4 Hz, C), 123.5 (d, J = 3.4 Hz, C), 128.5 (d, J = 13.2 Hz, C), 130.2 (d, J = 9.5 
Hz, C), 131.6 (t, J = 3.2 Hz, C), 131.9 (C), 132.3 (d, J = 11.1 Hz, C), 133.6 (CH), 142.5 (d, J 
= 7.4 Hz, CH), 149.3 (C), 159.3 (d, J =  247.0 Hz, CF). IR (ATR, cm−1): ν̃ = 3058 (w), 3014 
(w), 2938 (w), 2838 (w), 1723 (w), 1595 (w), 1563 (w), 1481 (m), 1439 (w), 1315 (w), 1280 
(w), 1250 (m), 1197 (w), 1160 (m), 1104 (w), 1023 (m), 935 (w), 870 (w), 801 (m), 718 (w), 
640 (w), 594 (w), 539 (w). GC-MS (EI, 70 eV): m/z (%) = 314 (100) [M]+, 311 (16), 310 (99), 
297 (18), 295 (19), 269 (16), 267 (18), 188 (65), 173 (11), 170 (14), 157 (15) 145 (18). 
HRMS (EI) calcd. for C18H15FO2S [M]+: 314.07768; found 314.06859. 
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1-(4´-Acetylphenyl)-4-(4´´-methoxyphenyl)-2-fluorobenzene (15b): Starting with 12 (200 
mg, 0.79 mmol), Cs2CO3 (385 g, 1.81 mmol), Pd(PPh3)4 (3 mol%), 4-
acetylyphenylboronic acid (129 mg, 0.79 mmol) and 1,4-dioxane (4 mL) and 4-
methoxyphenylboronic acid (144 mg, 0.95 mmol), 15b was isolated as a colorless 
solid (151 mg, 60%). Mp 89-90 °C. 1H NMR (300 MHz, CDCl3): δ = 2.57 (s, 3H, 
CH3), 3.79 (s, 6H, OCH3), 6.91-6.94 (m, 2H, CH), 7.28-7.50 (m, 5H, CH), 7.61-
7.65 (m, 2H, CH), 7.96-8.00 (m, 2H,CH).13C NMR (75 MHz, CDCl3): δ = 26.7 
(CH3), 55.4 (OCH3), 114.2, 114.2 (CH), 114.3(d, J =23.8 Hz, CH), 125.7(d, J =3.2 
Hz, CH), 127.1(d, J =16.1 Hz, CH), 128.1 (2CH), 128.8(2CH), 129.1 (2CH), 
130.1 (C), 130.3 (C), 136.2 (C), 140.4, 140.9 (C), 159.8 (C), 160.3(d, 1JCF=249 Hz, C), 
197.7(CO). 19F NMR (282 MHz, CDCl3): δ = -113.40 (CF). IR (ATR, cm−1): ν̃ = 2956 (w), 
2837 (w), 1675 (m), 1602 (m), 1578 (m), 1545 (m), 1484 (m), 1464 (m), 1393 (m), 1357 (m), 
1300 (m), 1249 (m), 1173 (m), 1127 (m), 1023 (m), 1045 (w), 1023 (m), 809 (s), 693 (m), 
577 (m), 3053 (w), (w). GC-MS (EI, 70 eV): m/z (%) = 320 (100) [M]+, 306 (16), 305 (72), 
277 (6), 234 (10), 233 (23), 153 (11), 117 (3). HRMS (EI) calcd. for C21H17FO2 [M]+: 
320.120627; found 320.12071. 
 
1-(3´,5´-Dimethylphenyl)-4-(phenyl)-2-fluorobenzene (15c): Starting with 12 (200 mg, 0.79 
mmol), Cs2CO3 (385 mg, 1.18 mmol), Pd(PPh3)4 (3 mol%), 3,5-di-
methylphenylboronic acid (118 mg, 0.79 mmol) and 1,4-dioxane (4 mL), and 
phenylboronic acid (114 mg, 0.95mmol) and 15c was isolated as a colorless 
solid (141 mg, 65%). Mp 85-87 °C. 1H NMR (300 MHz, CDCl3): δ = 2.29 (s, 
6H, CH3), 6.93 (s, 1H, ArH), 7.12-7.14 (m, 2H, ArH), 7.25-7.42 (m, 6H, ArH), 
7.49-7.54 (m, 2H, ArH). 13C NMR (75 MHz, CDCl3): δ = 21.4, 29.3 (CH3), 
114.6 (d, J = 23.8 Hz, CH), 126.3 (d, J = 2.8 Hz, CH), 126.9, (2CH), 127.7 (CH), 127.9 (CH), 
128.5 (d, J = 1.4 Hz, CH), 128.9 (d, J = 3.48 Hz, CH), 129.4 (CH), 129.5 (d, J = 4.1 Hz, C), 
130.8 (CH), 130.9 (d, J = 1.3 Hz, CH), 131.1 (C), 137.9, 138.5, 139.6 (C), 137.8, 142.4 (d, J = 
16.9 Hz, C), 160.0 (d, 1JCF = 247.1 Hz, CF). 19F NMR (282 MHz, CDCl3): δ = -117.7. IR 
(ATR, cm−1): ν̃ = 3052 (w), 3034 (w), 2915 (w), 2857 (w), 2732 (w), 1953 (w), 1892 (w), 
1771 (w), 1747 (w), 1620 (m), 1601 (m), 1555 (m), 1475 (m), 1395 (m), 1328 (w), 1258 (m), 
1183 (m), 1133 (m), 1037 (w), 1009 (w), 937 (m), 873 (m), 850 (m), 826 (s), 787 (m), 755 (s), 
695 (s), 644 (m), 589 (m), 538 (m). GC-MS (EI, 70 eV): m/z (%) = 276 (100) [M]+. HRMS 
(EI) calcd. for C20H17F [M]+: 276.13088; found 276.130583 
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General procedure for Suzuki–Miyaura reactions(17a-g, 18a,b): A 1,4-dioxane solution (4 
mL per 0.3 mmol of 17) of 17, Cs2CO3, Pd(PPh3)4 and arylboronic acid 8 were stirred at 90 
°C for 6 or 8 h. After cooling to room temperature, the organic and the aqueous layers were 
separated and the latter was extracted with CH2Cl2. The combined organic layers were dried 
(Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was purified by 
column chromatography. 
 
1,3-Diphenyl-4-fluorobenzene (17a): Starting with 16 (100 mg, 0.39 mmol), Cs2CO3 (253  
mg, 0.78 mmol), Pd(PPh3)4 (3 mol%), phenylboronic acid (94 mg, 0.78 mmol) 
and 1,4-dioxane (4 mL), 17a was isolated as a colorless oil (54 mg, 55%). 
1H NMR (300 MHz, CDCl3): δ = 7.09-7.16 (m, 1H, ArH), 7.23-7.32 (m, 2H, 
ArH), 7.33-7.45 (m, 5H, ArH), 7.47-7.63 (m, 5H, ArH. 13C NMR (75 MHz, 
CDCl3): δ = 116.3 (d, J = 23.6 Hz, CH), 127.1 (2CH), 127.6 (d, J = 8.02 Hz, 
CH), 128.6 (2CH), 128.9 (2CH), 129.1 (CH), 129.6 (CH), 130.9 (CH), 132.5 (C), 135.8 (C), 
137.7 (d, J= 3.57 Hz, C), 140.2 (C), 159.4, (d, JCF= 249.0 Hz, CF).19F NMR (282 MHz, 
CDCl3): δ = -120.67 (CF). IR (ATR, cm−1): ν̃ = 3058 (w), 3029 (w), 2956 (w), 2927 (w), 2857 
(w), 1948 (w), 1883 (w), 1806 (w), 1723 (m), 1600 (w), 1539 (w), 1478 (s), 1392 (w), 1332 
(w), 1257 (m), 1183 (w), 1121 (m), 1073 (m), 1000 (w), 945 (w), 892 (m), 823 (s), 759 (s), 
721 (m), 693 (s), 631 (s), 584 (s), 539 (m). MS (EI, 70 eV); m/z (%) = 248 (100) [M]+. HRMS 
(EI) calcd. for C18H13O F [M]+: 248.09958; found 248.8935680. 
 
1,3-Di(4´-methylphenyl)-4-fluorobenzene (17b): Starting with 16 (100 mg, 0.39 mmol), 
Cs2CO3 (253 mg, 0.78 mmol), Pd(PPh3)4 (3 mol%), 4-
methylphenylboronic acid (106 mg, .78 mmol) and 1,4-dioxane (4 mL), 
17b was isolated as a colorless solid (67 mg, 62%). Mp 96-98 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.32 (CH3), 2.34 (CH3), 7.08-7.21 (m, 
5H, ArH), 7.38-7.42 (m, 5H, CH), 7.51-7.58 (m, 1h, ArH). 13C NMR 
(75 MHz, CDCl3): δ = 21.1, 21.3 (CH3), 116.3 (d, J = 23.3 Hz, CH), 127.1 
(2CH), 127.1 (2CH), 127.1 (d, J = 8.0 Hz, CH), 128.9 (d, J = 8.0 Hz, CH), 129.1 (C), 129.3 
(C), 129.6 (2CH), 129.6 (2CH), 132.9 (2C), 137.7 (2C), 160.9 (d, JCF = 248.0 Hz, CF). 19F 
NMR (282 MHz, CDCl3): δ = -120.72 (CF). ν̃ = 3052 (w), 2975 (w), 2916 (w), 2848 (w), 
2734 (w), 1899 (w), 1797 (w), 1731 (w), 1645 (w), 1590 (w), 1515 (w), 1483 (m), 1450 (w), 
1381 (w), 1280 (w), 1249 (w), 1214 (w), 1126 (w), 1039 (w), 960 (w), 902 (w), 834 (w), 809 
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(s), 719 (m), 663 (w), 615 (w), 549 (m). IR (ATR, cm−1): GC-MS (EI, 70 eV); m/z (%) = 276 
(100) [M]+. HRMS (EI) calcd. for C20H17F [M]+: 276.13088; found 276.130620 
 
1,3-Di(2´-methoxyphenyl)-4-fluorobenzene (17c): Starting with 16 (100 mg, 0.39 mmol), 
Cs2CO3 (253 mg, 0.78 mmol), Pd(PPh3)4 (3 mol%), 2-methoxyphenylboronic 
acid (94 mg, 78 mmol) and 1,4-dioxane (4 mL), 17c was isolated as a colorless 
solid (73 mg, 60%). Mp 99-100 °C. 1H NMR (300 MHz, CDCl3): δ = 3.75, 
3.75 (s, 3H, OCH3), 6.89-6.98 (m, 4H, ArH), 7.04-7.11 (m, 1H, ArH), 7.17-
7.25 (m, 3H, ArH), 7.39-7.48 (m, 2H, ArH). 13C NMR (75 MHz, CDCl3): δ = 
55.6, 55.7 (OCH3), 111.1 (CH), 111.2 (CH), 114.9 (d, J = 22.5 Hz, CH), 120.5 
(CH), 120.9 (CH), 128.7 (2C), 125.7 (d, J = 15.8 Hz, C), 130.1 (d, J = 8.3 Hz, CH), 130.9 
(2CH), 131.5 (2CH), 133.0 (d, J = 8.3 Hz, CH), 134.1 (d, J = 3.8 Hz, C), 157.1, 157.6 (C), 
159.1 (d, J = 244.0 Hz, CF).19F NMR (282 MHz, CDCl3): δ = -116.36 (CF). IR (ATR, cm−1): 
ν̃ = 3053 (w), 2959 (m), 2924 (m), 2852 (m), 2836 (m), 1577 (m), 1494 (s), 1455 (s), 1434 
(m), 1390 (m), 1256 (m), 1228 (m), 1109 (m), 1022 (s), 825 (m), 792 (m), 825 (s), 792 (s), 
748 (s), 625 (m), 597 (m), 544 (m). GC-MS (EI, 70 eV); m/z (%) = 308 (100) [M]+, 278 (13), 
260 (6), 233 (10), 110 (3). HRMS (EI) calcd. for C20H17O2F[M]+: 308.12071; found 
308.120178. 
 
1,3-Di(4´-methoxyphenyl)-4-fluorobenzene (17d): Starting with 16 (100 mg, 0.39 mmol), 
Cs2CO3 (253 mg, 0.78 mmol), Pd(PPh3)4 (3 mol%), 4-
methoxyphenylboronic acid (85 mg, 70 mmol) and 1,4-dioxane (4 mL), 
17d was isolated as a colorless solid (94 mg, 70%). Mp 101-103 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.74, (s, 3H, OCH3), 3.76 (s, 3H, 
OCH3), 6.84-6.92 (m, 4H, ArH), 7.04-7.14 (m, 1H, ArH), 7.23-7.36 (m, 
2H, ArH), 7.39-7.49 (m, 4H, ArH). 13C NMR (75 MHz, CDCl3): δ = 
55.3, (OCH3) 55.4 (OCH3), 114.0 (2CH), 114.1 (2CH), 114.3 (d, J = 
23.7 Hz, CH), 116.4 (d, J = 23.3 Hz, CH), 126.6 (d, J = 8.57 Hz, CH), 127.7 (C), 128.1 
(2CH), 128.9 (C), 130.2 (2CH), 132.8 (C), 137.3 (d, J = 3.52 Hz, C) 159.1 (d, J = 247.0 Hz, 
CF), 159.1 (d, J = 10.9 Hz, C). 19F NMR (282 MHz, CDCl3): δ = -119.9 (CF). IR (ATR, 
cm−1): ν̃ = 3037 (w), 3000 (w), 2955 (w), 2907 (w), 2836 (w), 1605 (m), 1571 (w), 1500 (w), 
1480 (s), 1439 (m), 1383 (w), 1310 (w), 1247 (s), 1179 (s), 1114 (m), 1076 (m), 1016 (s), 
1000 (m), 962 (w), 886 (w), 832 (s), 808 (s), 791 (s), 765 (w), 717 (w), 656 (w), 589 (w), 550 
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(m), 529 (m). MS (EI, 70 eV): m/z (%) = 308 (100) [M]+, 293 (26), 265 (14). ESI-HRMS 
calcd. for C20H17FO2 [M+H]+: 308.12071; found 308.120987. 
 
1,3-Di(4´-trifluoromethylphenyl-4-fluorobenzene (17e): Starting with 16 (100 mg, 0.37 
mmol), Cs2CO3 (253 mg, 0.78 mmol), Pd(PPh3)4 (3 mol%), 4-
trifluoromethylphenylboronic acid (148 mg, 0.78 mmol) and 1,4-
dioxane (4 mL), 17e was isolated as a colorless solid (68 mg, 45%). Mp 
148-150 °C. 1H NMR (300 MHz, CDCl3): δ = 7.21 (dd, J = 18.6, 8.46 
Hz,  1H, ArH), 7.49-7.68 (m, 10H, ArH). 13C NMR (75 MHz, CDCl3): δ 
= 117.0 (d, J = 22.9 Hz, CH), 125.5 (dd, J = 7.85, 3.92 Hz, CH), 125.9 
(dd, J = 7.71, 3.49 Hz, CH), 127.4 (2CH), 128.7 (d, J = 9.1 Hz, CH), 
129.4 (d, J = 3.34 Hz, CH), 129.6 (d, J = 3.49 Hz, CH), 136.5 (C), 139.0 
(C), 143.3 (2C), 149.7 (C), 158.7 (d, JCF = 244.0 Hz, CF3), 159.2, (d, JCF = 239.0 Hz, CF3), 
159.9, (d, JCF = 252.0 Hz, CF). 19F NMR (282 MHz, CDCl3): δ = -62.5, -62.6 (CF3), -118.8 
(CF). IR (ATR, cm−1): ν̃ = 3052 (w), 3028 (w), 2959 (w), 2900 (w), 2864 (w), 1519 (w), 1484 
(m), 1420 (w), 1380 (w), 1319 (w), 1269 (m), 1212 (m), 1045 (w), 1007 (w), 964 (w), 896 
(w), 831 (m), 813 (m), 759 (w), 722 (w), 676 (w), 615 (w), 563 (m), 536 (w). MS (EI, 70 eV): 
m/z (%) = 384 (100) [M]+. ESI-HRMS calcd. for C20H11F7 [M+H]+: 384.07435; found 
384.074697. 
1,3-Di(2-thienyl)-4-fluorobenzene (17f): Starting with 16 (100 mg, 0.39 mmol), Cs2CO3 
(190 mg, 0.50 mmol), Pd(PPh3)4 (3 mol%), 2-thienylboronic acid (49 mg, 0.39 
mmol) and 1,4-dioxane (4 mL), 17f was isolated as a colourless solid (49 mg, 
48%). Mp 91-93 °C. 1H NMR (300 MHz, CDCl3): δ = 7.00-7.06 (m, 2H, 
ArH), 7.22-7.34 (m, 5H, ArH), 7.41–7.43 (m, 1H, ArH), 7.52–7.57 (m, 1H, 
ArH). 13C NMR (75.46 MHz, CDCl3): δ = 113.4 (d, J = 24.5 Hz, CH), 121.1 
(d, J = 13.5 Hz, C), 121.8 (d, J = 3.1 Hz, CH), 123.8 (CH), 125.6 (CH), 125.8 (d, J = 4.5 Hz, 
CH), 126.3 (d, J = 7.1 Hz, CH), 127.8 (CH), 128.3 (CH), 129.0 (d, J = 4.2 Hz, CH), 134.9 (d, 
J =  9.4 Hz, C), 136.9 (d, J = 3.87 Hz, C), 142.6 (d, J = 2.9 Hz, C), 159.2 (d, JCF = 250.2 Hz, 
CF). 19F NMR (282.4 MHz, CDCl3): δ = -107.4 (CF). IR (ATR, cm-1): ν̃ = 3102 (w), 3067 
(w), 2956 (w), 2871 (w), 1886 (w), 1799 (w), 1724 (w), 1605 (w), 1555 (w), 1484 (w), 1421 
(w), 1355 (w), 1289 (w), 1244 (w), 1177 (w), 1121 (w), 1071 (w), 999 (w), 960 (w), 866 (w), 
841 (w), 808 (m), 746 (w), 696 (m), 613 (w), 561 (w), 529 (w). GC-MS (EI, 70 eV); m/z (%) 
= 260 (100) [M]+, 215 (13). HRMS (EI) calcd. for C14H9FS2 [M]+: 260.01242; found 
260.0135983. 
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1,3-Di(2´,3´-dimethoxyphenyl)-4-fluorobenzene (17g): Starting with 16 (100 mg, 0.39 
mmol), Cs2CO3 (263 mg, 0.81 mmol), Pd(PPh3)4 (3 mol%), 2,3-
dimethoxyphenylboronic acid (141 mg, 0.78 mmol) and 1,4-dioxane (4 
mL), 17g was isolated as a colourless solid (84 mg, 58%). Mp 176-178 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.59 (s, 3H, OCH3), 3.75 (s, 3H, OCH3), 
3.81 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 6.76-6.87 (m, 4H, ArH), 7.01.-7.07 
(m, 2H, ArH), 7.28–7.32 (m, 3H, ArH). 13C NMR (75.46 MHz, CDCl3): δ = 
55.8 (OCH3), 55.9 (OCH3), 60.6 (OCH3),  60.7 (OCH3), 111.6 (CH), 112.1 (d, J = 32.6 Hz, 
CH), 116.3 (d, J = 25.2 Hz, CH), 122.4 (CH), 123.3 (d, J = 1.3 Hz, CH), 123.9 (d, J = 36.6 
Hz, CH), 124.5 (CH), 124.6 (d, J = 3.6 Hz, C), 130.1 (CH), 131.4 (d, J = 3.8 Hz, C), 134.4 (d, 
J = 1.8 Hz, C), 139.4 (d, J = 8.2 Hz, C), 146.9 (d, J = 36.8 Hz, C), 152.8 (C), 153.1 (d, J = 
21.2 Hz, C), 159.6 (d, J = 246.6 Hz, CF). 19F NMR (282.4 MHz, CDCl3): δ = -114.7 (CF). IR 
(ATR, cm-1): ν̃ = 3103 (w), 3058 (w), 3006 (w), 2962 (w), 2930 (w), 2837 (w), 1621 (w), 
1598 (w), 1579 (w), 1556 (w), 1515 (w), 1478 (w), 1441 (w), 1402 (m), 1316 (w), 1264 (m), 
1208 (w), 1188 (w), 1113 (m), 1084 (w), 1032 (m), 998 (m), 934 (w), 875 (w), 831 (w),  787 
(m), 751 (m), 651 (w), 600 (w), 535 (m). MS (MS, 70 eV): m/z (%) = 368 (100) [M]+, 338 
(38). HRMS (EI) calcd. for C22H21O4F[M]+: 368.14184; found 368.121183. 
 
3-Bromo-4(4'-methyl)-4-fluorobiphenyl (18a): Starting with 16 (100 mg, 0.39 mmol), 
Cs2CO3 (126 mg, 0.39 mmol), Pd(PPh3)4 (3 mol%), 4-methylphenylboronic acid 
(53 mg, 0.39 mmol) and 1,4-dioxane (4 mL), 18a was isolated as a colorless solid 
(65 mg, 63%). Mp 99-101 °C 1H NMR (300 MHz, CDCl3): δ = 2.33 (s, 3H, CH3), 
6.93-6.98 (m, 1H, ArH), 7.17-7.20 (m, 2H, ArH), 7.29-7.36 (m, 2H, ArH), 7.46-
7.49 (dd, J = 6.87, 2.60 Hz, 1H, ArH), 7.38 (d, J = 1.5 Hz, 1H, CH).13C NMR (75 
MHz, CDCl3): δ = 21.3 (OCH3), 108.9 (d, J = 21.0 Hz, C), 114.1 (2CH), 117.8 (d, 
J = 18.0 Hz, CH), 130.1, 130.2 (CH), 131.0 (C), 131.1 (C), 132.2 (C), 136.1 (C), 159.7 (C), 
165.8 (d, J = 248.0 Hz, CF).19F NMR (282 MHz, CDCl3): δ = -119.8 (CF). IR (ATR, cm−1): ν̃ 
= 3029 (w), 2918 (w), 2853 (w), 2733 (w), 1914 (w), 1755 (w), 1725 (w), 1596 (w), 1519 
(w),1468 (w), 1378 (w), 1288 (w), 1265 (m), 1131 (w), 1074 (w), 1014 (s), 949 (w), 881 (w), 
806 (s), 717 (w), 695 (m), 656 (w), 591 (w), 531 (w). GC-MS (EI, 70 eV): m/z (%) = 
264(100) (79Br [M]+, 185 (15), 184 (19), 183 (52), 170 (21), 165 (42). HRMS (EI) calcd. for 
C13H10BrF [M]+: 263.99444; found 263.994477 and calcd for C13H1081BrF [M] +: 265.99240; 
found 265.992517. 
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3-Bromo-1-(4'-methoxy)-4-fluorobiphenyl (18b): Starting with 16 (100 mg, 0.39 mmol), 
Cs2CO3 (126  mg, 0.78 mmol), Pd(PPh3)4 (3 mol%), 4-methoxyphenylboronic 
acid (59 mg, 0.39 mmol) and 1,4-dioxane (4 mL), 18b was isolated as a colorless 
solid (78 mg, 70%). Mp 66-68 °C. 1H NMR (300 MHz, CDCl3): δ = 3.78 (s, 3H, 
OCH3), 6.89-6.96 (m, 2H, ArH), 6.96 (d, J = 6.6 Hz, 1H, CH), 7.18-7.20 (m, 2H, 
CH), 7.34 (d, J = 1.5 Hz, 1H, CH), 7.38 (d, J = 1.5 Hz, 1H, CH). 13C NMR (75 
MHz, CDCl3): δ = 55.4 (OCH3), 108.9 (d, J = 21.0 Hz, C), 114.1 (2CH), 117.8 (d, 
J = 18.0 Hz, CH), 130.1, 130.2 (CH), 131.0 (CH), 131.1 (CH), 132.2 (C), 136.1 (C), 159.7 
(C), 165.8 (d, J = 248.0 Hz, CF). 19F NMR (282 MHz, CDCl3): δ = -119.8 (CF). IR (ATR, 
cm−1): ν̃ = 3074 (m), 3015 (m), 2960 (m), 2837 (w), 1605 (m), 1514 (m), 1295 (m), 1255 (s), 
1075 (s), 1016 (s), 875 (m), 792 (m), 696 (m), 624 (m), 576 (s). GC-MS (EI, 70 eV); m/z (%) 
= 280 (100) (79Br) [M]+, 267 (24), 265 (18), 239 (34), 237 (30), 213 (11), 170 (11), 158 (24), 
157 (51), 138 (9), 44 (11). HRMS (EI) calcd. for C13H10OBrF [M]+: 279.98936; found 
279.989522 and calcd. for C13H10O81BrF [M]+: 281.98731; found 281.987381. 
 
 
General procedure for the synthesis of 19a. 
The reaction was carried out in a pressure tube. To a dioxane suspension (4 mL) of 16 (200 
mg, 0.79 mmol), Pd(PPh3)4 (3 mol %) and Ar1B(OH)2 (0.79 mmol) was added Cs2CO3 (385 
mg, 1.18 mmol), and the resultant solution was degassed by bubbling argon through the 
solution for 10 min. The mixture was heated at 90 °C under Argon atmosphere for 8 h. The 
mixture was cooled to 20 °C and Ar2B(OH)2 (0.95 mmol) and Cs2CO3 (385 mg, 1.18 mmol) 
was added. The reaction mixtures were heated under Argon atmosphere for 6 h at 100 °C. 
They were diluted with water and extracted with CH2Cl2 (3 * 50 mL). The combined organic 
layers were dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue 
was purified by flash chromatography (silica gel, EtOAc/ hexane = 1:4). 
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1-(4`-Trifluoromethylphenyl)-3-(4`-methylphenyl)-4-fluorobenzene (19a): Starting with 
16 (200 mg, 0.78 mmol), Cs2CO3 (253 mg, 0.78 mmol), Pd(PPh3)4 (3 
mol%), 4-trifluoromethylphenylboronic acid (148 mg, 0.78 mmol) and 
4-methoxyphenylboronic acid(142 mg, 0.93 mmol) and 1,4-dioxane (4 
mL), 19a was isolated as a colorless solid (79 mg, 58%). Mp 149-151 
°C. 1H NMR (300 MHz, CDCl3): δ = 3.73 (s, OCH3), 6.86-6.95 (m, 4H, 
ArH), 7.05-7.16  (m, 1H, ArH), 7.26-7.45 (m, 2H, ArH), 7.60-7.65 (m, 
4H, ArH). 13C NMR (75 MHz, CDCl3): δ = 55.4 (OCH3), 110.3 (CH), 
110.4 (CH), 111.3 (CH), 114.1 (CH), 114.4 (CH), 116.6 (d, J = 22.8 Hz, CH), 125.4 (d, J = 
24.5, Hz, CH), 126.7 (C), 127.1 (CH), 127.4 (CH), 128.1 (t, J = 3.87 Hz, CH), 129.4 (CH), 
130.2 (CH), 132.4 (C), 155.4 (C), 157.9 (d, J = 13.3 Hz, C), 158.2, (d, JCF= 247.8 Hz, CF), 
159.4, (d, J = 11.2.0 Hz, C), 160.0 (d, J = 9.6 Hz, C). 19F NMR (282 MHz, CDCl3): δ = -61.9, 
-(CF3), -110.7 (CF). IR (ATR, cm−1): ν̃ = 3072 (w), 3037 (w), 2957 (w), 2912 (w), 2837 (w), 
1605 (m), 1569 (m), 1517 (m), 1486 (s), 1439 (s), 1384 (m), 1323 (s), 1273 (s), 1234 (s), 
1177 (s), 1124 (s), 1069 (s), 1012 (s), 962 (w), 891 (w), 835 (m), 809 (s), 794 (m), 765 (m), 
714 (w), 656 (w), 598 (w), 550 (m), 530 (m). MS (EI, 70 eV): m/z (%) = 346 (100) [M]+ , 331 
(11). HRMS (EI) calcd. for C20H14OF4 [M]+: 346.09753; found 346.096887. 
7.7 Direct Periodination of Aromatic Compounds; General Procedure 
Required molar amount of arene (1.0 mmol), molecular I2 (1.27 g, 5.0 mmol), and K2S2O8 
(1.35 g, 5.0 mmol) were dissolved in DCE (10 mL). The reaction mixture was stirred in an ice 
bath for about 5 min, and then TFA (4 mL) and aq concd H2SO4 (0.18 mL, 1 mmol) were 
gradually added with constant stirring. The mixture was stirred for about 10 min in the ice 
bath and stirred further for 15 min at r.t. The temperature of the mixture was then gradually 
increased to the required temperature and stirred until the completion of the reaction. The 
mixture was cooled and poured into ice-cold H2O (40-50 mL). The precipitated solid was 
collected by suction, washed with H2O (30-40 mL), and CH2Cl2 (20-25 mL) or CH2Cl2-
hexane to remove the unreacted I2. 
 
1,2-Difluoro-3,4,5,6-tetraiodobenzene (21): Starting with 20 (1 g, 0.008 mol), K2S2O8 (11 g, 
0.044 mol), TFA (11.8g, 0.044 mol) and I2 (12.1 g, 0.048 mmol) was refluxed 
in DCE, was isolated as a yellow crystalline solid (4.8 g, 90%). Mp 153-155 °C. 
19F NMR (282 MHz, CDCl3): δ = -94.3. 13C NMR (62.8 MHz, CDCl3): δ = 97.3 
(d, 2J = 23.3 Hz, C), 115.3 (C), 150.3 (d, 1J = 243.2 Hz, C). IR (KBr): ν~  = 
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2635, 2366, 2340, 2188, 2043, 1979 (w), 1537 (m), 1408, 1402 (s), 1316, 1224, 1172, 1046, 
876, 702 (m), 678, 656, 557 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 617 ([M]+, 100), 490 
(24), 237 (22), 127 (10), 110 (22). HRMS (EI) calcd. for C6F2I4 [M]+: 617.61413 found 
617.613808. Anal. Calcd for C6F2I4: C, 11.67. Found: C, 11.68 
 
1,3-Difluoro-2,4,5,6-tetraiodobenzene (23): Starting with 22 (1 g, 0.008 mol), K2S2O8 (11 g, 
0.044 mol), TFA (11.8g, 0.044 mol) was refluxed in DCE, was isolated as a 
yellow crystalline solid (4.7g, 88%). Mp 176-177 °C. IR (KBr): ν~  = 2921 (w), 
2764 (w), 2591 (w), 2412 (w), 2351 (w), 1667 (w), 1604 (w), 1474 (w), 1380 
(w), 1355 (w), 1275 (w), 1238 (w), 1188 (w), 1079 (w), 1033 (w), 923 (w), 889 
(w), 820 (w), 699 (w), 634 (w), 559 (w) cm-1. M, 70 eV): m/z (%) = 617 (100) [M]+, 490 (2), 
237 (22), 127 (10), 110 (22). HRMS (EI) calcd. for C6F2I4 [M]+: 617.61413; found 
617.61438. Anal. Calcd for C6F2I4: C, 11.67. Found: C, 12.147 
 
1,4-Difluoro-2,3,5,6-tetraiodobenzene (25): Starting with 24 (1 g, 0.008 mol), K2S2O8 (11 g, 
0.044 mol), TFA (11.8g, 0.044 mol) was refluxed in DCE, was isolated as a 
yellow crystalline solid (4.3g, 80%). Mp 253-255 °C. 19F NMR (282 MHz, 
CDCl3): δ = -54.40. 13C NMR (62.8 MHz, DMSO-d6): δ = 98.0 (dd, J = 38.6, 
4.74 Hz, C), 156.9 (dd, J = 239.5, 4.5 Hz, C). IR (KBr): ν~  = 2773 (w), 2655 
(w), 2515 (w), 1380 (w), 1311 (w), 1268 (w), 1222 (w), 1172 (w), 1099 (w), 1005 (w), 920 
(w), 806 (w), 705 (w), 664 (w), 616 (w), 586 (w), 538 (w) cm-1. MS (EI, 70 eV): m/z (%) = 
617 (100) [M]+, 491 (17), 490 (11), 363 (31), 237 (14), 128 (13), 110 (17), 43 (14). HRMS 
(EI): calcd for C6F2I4 [M]+: 617.61413; found 617.614004. Anal. Calcd for C6F2I4: C, 11.67. 
Found: C, 11.94 
 
1-Fluoro-2,3,4,5,6-pentaiodobenzene (27): Starting with 26 (1 g, 0.008 mol), K2S2O8 (11 g, 
0.044 mol), TFA (11.8g, 0.044 mol) was refluxed in DCE, was isolated as a 
yellow crystalline solid (4.1g, 76%). Mp 259-260 °C. 19F NMR (282 MHz, 
CDCl3): δ = -39.8. 13C NMR (62.8 MHz, CDCl3): δ = 96.6 (d, J = 31.7 Hz, C), 
117.8 (d, J = 3.92 Hz, C), 124.1 (C), 158.8 (d, J = 241.6 Hz, C). IR (KBr): ν~  = 
2924 (m), 2810 (m), 2778 (m), 2533 (m), 2477 (m), 2351 (m), 1693 (m), 1650 (m), 1587 (m), 
1494 (m), 1471 (m), 1327 (s), 1274 (s), 1206 (m), 1150 (m), 1052 (m), 923 (m), 875 (s), 802 
(m), 764 (m), 688 (m), 620 (s), 584 (s), 539 (m) cm-1. MS (EI, 70 eV): m/z (%) = 726 (30) 
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[M]+, 600 (100), 473 (25), 346 (22), 219 (16), 92 (19). HRMS (EI) calcd. for C6F1I5 [M]+: 
725.52319; found: 725.519725. 
 
7.8 Synthesis of fluorinated polyethynylbenzenes by Sonogashira reactions 
General Procedure for Sonogashira coupling Reactions  
A suspension of tetraiodobenzenes (21, 23, 25, 27), X-phos (10 mol %), Pd(OAc)2 (5 mol %), 
CuI (5 mol %), Cs2CO3 (5 eq) in DMF was degassed three time in ace pressure tube. 
Acetylene (1.2 eq per bromine atom) were added using a syringe. The mixture was heated at 
the indicated temperature (60–100 °C) for 60-100 h. The reaction mixture was filtered and 
residue washed with CH2Cl2 . The filtrate was washed with saturated solution of ammonium 
chloride (2 x 25ml), water (2 x 25ml) and dried over anhydrous Na2SO4. Solvent was 
removed in vacuo. The product was purified by column chromatography on silica gel.  
 
1,2-Difluoro-3,4,5,6-tetrakis(phenylethynyl)benzene (29a): starting with 21 (150 mg, 0.24 
mmol), phenylacetylene 28a (149 mg, 1.45 mmol), CuI (5 
mol%), X-Phos (10 mol%), Pd(OAc)2 (5 mol%), Cs2CO3 (5 
eq)  and DMF (5mL), 29a was isolated as yellow solid (97 
mg, 78%). Mp. 150–152 °C. 1H NMR (300 MHz, CDCl3): δ 
= 7.27-7.34 (m, 10H, ArH), 7.52-7.57 (m, 10H, ArH). 13C 
NMR (75.4 MHz, CDCl3): δ = 80.8 (C C), 85.9 (C C), 
98.5 (C C), 101.4 (C C), 116.1 (t, J = 6.25 Hz,C), 122.6 
(d, J = 58.7 Hz, C), 125.1 (C), 128.2 (CH), 128.5 (CH), 129.1 (d, J = 38.7 Hz, CH), 131.6 
(CH), 131.7 (CH), 131.9 (CH), 150.1 (dd, J = 256.2, 16.3 Hz, CF). 19F NMR (282 MHz, 
CDCl3): δ = -131.12. IR (ATR, cm−1): ν~  = 3078 (w), 3052 (w),3030 (w), 2928 (w), 2872 (w), 
2714 (w), 2524 (w), 2435 (w), 2393 (w), 2207 (w), 1947 (w), 1872 (w), 1798 (w), 1744 (w), 
1666 (w), 1584 (w), 1492 (m), 1453 (m), 1441 (m), 1409 (m), 1355 (w) 1327 (w), 1276 (w), 
1235 (w), 1194 (w), 1174 (w), 1132 (w), 1093 (w), 1066 (m), 1023 (m), 998 (w),966 (w) 934 
(m), 910 (w), 871 (w), 835 (w), 771 (w), 748 (s), 682 (s), 622 (w), 577 (m), 528 (m). MS (EI, 
70 eV); m/z (%) = 514 (100) [M]+, 513 (19), 512 (17), 492 (10), 436 (14), 385 (19), 384 (78), 
369 (10).198 (11). HRMS (EI) calcd. for C38H20F2 [M]+: 514.15276; found 514.153109 
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1,2-Difluoro-3,4,5,6-tetrakis(4-methylphenylethynyl)benzene (29b): starting with 21 (150 
mg, 0.24 mmol), 4-methylphenylacetylene (28b) (168 
mg, 1.45 mmol), CuI (5 mol%), X-Phos (10 mol%), 
Pd(OAc)2 (5 mol%), Cs2CO3 (5 eq) and DMF (5mL), 
29b was isolated as yellow solid (90 mg; 65%). Mp 
171–173 °C. 1H NMR (300 MHz, CDCl3): δ = 2.33 
(s, 12H, CH3), 7.09-7.14 (m, 8H, ArH), 7.42-7.45 (m, 
8H, ArH). ). 13C NMR (75.4 MHz, CDCl3): δ =21.60, 
21.63, 29.6 (CH3), 80.5 (C C), 85.5 (C C), 98.5 
(C C), 101.5 (C C), 115.9 (CH), 119.4 (C), 119.9 (C), 125.0 (C), 128.2 (CH), 129.5 (CH), 
131.6 (CH), 139.1 (C), 139.6 (C), 159.8 (d, JCF = 247.6 Hz, CF). 19F NMR (282 MHz, 
CDCl3): δ = -131.78. IR (ATR, cm−1): ν~  = 3051 (w), 3028 (w), 2960 (w), 2917 (w), 2849 
(w), 2733 (w), 2204 (w), 1895 (w), 1739 (w),  1603 (m), 1581 (w), 1509 (m), 1450 (m), 1412 
(w), 1378 (w), 1316 (w), 1280 (w), 1260 (w), 1212 (w), 1195 (w), 1177 (w), 1101 (m), 1076 
(w), 1037 (w), 1019 (m), 941 (m), 869 (w), 810 (s) 728 (w), 659 (w), 646 (w). MS (EI, 70 
eV); m/z (%) = 6570 (41) [M]+. HRMS (EI) calcd. for C42H28F2 [M]+: 570.21536; found 
570.213690. 
 
1,2-Difluoro-3,4,5,6-tetrakis(4-methoxylphenylethynyl)benzene (29c): starting with 21 
(150 mg, 0.24 mmol), 4-
methoxylphenylacetylene (28c) (191 mg, 1.45 
mmol), CuI (5 mol%), X-Phos (10 mol%), 
Pd(OAc)2 (5 mol%), Cs2CO3 (5 eq)  and DMF 
(5mL), 29c was isolated as yellow solid (107 
mg; 70%). Mp 151–153 °C. 1H NMR (300 MHz, 
CDCl3): δ = 3.75 (s, 6H, OCH3), 3.76 (s, 6H, 
OCH3), 6.79-6.83 (m, 8H, ArH), 7.44-7.48 (m, 
8H, ArH). 13C NMR (75.4 MHz, CDCl3): δ = 55.4 (2OCH3), 80.1 (C C), 85.1 (C C), 98.3 
(C C), 101.4 (C C), 114.2 (CH), 114.6 (CH), 115.2 (C), 122.2 (C), 124.8 (C), 128.8 (CH), 
130.9 (CH), 133.3 (CH), 133.5 (CH), 152.2 (d, J = 258.0 Hz, CF), 160.1 (C), 167.8 (C). 19F 
NMR (282 MHz, CDCl3): δ = -132.35. IR (ATR, cm−1): ν~  = 2957 (w), 2931 (w), 2838 (w), 
2536 (w), 2206 (w), 2041 (w), 1907 (w), 1722 (w), 1660 (w), 1602 (m), 1565 (w), 1509 (s), 
1455 (m), 1415 (w), 1389 (w), 1286 (m), 1244 (s), 1203 (w), 1177 (m), 1167 (s), 1103 (m), 
1072 (w) 1022 (s), 939 (m), 832 (s), 795 (m) 743 (w), 705 (w), 651 (w), 642 (w), 636 (w), 
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533 (m). MS (EI, 70 eV); m/z (%) = 634 (100) [M]+. HRMS (EI) calcd. for C42H28O4F2 [M]+: 
634.19502; found 634.195842. 
1,2-Difluoro-3,4,5,6-tetrakis(4-tert-butylphenylethynyl)benzene (29d): starting with 21 
(100 mg, 0.16 mmol), 4-tert-butylphenylacetylene 
28d (153 mg, 0.97 mmol), CuI (5 mol%), X-Phos 
(10 mol%), Pd(OAc)2 (5 mol%), Cs2CO3 (5 eq) 
and DMF (5mL), 29d was isolated as yellow oil. 
(74 mg; 62%). 1H NMR (300 MHz, CDCl3): δ = 
1.27 (s, 18H, CH3), 1.28 (s, 18H, CH3), 7.19-7.35 
(m, 8H, ArH), 7.47-7.50 (m, 8H, ArH). 13C NMR 
(75.4 MHz, CDCl3): δ = 31.2 [(CH3)3C], 34.9 
(C(CH3)), 80.5 (C C), 85.5 (C C), 98.5 (C C), 
101.5 (C C), 119.5 (C), 120.0 (C), 125.04 (C), 
125.5 (CH), 131.6 (CH), 131.7 (CH), 152.3 (C), 152.6 (C), 158.1 (d, J = 242.2 Hz, CF). 19F 
NMR (282 MHz, CDCl3): δ = -131.77, -131.77. IR (ATR, cm−1): ν~  = 3083 (w), 3035 (w), 
2956 (m), 2901 (w), 2865 (w), 2710 (w), 2212 (w), 1912 (w), 1660 (w), 1607 (w), 1587 (w), 
1552 (w), 1515 (w), 1455 (m), 1409 (w), 1391 (w), 1315 (w), 1267 (w), 1200 (w), 1182 (w), 
1107 (m), 1079 (w), 1064 (w), 1015 (w), 943 (m), 830 (s), 784 (w), 735 (w), 697 (w), 656 
(w), 620 (w), 559 (s), 528 (w). MS (EI, 70 eV); m/z (%) = 728 (36) [M]+, 617 (73), 364 (15), 
237 (10), 128 (27), 110 (20), 57 (17), 44 (100). HRMS (EI) calcd. for C54H52F2 [M]+: 
738.40316; found 738.409188. 
 
1,2-Difluoro-3,4,5,6-tetrakis(4-n-propyl-phenylethynyl)benzene (29e): starting with 21 
(100 mg, 0.16 mmol), 4-n-propyl-
butylphenylacetylene 28e (139 mg, 0.97 
mmol), CuI (5 mol%), X-Phos (10 mol%), 
Pd(OAc)2 (5 mol%), Cs2CO3 (5 eq)  and 
DMF (5mL), 29e was isolated as yellow 
oil (74 mg; 67%). 1H NMR (300 MHz, 
CDCl3): δ = 0.89 (t, J = 7.11 Hz, 12H, 
CH3), 1.53-1.66 (sext, 8H, CH2), 2.54 (t, J 
= 7.4, 8H, CH2), 7.09-7.13 (m, 8H, ArH), 
7.44-7.47 (m, 8H, ArH). 13C NMR (75.4 MHz, CDCl3): δ =13.8 (2CH3), 24.3 (2CH2), 38.0 
(2CH2), 80.5 (C C), 85.5 (C C), 98.6 (C C), 101.6 (C C), 119.7 (C), 120.2 (C), 125.0 (C), 
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128.6 (C), 128.7 (CH), 131.5 (CH), 131.8 (CH), 143.9 (C), 144.3 (C), 160.2 (dd, J = 251.0, 
13.6 Hz, CF) 19F NMR (282 MHz, CDCl3): δ = -131.76. IR (ATR, cm−1): ν~  = 3400 (w), 3119 
(w), 3078 (w), 2956 (m), 2927 (m), 2869 (m), 2732 (w), 2668 (w), 2206 (m), 1906 (w), 1787 
(w), 1703 (w), 1666 (w), 1604 (w), 1553 (w), 1509 (m), 1454 (s), 1412 (m), 1338 (m), 1258 
(m), 1178 (m), 1113 (m), 1079 (m), 1018 (m), 941 (m), 867 (m), 800 (s), 741 (m), 660 (m), 
561 (m), 528 (m). MS (EI, 70 eV); m/z (%) = 682 (91) [M]+, 653 (11), 397 (17), 396 (78), 394 
(20), 329 (12), 153 (10), 44 (100). HRMS (EI) calcd. for C50H44F2 [M]+ 682.34056; found 
682.339960. 
 
1,2-Difluoro-3,4,5,6-tetrakis(4-n-butyl-ethynyl)benzene (29f): starting with 21 (100 mg, 
0.16 mmol), 4-n-butyl-acetylene (28f) (80 mg, 0.97 mmol), 
CuI (5 mol%), X-Phos (10 mol%), Pd(OAc)2 (5 mol%), 
Cs2CO3 (5 eq) and DMF (5mL), 29f was isolated as yellow 
oil (45 mg; 64%). 1H NMR (300 MHz, CDCl3): δ = 0.88 (t, J 
= 7.20, 12H, CH3), 1.40-1.57 (m, 16H CH2), 2.40-2.46 (sext, 
8H, CH2). 13C NMR (75.4 MHz, CDCl3): δ =13.6 (2CH3), 
19.6 (2CH3), 21.9 (2CH2), 22.6 (2CH2), 29.6 (2CH2), 30.6 
(2CH2), 31.5 (2CH2), 38.1 (2CH2), 59.5 (C C), 72.3 (C C), 
98.5 (C C), 102.1 (C C), 125.9 (C), 135.5 (C), 137.0 (C), 148.3 (C), 150.9 (dd, JCF = 246.8, 
14.3 Hz, CF). 19F NMR (282 MHz, CDCl3): δ = -133.81. IR (ATR, cm−1): ν~  = 3390 (w), 
2956 (w), 2930 (w), 2871 (w), 2228 (w), 1714 (w), 1683 (w), 1608 (w), 1558 (w), 1509 (w), 
1456 (m), 1378 (w), 1341 (w), 1246 (w), 1180 (w), 1119 (w), 1068 (w), 997 (w), 900 (w), 828 
(w), 745 (w), 723 (w), 694 (w), 541 (m). MS (EI, 70 eV); m/z (%) = 434 (36) [M]+, 397 (33), 
396 (94), 394 (36), 331 (11), 329 (21), 277(15), 210 (15), 198 (11), 186 (16), 44 (100). 
HRMS (EI) calcd. for C30H36F2 [M]+: 434.27786; found 434.278396. 
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1,3-Difluoro-2,4,5,6-tetrakis(4-methoxylphenylethynyl)benzene (30a): starting with 23 
(100 mg, 0.16 mmol), 4-
methoxyphenylacetylene (28c) (128 mg, 0.97 
mmol), CuI (5 mol%), X-Phos (10 mol%), 
Pd(OAc)2 (5 mol%), Cs2CO3 (5 eq) and DMF 
(5mL), 30a was isolated as yellow solid (69 mg; 
68 %). Mp 124–126 °C. 1H NMR (300 MHz, 
CDCl3): δ = 3.88-3.94 (m, 12H, OCH3), 6.90-
6.97 (m, 9H, ArH), 7.07 (d, J = 8.5 Hz, 2H, 
ArH), 7.55-7.60 (m, 5H, ArH). 19F NMR (282 
MHz, CDCl3): δ = -102.21. IR (ATR, cm−1): ν~  
= 2917 (w), 2542 (w), 2205 (w), 1644 (w), 1602 
(w), 1567 (w), 1509 (w), 1447 (w), 1368 (w), 
1289 (w), 1245 (w), 1169 (w), 1104 (w), 1028 (w), 955 (w), 913 (w), 868 (w), 828 (w), 766 
(w), 708 (w), 679 (w), 615 (w), 532 (w). MS (EI, 70 eV); m/z (%) = 634 (17) [M]+, 397 (23), 
396 (100), 394 (25), 329 (13), 210 (10), 186 (10), 153 (10), 152 (10). HRMS (EI) calcd. for 
C42H28O4F1 [M]+: 634.19502; found 634.197057. 
 
1,4-Difluoro-2,3,5,6-tetrakis(4-methoxylphenylethynyl)benzene (31a): starting with 25 
(100 mg, 0.16 mmol), 4-
methoxyphenylacetylene (28c) (128 mg, 0.97 
mmol), CuI (5 mol%), X-Phos (10 mol%), 
Pd(OAc)2 (5 mol%), Cs2CO3 (5 eq) and DMF 
(5mL), 31a was isolated as yellow solid (80 mg, 
78%). Mp 179–180 °C. 1H NMR (300 MHz, 
CDCl3): δ = 3.78 (s, 12H, OCH3), 6.83 (dt, J = 9.00 Hz, 8H, ArH), 7.47 (dt, J = 9.00 Hz, 8H, 
ArH). 13C NMR (75.4 MHz, CDCl3): δ = 55.4 (OCH3), 80.2 (C C), 101.1 (C C), 114.2 
(CH), 114.7 (C), 132.2 (C), 133.5 (CH), 160.4 (C), 162.9 (d, JCF = 257.2 Hz, CF) 19F NMR 
(282 MHz, CDCl3): δ = -103.13. IR (ATR, cm−1): ν~  = 2914 (w), 2847 (w), 2206 (w), 1604 
(w), 1566 (w), 1513 (w), 1467 (w), 1413 (w), 1376 (w), 1343 (w), 1292 (w), 1249 (w), 1170 
(w), 1105 (w), 1025 (w), 944 (w), 821 (w), 792 (w), 718 (w), 660 (w), 643 (w), 628 (w), 594 
(w), 531 (m). MS (EI, 70 eV); m/z (%) = 634 (70) [M]+, 396 (15), 119 (25), 91 (25), 69 (10), 
57 (14), 55 (11), 44 (100), 41 (15). HRMS (EI) calcd. for C42H28F2O4 [M]+: 634.19502; found 
634.197451. 
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1-Fluoro-2,3,4,5,6-pentakis(4-methylphenylethynyl)benzene (32a): starting with 27 (100 
mg, 0.14 mmol), 4-methylphenylacetylene 28b (95 
mg, 0.82 mmol), CuI (5 mol%), X-Phos (10 mol%), 
Pd(OAc)2 (5 mol%), Cs2CO3 (5 eq) and DMF (5mL), 
32a was isolated as yellow solid (63 mg, 69%). Mp 
102–104 °C. 1H NMR (300 MHz, CDCl3): δ = 2.32 (s, 
15H, CH3), 7.09-7.13 (m, 10H, ArH), 7.43-7.45 (m, 
10H, ArH). 19F NMR (282 MHz, CDCl3): δ = -103.13. 
IR (ATR, cm−1): ν~  = 3171 (w), 3077 (w), 3025 (w), 
2952 (w), 2918(w), 2856 (w), 2729 (w), 2204 (w), 1903 (w), 1726 (w), 1604 (w), 1115 (w), 
1069 (w), 1019 (w), 985 (w), 961 (w), 945 (w), 932 (w), 811 (s), 741 (w), 721 (w), 706 (w), 
690 (w), 659 (w), 645 (w), 526 (w). MS (EI, 70 eV); m/z (%) = 666 (36) [M]+, 397 (33), 396 
(94), 394 (36), 331 (11), 329 (21), 277(15), 210 (15), 198 (11), 186 (16), 44 (100). HRMS 
(EI) calcd. for C51H35F1 [M]+: 666.27173; found 666.273441. 
 
1-Fluoro-2,3,4,5,6-pentakis(4-methoyphenylethynyl)benzene (32b): starting with 27 (100 
mg, 0.16 mmol), 4-methoxyphenylacetylene 
(28c) (108 mg, 0.82 mmol), CuI (5 mol%), X-
Phos (10 mol %), Pd(OAc)2 (5 mol %), Cs2CO3 
(5 eq) and DMF (5mL), 32b was isolated as 
yellow solid (94 mg, 78%). Mp 151–153 °C. 1H 
NMR (300 MHz, CDCl3): δ = 3.77 (s, 6H, 
OCH3), 3.78 (s, 9H, OCH3), 6.79-6.84 (m, 10H, 
ArH), 7.45-7.48 (m, 10H, ArH). 13C NMR (75.4 
MHz, CDCl3): δ = 55.4 (2OCH3), 55.5 
(2OCH3), 80.5 (C C), 100.1 (C C), 100.2 (C C), 114.1 (CH), 114.2 (CH), 115.0 (C), 115.5 
(C), 116.6 (C), 133.2 (CH), 133.3 (CH), 160.0 (C), 160.2 (C), 160.9*.  19F NMR (282 MHz, 
CDCl3): δ = -103.84. IR (ATR, cm−1): ν~  = 3045 (w), 2999 (w), 2954 (w), 2835 (w), 2536 
(w), 2203 (w), 1715 (w), 1603 (m), 1565 (w), 1505 (s), 1455 (m), 1413 (w), 1361 (w), 1288 
(m), 1243 (s), 1167 (s), 1104 (m), 1024 (m), 932 (m), 825 (s), 717 (w), 665 (w), 642 (w), 627 
(w), 531 (m). MS (EI, 70 eV); m/z (%) = 746 (100) [M]+, 135 (10), 57 (15). HRMS (EI) calcd. 
for C51H35O5F [M]+: 746.24630; found 746.248188. *: CF-group not resolved in 13C-NMR 
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1-Fluoro-2,3,4,5,6-pentakis(4-tert-butylphenylethynyl)benzene (32c): starting with 27 (100 
mg, 0.16 mmol), 4-butylphenylacetylene 28d (129 
mg, 0.82 mmol), CuI (5 mol%), X-Phos (10 mol%), 
Pd(OAc)2 (5 mol%), Cs2CO3 (5 eq) and DMF 
(5mL), 32c was isolated as yellow solid (96 mg, 
68%). Mp 161–163 °C. 1H NMR (300 MHz, 
CDCl3): δ = 1.28 (s, 27H, CH3), 1.29 (s, 9H, CH3), 
1.48 (s, 9H, CH3), 7.31-7.35 (m, 10H, ArH), 7.48-
7.51 (m, 10H, ArH). ). 13C NMR (75.4 MHz, 
CDCl3): δ = 31.2 ((CH3)3C), 34.9 (C(CH3)3) 80.3 
(C C), 80.9 (C C), 83.3 (C C), 86.2 (C C), 89.8 (C C), 100.3 (C C), 100.5 (C C), 119.8 
(C), 120.1 (C), 125.5 (CH), 125.6 (CH), 131.5 (C), 131.6 (C), 131.7 (C), 152.0 (C) 152.4 
(C).* 19F NMR (282 MHz, CDCl3): δ = -103.10. IR (ATR, cm−1): ν~  = 3082 (w), 3033 (w), 
2958 (w), 2902 (w), 2866 (w), 2205 (w), 1605 (w), 1513 (w), 1504 (w), 1462 (w), 1406 (w), 
1361 (w), 1267 (w), 1201 (w), 1107 (w), 1016 (w), 934 (w), 876 (w), 831 (m),736 (w), 665 
(w), 614 (w), 559 (w). MS (EI, 70 eV); m/z (%) = 876 (17) [M]+, 207 (11), 97 (10), 69 (23), 
44 (100). HRMS (EI): calcd for C66H65F [M]+: 876.50648; found 876.513743. Anal. Calcd for 
C66H65F1: C, 90.37. H, 7.47 Found: C, 90.35. H, 6.70 *: CF-group not resolved in 13C-NMR 
 
1-Fluoro-2,3,4,5,6-pentakis(2-methylphenylethynyl)benzene (32d): starting with 27 (100 
mg, 0.16 mmol), 2-methylphenylacetylene 28g (95 mg, 0.82 
mmol), CuI (5 mol%), X-Phos (10 mol%), Pd(OAc)2 (5 mol 
%), Cs2CO3 (5 eq) and DMF (5mL), 32d was isolated as 
yellow solid (59 mg, 55%). Mp 128–130 °C. 1H NMR (300 
MHz, CDCl3): δ = 2.37 (s, 3H, CH3), 2.39 (s, 6H, CH3), 
2.46 (s, 6H, CH3), 7.04-7.17 (m, 15H, ArH), 7.21-7.49 (m, 
5H, ArH). 13C NMR (75.4 MHz, CDCl3): δ = 20.8, 20.9, 
21.0, 29.7 (CH3), 85.2 (C C), 85.3 (C C), 90.7 (C C), 99.1 (C C), 122.4 (CH), 122.6 (CH), 
125.5 (CH), 1125.6 (CH), 129.1 (d, J = 3.85 Hz, C), 132.2 (C), 132.4 (C), 140.6 (C), 140.8 
(C), 140.9 (C), 155.9 (C) 157.9 (d, J = 233 Hz, CF). 19F NMR (282 MHz, CDCl3): δ = -
102.35. MS (EI, 70 eV): m/z (%) = 666 (100) [M]+. HRMS (EI) calcd. for C51H35F1 [M]+: 
666.271173; found 666.271113. 
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7.9 Synthesis of Fluorinated polyarenes by Suzuki-Miyaura cross coupling reaction 
General Procedure for Poly Suzuki cross coupling Reaction  
The reaction was carried out in a pressure tube. To a suspension 21, 23, 25, 27 (100 mg, 0.1 
mmol), Pd(PPh3)4 (10 mol %), arylboronic acid (1.1 eq per bromine atom) and Cs2CO3 (5eq) 
in dioxin, was added. The mixture was heated at the indicated temperature (60-100 °C) for the 
indicated period of time (60-100h). The reaction mixture was diluted with water and extracted 
with CH2Cl2 (3 x 25ml). The combined organic layers were dried over Na2SO4, filtrated and 
the filtrate was concentrated in vacuo the residue was purified by flash chromatography (silica 
gel, ethyl acetate / heptanes)  
 
1,2-Difluoro-3,4,5,6-tetrakis(4-methxphenyl)benzene (33a): Starting with 21 (100 mg, 0.16 
mmol), Pd(PPh3)4 (10 mol%), Cs2CO3 (5eq) and p-tolylboronic 
acid (130 mg, 0.96 mmol), 33a was isolated as a white solid (61 
mg, 80%). Mp 164–166°C. 1H NMR (300 MHz, CDCl3): δ = 
2.03 (s, 6H, 2CH3), 2.19 (s, 6H, 2CH3), 6.51-6.54 (m, 8H, ArH), 
6.59-6.61 (m, 8H, ArH). 19F NMR (282 MHz, CDCl3): δ = -
140.2. 13C NMR (75.4 MHz, CDCl3): δ = 20.0, 20.1 (CH3), 
126.6, 127.3 (CH), 128.8 (t, J = 6.1 Hz, C), 129.4 (CH), 129.9 (C), 130.1 (CH), 134.1 (CH), 
134.5 (C), 135.6 (CH), 136.4 (t, J = 2.7 Hz, C), 146.3 (dd, JCF = 247.9, 16.3 Hz, CF). IR 
(KBr): ν~  = 3023, 2921, 2856, 1605, 1558, 1518, 1460 (w), 1443, 1398 (m), 1348, 1260, 
1202, 1185, 1176, 1109 (w), 1094, 1020, 913, 840 (m), 806, 754 (s), 726 (m), 684, 641, 576 
(w), 539 (m), 528 (s) cm-1. GC-MS (EI, 70 eV); m/z (%) = 474 (100) [M]+, 459 (12), 419 (6), 
367 (5), 207 (10), 44 (10). HRMS (EI) calcd. for C34H28F2 [M]+: 474.21536; found 
474.215243. 
 
1,2-Difluoro-3,4,5,6-tetrakis(4-tert-butylphenyl)benzene (33b): Starting with 21 (100 mg, 
0.16 mmol), Pd(PPh3)4 (10 mol%), Cs2CO3 (5eq) and 4-
tert-phenylboronic acid (113 mg, 0.96 mmol), 33b was 
isolated as a white solid (88 mg, 85%). Mp 203–205°C. 
1H NMR (300 MHz, CDCl3): δ = 1.03 (s, 18H, 6CH3), 
1.17 (s, 18H, 6CH3), 6.52 (d, 4H, J = 8.4Hz, ArH), 6.76 
(d, 4H, J = 8.4Hz, ArH), 6.93 (d, 4H, J = 8.4Hz, ArH), 
7.09 (d, 4H, J = 8.4Hz, ArH). 19F NMR (282 MHz, CDCl3): δ = -140.6. 13C NMR (75.4 MHz, 
CDCl3): δ = 31.14, 31.22 (CH3), 34.12, 34.41 (C), 123.4, 124.3 (CH), 1298.8 (t, J = 6.6 Hz, 
F
F
FF
131 
 
C), 130.3, 131.0 (CH), 135.6 (C), 137.5 (t, J = 2.6 Hz, C), 147.0 (dd, J = 248.4, 16.6 Hz, CF), 
148.4, 149.7 (C). IR (KBr): ν~  = 3030, 2949, 2922, 2853 (m), 1731, 1610, 1513 (m), 1446 (s), 
1392, 1362 (m), 1313 (w), 1268 (m), 1202, 1120, 1087, 1019, 853 (m), 834 (s), 779, 720, 
677,568 (m) cm-1. MS (EI, 70 eV); m/z (%) = 642 (100) [M+], 628 (22), 627 (51), 306 (22), 57 
(82). HRMS (EI) calcd. for C46H52F2 [M]+: 642.40316; found 642.40384. 
 
1,2-Difluoro-3,4,5,6-tetrakis(3,5-dimethylphenyl)benzene (33c): Starting with 21 (100 mg, 
0.16 mmol), Pd(PPh3)4 (10 mol%), Cs2CO3 (5eq) and 3,5-
dimethylphenylboronic acid (144 mg, 0.96 mmol), 33c was 
isolated as a white solid (67 mg, 78%). Mp 163–165 °C. 1H 
NMR (300 MHz, CDCl3): δ = 1.89 (s, 12H, 4CH3), 2.10 (s, 
12H, 4CH3), 6.30, 6.39, 6.66, 6.70 (s, 12H, ArH). 19F NMR 
(282 MHz, CDCl3): δ = -140.7. 13C NMR (75.4 MHz, CDCl3): δ 
= 20.9 (CH3), 21.1 (CH3), 127.0, 128.4, 128.6, 129.2 (CH), 129.8 (t, J = 8.7 Hz, C), 131.7 
(C), 135.5, 136.6 (C), 137.7 (t, J = 2.8 Hz, C), 138.1 (C), 147.1 (dd, J = 247.3, 15.9 Hz, C). 
IR (KBr): ν~  = 3023, 2916, 2851, 2723 (w), 1601, 1435, 1375 (m), 1302, 1261, 1219, 1163 
(w), 1125, 1034 (m), 962, 910 (w), 859 (m), 843 (s), 813, 763 (m), 699 (s), 676 (m), 616, 559 
(m) cm-1. GC-MS (EI, 70 eV); m/z (%) = 530 (100) [M]+, 426 (4), 207 (8), 44 (10). HRMS 
(EI) calcd. for C38H36F2 [M+]: 530.27796; found 530.278685. 
 
1,2-Difluoro-3,4,5,6-tetrakis(3-methoxyphenyl)benzene (33d) Starting with 21 (100 mg, 
0.16 mmol), Pd(PPh3)4 (10 mol%), Cs2CO3 (5eq) and 3-
methoxyphenylboronic acid (145 mg, 0.96 mmol), 33d 
was isolated as a white solid (62 mg, 72%). Mp 136–
138°C. 1H NMR (300 MHz, CDCl3): δ = 3.77 (s, 6H, 
OCH3), 3.79 (s, 6H, OCH3), 6.84-6.90 (m, 6H), 6.92-6.97 
(m, 6H), 7.01-7.03 (m, 4H). 19F NMR (282 MHz, CDCl3): 
δ = -140.24. 13C NMR (75.4 MHz, CDCl3): δ = 55.3, 55.4 
(OCH3), 110.9, 114.2, 114.3, 120.5, 122.8 (CH), 123.7 (C), 126.4, 127.7 (CH), 128.0 (t, J = 
2.7 Hz, C), 128.3 (C), 133.4 (C), 150.6 (dd, J = 244.7, 13.6 Hz, C),158.6, 159.9 (C). IR 
(KBr): ν~  = 3032, 2960, 2926, 2904, 2853 (m), 1601, 1519 (w), 1474, 1439, 1392, 1361 (m), 
1260, 1096, 1017 (s), 946, 928, 879 (m), 831, 797 (s), 733, 720, 679,564 (m) cm-1. GC-MS 
(EI, 70 eV); m/z (%) = 538 (100) [M]+. HRMS (EI) calcd. for C34H28O4F2 [M]+: 538.19557; 
found 538.19345. 
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1,3-Difluoro-2,4,5,6-tetrakis(4-methylphenyl)benzene (34a): Starting with 23 (100 mg, 
0.16 mmol), Pd(PPh3)4 (10 mol%), Cs2CO3 (5eq) and p-
tolylboronic acid (130 mg, 0.96 mmol), 34a was isolated as a 
white solid (68 mg, 78%). Mp 166–168 °C. 1H NMR (300 MHz, 
CDCl3): δ = 2.08 (s, 3H, CH3), 2.19 (s, 6H, CH3), 2.33 (s, 3H, 
CH3), 6.56-6.69 (m, 4H, ArH), 6.83-6.94 (m, 8H, ArH), 7.21-
7.57 (m, 4H, ArH). 13C NMR δ = 21.2 (CH3), 21.3 (CH3), 21.4 
(CH3), 112.(C), 116.9 (C), 124.4 (d, J = 4.8 Hz, C), 125.4 (d, J = 
8.9 Hz, C), 126.7 (C), 127.9 (CH), 127.9 (CH), 128.4 (CH), 
128.9 (CH), 130.4 (CH), 130.8 (CH), 130.9 (C), 131.0 (CH), 131.4 (C), 134.6 (d, J = 2.6 Hz, 
C), 135.6 (C), 136.4 (C), 137.9 (C), 142.0 (C), 156.1 (d, JCF = 248.6 Hz, CF). IR (KBr): ν~  = 
3084 (w), 3051 (w), 2958 (w), 2919 (w), 2867 (w), 2850 (w), 1899 (w), 1722 (w), 1657 (w), 
1607 (w), 1579 (w), 1518 (w), 1430 (w), 1393 (w), 1360 (w), 1310 (w), 1262 (w), 1213 (w), 
1195 (w), 1130 (w), 1111 (w), 1070 (w), 1030 (w), 960 (w), 926 (w), 891 (w), 841 (w), 834 
(w), 784 (w), 744 (w), 685 (w), 664 (w), 587 (m), 566 (w), 536 (w) cm-1. GC-MS (EI, 70 eV); 
m/z (%) = 474 (100) [M]+. HRMS (EI) calcd. for C34H28F2 [M]+: 474.21591; found 
474.20942. 
 
1,3-Difluoro-2,4,5,6-tetrakis(4-methoxyphenyl)benzene (34b): Starting with 23 (100 mg, 
0.16 mmol), Pd(PPh3)4 (10 mol%), Cs2CO3 (5eq) and 4-
methoxyphenylboronic acid (145 mg, 0.96 mmol), 34b 
was isolated as a white solid (69 mg, 80%). Mp 236–238 
°C . 1H NMR (300 MHz, CDCl3): δ = 3.60 (s, 3H, OCH3), 
3.68 (s, 6H, 2OCH3), 3.78 (s, 3H, OCH3), 6.42-6.46 (m, 
2H, ArH), 6.59-6.71 (m, 6H, ArH), 6.89-6.94 (m, 6H, 
ArH), 7.42-7.46 (m, 2H, ArH). 13C NMR (75.4 MHz, 
CDCl3): δ = 55.0 (OCH3), 55.1 (OCH3), 55.3 (OCH3), 
112.1, 112.7, 113.2, 113.7 (CH), 117.6 (d, 3J = 3.89 Hz, C), 120.5 (d, 3J = 8.3 Hz, C), 126.7 
(C), 131.7 (CH), 132.0 (CH), 132.4 (CH), 140.4 (d, J = 2.8 Hz, C), 141.7 (C), 150.5 (d, J = 
20.6 Hz, C), 154.3 (C), 154.6 (C), 156.1 (C), 158.3 (C),161.0 (d, JCF = 241.9 Hz, CF). IR 
(KBr): ν~  = 3000, (w), 2959 (w), 2916 (w), 2838 (w), 1609 (w), 1575 (w), 1536 (w), 1462 
(w), 1433 (w), 1398 (w), 1357 (w), 1303 (w), 1289 (w), 1241 (m), 1199 (w), 1174 (w), 1108, 
(w), 1031 (m), 959 (w),  894 (w), 829 (w), 790 (w), 747 (w), 696 (w), 664 (w), 595 (w) cm-1. 
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GC-MS (EI, 70 eV); m/z (%) = 538 (100) [M]+, 536 (17), 131 (10), 71 (10), 69 (40), 57 (17), 
55 (14), 44 (36), 43 (21), 41 (14). HRMS (EI) calcd for C34H28F2O4 [M]+: 538.19502; found 
538.195178. 
 
1,3-Difluoro-2,4,5,6-tetrakis(4-tert-butylphenyl)benzene (34c): Starting with 23 (100 mg, 
0.16 mmol), Pd(PPh3)4 (10 mol%), Cs2CO3 (5eq) and 4-tert-
phenylboronic acid (113 mg, 0.96 mmol), 34c was isolated 
as a white solid (75 mg, 73%). Mp 166–168 °C. 1H NMR 
(300 MHz, CDCl3): δ = 1.06 (s, 9H, CH3), 1.16 (s, 18H, 
CH3), 6.55 (d, J = 8.39 Hz, 2H ArH)-6.81(d, J = 8.39 Hz, 
2H, ArH), 6.91 (d, J = 8.39 Hz, 4H, ArH), 7.08 (d, J = 8.39 
Hz, 4H, ArH), 7.38-7.47 (m, 4H, ArH). 19F NMR (282 
MHz, CDCl3): δ = -115.8. 13C NMR (75.4 MHz, CDCl3): δ 
= 31.1 (CH3), 31.2 (CH3), 31.3 (CH3), 34.2 (C), 34.4 (C), 
34.6 (C) 116.3 (d, J = 22.6 Hz, C), 123.6 (CH), 124.3 (CH), 125.1 (CH), 125.5 (d, J = 22.6 
Hz, C), 126.7 (C), 130.2 (CH), 130.6 (CH), 130.8 (CH), 131.4 (C), 134.8 (t, J = 2.7 Hz, C), 
142.5 (t, J = 4.0 Hz, C), 148.9 (C), 149.5 (C), 150.9 (C), 156.0 (dd, JCF = 246.9, 8.0 Hz, CF). 
IR (KBr): ν~  = 3089, (w), 3056 (w), 2960 (m), 2902 (w), 2866 (w),  1904 (w),  1786 (w), 
1737 (w), 1661 (w), 1604 (w), 1573 (w), 1520 (w), 1460 (w), 1433 (w), 1392 (w), 1320 (w), 
1267 (w), 1235 (w), 1203 (w), 1189 (w), 1120 (w), 1100, (w), 1031 (m), 1020 (w), 964 (w), 
922 (w), 897 (w), 854 (w), 833 (m), 797 (m), 742 (w), 698 (w), 664 (w), 562 (m) cm-1. GC-
MS (EI, 70 eV); m/z (%) = 642 (100) [M]+, 628 (20), 627 (43), 306 (18), 91 (82). HRMS (EI) 
calcd. for C46H52F2 [M]+: 642.403161; found 642.402961. 
 
1,4-Difluoro-2,3,5,6-tetrakis(phenyl)benzene (35a): Starting with 25 (100 mg, 0.16 mmol), 
Pd(PPh3)4 (10 mol%), Cs2CO3 (5eq) and phenylboronic acid (116 mg, 
0.96 mmol), 35a was isolated as a white solid (51 mg, 76%). Mp 273–
275 °C. 1H NMR (300 MHz, CDCl3): δ = 7.08-7.17 (m, 20H, ArH). 
13C NMR (75.4 MHz, CDCl3): δ = 127.7 (CH), 127.8 (CH), 129.3 (dd, 
J = 13.4, 9.9 Hz, C), 130.9 (CH), 133.5 (C), 152.6 (d, JCF = 243.0, CF) IR (KBr): ν~  = 3085 
(w), 3059 (w), 3024 (w), 2918 (w), 2849 (w), 1953 (w), 1884 (w), 1810 (w), 1764 (w), 1599 
(w), 1578 (w), 1502 (w), 1455 (w), 1438 (w), 401 (m), 1301 (w), 1183 (w), 1162 (w), 1117 
(w), 1081 (w), 1068 (w), 1030 (w), 1000 (w), 966 (w), 924 (w), 907 (w), 870 (m), 854 (w), 
776 (m), 755 (m), 740 (m), 693 (s), 672 (m), 660 (m), 612 (w), 540 (m) cm-1. GC-MS (EI, 70 
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eV); m/z (%) = 418 [M]+, (100), 403 (10). HRMS (EI, 70 eV) calcd. for C30H20F2 [M]+: 
418.15276; found 418.274205. 
 
1,4-Difluoro-2,3,5,6-tetrakis(4-methoxyphenyl)benzene (35b): Starting with 25 (100 mg, 
0.16 mmol), Pd(PPh3)4 (10 mol%), Cs2CO3 (5eq) and 4-
methoxyphenylboronic acid (145 mg, 0.96 mmol), 35b 
was isolated as a white solid (69 mg, 80%). Mp 213–215 
°C. 1H NMR (300 MHz, CDCl3): δ = 3.70 (s, 3H, OCH3), 
6.69 (td, J = 8.7 Hz, 8H, ArH), 7.00 (td, J = 8.7 Hz, 8H, 
ArH). 13C NMR (75.4 MHz, CDCl3): δ = 55.2 (OCH3), 113.3 (CH), 126.0 (C), 128.5 (d, J = 
21.9 Hz, C), 132.1 (CH), 153.3 (d, JCF = 244.4 Hz, CF), 158.6 (C). IR (KBr): ν~  = 3007 (w), 
2958 (w), 2930 (w), 2847 (w), 2836 (w), 1608 (w), 1579 (w), 1518 (w), 1461 (w), 1430 (w), 
1391 (w), 1284 (w), 1246 (m), 1175 (w), 1150 (w), 1110 (w), 1071 (w), 1027 (m), 934 (w), 
875 (w), 847 (w), 822 (m), 787 (w), 775 (w), 734 (w), 702 (w), 677 (w), 638 (w), 593 (w), 
563 (w), 538 (w) cm-1. GC-MS (EI, 70 eV); m/z (%) = 538 (100) [M]+, 281 (10), 231 (12), 
181 (26), 131 (30), 119 (25), 108 (22), 71 (17), 55 (27), 44 (43), 43 (28), 41 (31). HRMS (EI) 
calcd. for C34H28F2O4 [M]+: 538.19502; found 538.194659. 
 
1-Fluoro-2,3,4,5,6-pentakis(4-methylphenyl)benzene (36a): Starting with 27 (100 mg, 0.16 
mmol), Pd(PPh3)4 (10 mol%), Cs2CO3 (5eq) and p-tolylboronic 
acid (130 mg, 0.96 mmol), 36a was isolated as a white solid (54 
mg, 72%). 1H NMR (300 MHz, CDCl3): δ = 2.03 (s, 3H, CH3), 
2.06 (s, 6H, CH3), 2.19 (s, 6H, CH3), 6.52-6.64 (m, 12H, ArH), 
6.88-6.96 (m, 8H, ArH). 13C NMR (75.4 MHz, CDCl3): δ = 21.0 
(CH3), 21.1 (CH3), 21.2 (CH3) 127.5 (d, J = 15.0 Hz, CH), 127.9 
(C), 128.2 (CH), 130.7 (CH), 131.1 (CH), 131.4 (CH), 132.1 (C), 134.4 (C), 134.9 (C), 136.1 
(C), 136.3 (d, J = 2.8 Hz, C), 137.1 (d, J = 18.0 Hz, C), 137.3 (C), 141.7 (d, J = 3.2 Hz,C), 
156.1 (d, J = 257.9 Hz, CF). 19F NMR (282 MHz, CDCl3): δ = -115.87. IR (ATR, cm−1): ν~  = 
3131 (w), 3047 (w), 2991 (w), 2919 (w), 2861 (w), 2730 (w), 1898 (w), 1789 (w), 1613 (w), 
1585 (w), 1517 (w), 1446 (w), 1390 (w), 1319 (w), 1269 (w), 1212 (w), 1182 (w), 1144 (w), 
1095 (w), 1021 (w), 940 (w), 848 (w), 800 (w), 740 (w), 704 (w), 669 (w), 630 (w), 578 (w), 
532 (m). MS (EI, 70 eV); m/z (%) = 546 (74) [M]+, 281 (10), 231 (14), 219 (11), 181 (24), 
169 (21), 131 (31), 119 (28), 83 (12), 69 (100), 57 (22), 55 (20), 44 (72), 43 (31), 41 (23), 40 
(40). HRMS (EI) calcd. for C41H35F1 [M]+: 546.27173; found 546.271731. 
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1-Fluoro-2,3,4,5,6-pentakis(4-methoxyphenyl)benzene (36b): Starting with 27 (100 mg, 
0.16 mmol), Pd(PPh3)4 (10 mol%), Cs2CO3 (5eq) and 4-
methoxyphenylboronic acid (145 mg, 0.96 mmol) 36b 
was isolated as a white solid (67 mg, 78%). Mp 100–102 
°C. 1HNMR (300 MHz, CDCl3): δ = 3.55 (s, 3H, OCH3), 
3.57 (s, 6H, OCH3), 3.67 (s, 6H, OCH3), 6.33-6.40 (m, 
6H, ArH), 6.54-6.66 (m, 10H, ArH), 6.95-6.99 (m, 4H, 
ArH). 13C NMR (75.4 MHz, CDCl3): δ = 54.9 (2OCH3), 55.1 (OCH3), 112.3 (CH), 112.4 
(CH), 113.0 (CH), 127.4 (C), 127.8 (d, J = 16.5 Hz, C), 131.8 (d, J = 2.8 Hz, C), 131.9 (CH), 
132.5 (CH), 132.6 (C), 137.2 (d, J = 3.8 Hz, C), 141.4 (d, J = 3.2 Hz, C),155.0 (d, J = 256.0 
Hz, CF) 156.9 (C), 157.3 (C), 157.9 (C), 158.1 (C), 162.5 (C). 19F NMR (282 MHz, CDCl3): δ 
= -115.84. IR (ATR, cm−1): ν~  = 3034 (w), 2998 (w), 2954 (w), 2932 (w), 2835 (w), 1678 
(w), 1608 (w), 1575 (w), 1514 (w), 1462 (w), 1424 (w), 1394 (w), 1322 (w), 1286 (w), 1241 
(m), 1174 (m), 1108 (w), 1029 (w), 927 (w), 852 (w), 831 (w), 806 (m), 771 (w), 729 (w), 675 
(w), 648 (w), 625 (w), 590 (w), 544 (m). MS (EI, 70 eV): m/z (%) = 626 (100) [M]+, 231 (10), 
181 (18), 169 (16), 131 (25), 119 (22), 69 (81), 44 (34). HRMS (EI) calcd. for C41H35FO5 
[M]+: 626.24630; found 626.246476. Anal. Calcd for C41H35F1O5: C, 78.57. H, 5.63 Found: 
C, 78.59. H, 5.75. 
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Appendix.  Crystal Data and Structure Refinement 
Table 29. Crystal data and structure refinement for 4e 
 
Identification code  4e 
Empirical formula  C24 H15 Cl 
Formula weight  338.81 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  `C c´ 
Space group (Hall) ´C -2yc´ 
Unit cell dimensions a = 24.956(14) Å α. = 90.00. 
b = 4.293(2) Å β = 98.943 
c = 31.007(14) Å γ = 90.00. 
Volume 3282(3) Å3 
Z 8 
Density (calculated) 1.371 Mg/m3 
Absorption coefficient 0.235mm
-1
 
F(000) 1408 
Crystal size 0.46x 0.15x 0.14mm3 
Θ range for data collection 4.82 to 28.00°. 
Index ranges -31≤h≤32, -5≤k≤5, -40≤l≤40 
Reflections collected 26598 
Independent reflections 7784 [R(int) = 0.0453] 
Completeness to Θ = 29.00° 99.6% 
Absorption correction 0.89997-0.9679 
Max. and min. transmission 0.900 and 0.968 
Refinement method Hydrogen site location: infrared from 
neighbouring sites  
Data / restraints / parameters 5781 / 2 / 451 
Goodness-of-fit on F2 1.000 
Final R indices [I>2σ(I)] R1 = 0.0403, wR2 = 0.0892 
R indices (all data) R1 = 0.0673, wR2 = 0.0976 
Largest diff. Peak and hole 0.207 and -0.221 e.Å-3 
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Table 30. Crystal data and structure refinement for 4i 
Identification code  4i 
Empirical formula  C26 H18 O2 
Formula weight  362.40 
Temperature  173 (2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  ´P 21´ 
Space group (Hall)  ´P 2yb 
Unit cell dimensions a = 9.717(18) Å α = 90.00. 
b = 6.861(14) Å β = 95.15 
c = 13.69(3) Å γ = 90.00. 
Volume 909 (4) Å3 
Z 2 
Density (calculated) 1.324 Mg/m3 
Absorption coefficient 0.08mm
-1
 
F(000) 380 
Crystal size 0.99x 0.21x 0.04mm3 
Θ range for data collection 4.21 to 30.00°. 
Index ranges -13≤h≤13, -9≤k≤4, -19≤l≤19 
Reflections collected 10297 
Independent reflections 3682 [R(int) = 0.0364] 
Completeness to Θ = 29.00° 99.3% 
Max. and min. transmission 0.9227 and 0.9967 
Refinement method Hydrogen site location: infrared from 
neighbouring sites 
Data / restraints / parameters 3128 / 1 / 255 
Goodness-of-fit on F2 1.078 
Final R indices [I>2σ(I)] R1 = 0.0406, wR2 = 0.0989 
R indices (all data) R1 = 0.0522, wR2 = 0.10944 
Largest diff. Peak and hole 0.300 and -0.221 e.Å-3 
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Table 31. Crystal data and structure refinement for 10f 
 
Identification code  10f 
Empirical formula  C14H11 Br F2 O2 
Formula weight  329.14 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  ´P -1´ 
Space group (Hall)  ´ -P 1´ 
Unit cell dimensions a = 8.304 (5) Å α = 86.185 
b = 8.382 (5) Å β = 82.352 
c = 9.533 (5) Å γ = 80.395 
Volume 647.7 (6) Å3 
Z 2 
Density (calculated) 1.688 Mg/m3 
Absorption coefficient 3.19 mm
-1
 
F(000) 328 
Crystal size 0.67x 0.37x 0.16 mm3 
Θ range for data collection 2.16 to 30.12°. 
Index ranges -11≤h≤11, -11≤k≤9, -13≤l≤13 
Reflections collected 13433 
Independent reflections 3769 [R(int) = 0.0214] 
Completeness to Θ = 29.00° 98.7% 
Max. and min. transmission 0.224 and 0.629 
Refinement method Secondary atom site location: Difference Fourier  
map 
Data / restraints / parameters 3446 / 0 / 174 
Goodness-of-fit on F2 1.047 
Final R indices [I>2σ(I)] R1 = 0.0254, wR2 = 0.0683 
R indices (all data) R1 = 0.0299, wR2 = 0.0701 
Largest diff. Peak and hole 0.973 and -0.374 e.Å-3 
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Table 32. Crystal data and structure refinement for 14f 
 
Identification code  14f 
Empirical formula  C16H16BrF 
Formula weight  307.20 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  ´ p b c a´ 
Space group (Hall)  -P 2ac 2ab 
Unit cell dimensions a = 18.472(5) Å α = 90.000(5)° 
 b = 6.058(5) Å β = 90.00(5)° 
 c = 24.298(5) Å γ = 90.00(14)°. 
Volume 2719(2) Å3 
Z 8 
Density (calculated) 1.501 Mg/m3 
Absorption coefficient 3.014 mm-1 
F(000) 1248 
Crystal size 0.99 x 0.65 x 0.20 mm3 
Θ range for data collection 2.20 to 28.00°. 
Index ranges -24≤h≤24, -4≤k≤8, -32≤l≤32 
Reflections collected 24785 
Independent reflections 3270 [R(int) = 0.0522] 
Completeness to Θ = 29.00° 99.9%  
Absorption correction ´multi-scan´ 
Max. and min. transmission 0.1543 and 0.5839 
Data / restraints / parameters 2573 / 0 / 166 
Goodness-of-fit on F2 1.090 
Final R indices [I>2σ(I)] R1 = 0.0548, wR2 = 0.1131 
R indices (all data) R1 = 0.0782, wR2 = 0.1212 
Largest diff. peak and hole 0.935 and -0.507 e.Å-3 
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Table 33. Crystal data and structure refinement for 13c 
 
Identification code  13c 
Empirical formula  C22H20FO2 
Formula weight  335.38 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  triclinic 
Space group (H.-M.)  ´ P -1´ 
Space group (Hall) ´ -P 1´ 
Unit cell dimensions a = 7.1559 (7) Å α = 78.858 
 b = 7.7609 (8) Å β = 85.856 
 c = 15.8149 (6) Å γ = 82.055 
Volume 852.54 (14) Å3 
Z 2 
Density (calculated) 1.306 Mg/m3 
Absorption coefficient   11.53mm
-1  
 
F(000) 354 
Crystal size 0.70x 0.22x 0.02 mm3 
Θ range for data collection 3.22 to 28.99°. 
Index ranges -9≤h≤9, -10≤k≤10, -21≤l≤21 
Reflections collected 16675 
Independent reflections 4501 [R(int) = 0.0496] 
Completeness to Θ = 29.00° 99.1% 
Absorption correction  multi-scan 
Max. and min. transmission 0.9399 and 0.9982 
Data / restraints / parameters 2836 / 0 / 255 
Goodness-of-fit on F2 1.011 
Final R indices [I>2σ(I)] R1 = 0.0495, wR2 = 0.1258 
R indices (all data) R1 = 0.0906, wR2 = 0.1390 
Largest diff. Peak and hole 0.363 and -0.221 e.Å-3 
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Table 34. Crystal data and structure refinement for 17b 
 
Identification code  17b 
Empirical formula  C20H17 F 
Formula weight  276.34 
Temperature  150  K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P2 (1)/C 
Unit cell dimensions a = 7.0936 (3) Å α = 90.00. 
b = 11.7294 (3) Å β = 96.539 
c = 17.3372 (7) Å γ = 90.00 
Volume 1433.13 (9) Å3 
Z 4 
Density (calculated) 1.281 Mg/m3 
Absorption coefficient 0.08 mm
-1
 
F(000) 584 
Crystal size 0.48x 0.28x 0.26 mm3 
Θ range for data collection 2.1 to 29.7°. 
Index ranges -9≤h≤9, -16≤k≤16, -23≤l≤23 
Reflections collected 27058 
Independent reflections 3871 [R(int) = 0.034] 
Completeness to Θ = 29.00° 99.7% 
Refinement method Hydrogen site location: infrared from 
neighbouring sites 
Data / restraints / parameters 2795 / 0 / 192 
Goodness-of-fit on F2 0.963 
Final R indices [I>2σ(I)] R1 = 0.0363, wR2 = 0.0928 
R indices (all data) R1 = 0.0548, wR2 = 0.0968 
Largest diff. Peak and hole 0.238 and -0.175 e.Å-3 
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Table 35. Crystal data and structure refinement for 24 
 
Identification code     24 
Empirical formula  C5I4 F2 
Formula weight  617.66 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  tetragonal 
Space group (H.-M.)    P -41/a 
Space group (Hall) ´ -1 4ad´ 
Unit cell dimensions a = 21.0421 (8) Å α = 90.0000 
 b = 21.0421 (8) Å β = 90.0000 
 c = 9.7438 (6) Å γ = 90.0000 
Volume 4314.3 (3) Å3 
Z 16 
Density (calculated) 3.804 Mg/m3 
Absorption coefficient     11.53 mm
-1  
 
F(000)  4256 
Crystal size 0.37x 0.25x 0.21 mm3 
Θ range for data collection 5.476 to 65.284°. 
Index ranges -30≤h≤31, -30≤k≤31, -14≤l≤12 
Reflections collected 18097 
Independent reflections 3864 [R(int) = 0.0266] 
Completeness to Θ = 29.00° 99.0% 
Absorption correction  numerical 
Max. and min. transmission 0.1000 and 0.1957 
Data / restraints / parameters 3583 / 0 / 110 
Goodness-of-fit on F2 1.122 
Final R indices [I>2σ(I)] R1 = 0.0213, wR2 = 0.0423 
R indices (all data) R1 = 0.0247, wR2 = 0.0431 
Largest diff. Peak and hole 0.902 and -0.931 e.Å-3 
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Table 36. Crystal data and structure refinement for 26 
 
Identification code     26 
Empirical formula  C6I4 F2 
Formula weight  617.66 
Temperature  150 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P2 (1) 
Unit cell dimensions a = 8.9948 (8) Å α = 90.00 
b = 4.3318 (3) Å β = 101.428 
c = 13.7958 (12) Å γ = 90.00. 
Volume 526.88 (8) Å3 
Z 2 
Density (calculated) 3.893 Mg/m3 
Absorption coefficient 11.80mm
-1
 
F(000) 532 
Crystal size 0.40x 0.13x 0.06 mm3 
Θ range for data collection 1.5 to 27.2°. 
Index ranges -11≤h≤11, -5≤k≤5, -17≤l≤17 
Reflections collected 8124 
Independent reflections 2238 [R(int) = 0.0777] 
Completeness to Θ = 29.00° 99.9% 
Absorption correction k = -5to 5 
Max. and min. transmission 0.069 and 0.6407 
Refinement method Secondary atom site location: Difference Fourier 
 map 
Data / restraints / parameters 2147 / 1 / 109 
Goodness-of-fit on F2 1.062 
Final R indices [I>2σ(I)] R1 = 0.0395, wR2 = 0.1011 
R indices (all data) R1 = 0.0415, wR2 = 0.1029 
Largest diff. Peak and hole 1.839 and -1.793 e.Å-3 
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Table 37. Crystal data and structure refinement for 28 
 
Identification code     28 
Empirical formula  C6I4 F2 
Formula weight  617.66 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P 21/n 
Space group (Hall) ´ -P 2yn 
Unit cell dimensions a = 7.7983 (5) Å α = 90.00 
 b = 5.2394 (3) Å β = 101.625 
 c = 13.2812 (7) Å γ = 90.00. 
Volume 531.52 (6) Å3 
Z 2 
Density (calculated) 3.859 Mg/m3 
Absorption coefficient  11.699 mm
-1  
 
F(000) 532 
Crystal size 0.22x 0.20x 0.10 mm3 
Θ range for data collection 3.13 to 29.00°. 
Index ranges -10≤h≤10, -7≤k≤6, -18≤l≤16 
Reflections collected 4913 
Independent reflections 1388 [R(int) = 0.0212] 
Completeness to Θ = 29.00° 98.4% 
Absorption correction multi-scan 
Max. and min. transmission 0.1828 and 0.3875 
Data / restraints / parameters 1286 / 0 / 55 
Goodness-of-fit on F2 1.0099 
Final R indices [I>2σ(I)] R1 = 0.0166, wR2 = 0.0358 
R indices (all data) R1 = 0.0192, wR2 = 0.0363 
Largest diff. Peak and hole 0.534 and -0.775 e.Å-3 
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Table 38. Crystal data and structure refinement for 30 
 
Identification code     30 
Empirical formula  C5I5 F 
Formula weight  725.56 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)   ´P -1´ 
Space group (Hall) ´ -P 1´ 
Unit cell dimensions a = 8.5263 (3) Å α = 96.8430 
 b = 9.0042 (3) Å β = 105.5000 
 c = 15.9132 (6) Å γ = 90.0580 
Volume 1168.19 (7) Å3 
Z 4 
Density (calculated) 4.125 Mg/m3 
Absorption coefficient   13.275 mm
-1  
 
F(000)  1240 
Crystal size 0.28x 0.04x 0.04 mm3 
Θ range for data collection 1.34 to 30.06°. 
Index ranges -12≤h≤11, -12≤k≤12, -22≤l≤22 
Reflections collected 24078 
Independent reflections 6734 [R(int) = 0.0252] 
Completeness to Θ = 29.00° 98.5% 
Absorption correction multi-scan 
Max. and min. transmission 0.1186 and 0.6188 
Data / restraints / parameters 5518 / 0 / 218 
Goodness-of-fit on F2 1.011 
Final R indices [I>2σ(I)] R1 = 0.0229, wR2 = 0.0382 
R indices (all data) R1 = 0.0361, wR2 = 0.0404 
Largest diff. Peak and hole 1.075 and -0.977 e.Å-3 
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Table 39. Crystal data and structure refinement for 38a 
 
Identification code     38a 
Empirical formula  C41H35 F1 
Formula weight  546.47 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P-1 
Unit cell dimensions a = 10.9740 (5) Å α = 91.08 
 b = 12.4164 (7) Å β = 104.89 
 c = 13.7056 (7) Å γ = 105.28. 
Volume 1733.43 (15) Å3 
Z 2 
Density (calculated) 1.121 Mg/m3 
Absorption coefficient 0.067mm
-1
 
F(000) 623 
Crystal size 0.40x 0.32x 0.16 mm3 
Θ range for data collection 2.0 to 27.50°. 
Index ranges -14≤h≤14, -15≤k≤16, -17≤l≤17 
Reflections collected 28842 
Independent reflections 7979 [R(int) = 0.0607] 
Completeness to Θ = 29.00° 100.0% 
Absorption correction numerical 
Max. and min. transmission 0.9407 and 0.9893 
Data / restraints / parameters 3937 / 14 / 416 
Goodness-of-fit on F2 0.819 
Final R indices [I>2σ(I)] R1 = 0.0532, wR2 = 0.1306 
R indices (all data) R1 = 0.1133, wR2 = 0.1438 
Largest diff. Peak and hole 0.500 and -0.250 e.Å-3 
 
 
 
147 
 
Abbreviations 
 
Ac  Acetyl  
Anal  Elemental Analysis  
bp  Boiling point  
calcd  Calculated  
CI  Chemical Ionization  
COSY  Correlated Spectroscopy  
DEPT  Distortionless Enhancement by Polarization Transfer  
dr  Diastereomeric ratio  
ee  Enantiomeric excess  
EI  Electron Impact   
Et2O  Diethyl ether  
EtOH  Ethanol  
GC  Gas Chromatography  
GP  General Procedure  
HMBC Heteronuclear Multiple Bond Correlation  
HPLC  High Performance Liquid Chromatography  
HRMS  High Resolution Mass Spectrometry  
IR  Infrared Spectroscopy  
MS  Mass Spectrometry  
mp  Melting point  
NaOEt  Sodium ethanolate  
nBuLi  n-Butyllithium  
NEt3  Triethylamine  
NMR  Nuclear Magnetic Resonance  
NOESY Nuclear Overhauser and Exchange Spectroscopy 
ORTEP Oak Ridge Thermal Ellipsoid Plot   
OTf  Triflate  
Ph  Phenyl  
ppm  Parts per million  
Rf  Retention factor  
Tf2O  Trifluoromethanesulfonic anhydride (triflic anhydride) 
TFA  Trifluoroacetic acid  
THF  Tetrahydrofuran  
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TLC  Thin Layer Chromatography  
TMS   Tetramethylsilane  
Tol  Tolyl (p-MeC6H4)  
Tos  Tosyl (p-MeC6H4SO2  
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